Your 2021 Prescription Drug List - UHC

56
Pharmacy | PDL Your 2021 Prescription Drug List Traditional 4-Tier Effective September 1, 2021 This Prescription Drug List (PDL) is accurate as of September 1, 2021 and is subject to change after this date. This PDL applies to members of our UnitedHealthcare and Student Resources medical plans with a pharmacy benefit subject to the Traditional 4-Tier PDL. Your estimated coverage and copayment/coinsurance may vary based on the benefit plan you choose and the effective date of the plan.

Transcript of Your 2021 Prescription Drug List - UHC

Pharmacy | PDL

Your 2021 Prescription Drug List

Traditional 4-TierEffective September 1, 2021

This Prescription Drug List (PDL) is accurate as of September 1, 2021 and is subject to change after this date. This PDL applies to members of our UnitedHealthcare and Student Resources medical plans with a pharmacy benefit subject to the Traditional 4-Tier PDL. Your estimated coverage and copayment/coinsurance may vary based on the benefit plan you choose and the effective date of the plan.

Table of contentsUnderstanding your Prescription Drug List (PDL) . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4Medication tips . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5Reading your PDL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6Questions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7Analgesics

Drugs for Pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Drugs for Pain and Inflammation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9

Anti-Addiction / Substance Abuse Treatment Agents . . . . . . . . . . . . . . . . . . . . . . . . . 9Antibacterials

Drugs for Infections . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10Anticoagulants

Drugs to Treat or Prevent Blood Clots . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11Anticonvulsants

Drugs for Seizures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11Antidementia Agents

Drugs for Alzheimer’s Disease and Dementia . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12Antidepressants

Drugs for Depression . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12Antiemetics

Drugs for Nausea and Vomiting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12Antifungals

Drugs for Fungal Infections . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13Antigout Agents

Drugs for Gout . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13Antimigraine Agents

Drugs for Migraines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13Antineoplastics

Drugs for Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14Antiparasitics

Drugs for Parasitic Infections . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4Antiparkinson Agents

Drugs for Parkinson’s Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14Antiplatelets

Drugs for Heart Attack and Stroke Prevention . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14Antipsychotics

Drugs for Mood Disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14Antivirals

Drugs for Viral Infections . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15Anxiolytics

Drugs for Anxiety . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15Bipolar Agents

Drugs for Mood Disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16Cardiovascular Agents

Drugs for Heart and Circulation Conditions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16Central Nervous System Agents

Drugs for Attention Deficit Disorder . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18 Drugs for Multiple Sclerosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19 Miscellaneous . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19

Dental and Oral Agents Drugs for Mouth and Throat Conditions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19

2

Dermatological Agents Drugs for Skin Conditions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20

Diabetes Glucose Monitoring . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 Insulin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23 Non-Insulin Agents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23

Drugs for Blood Disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24Drugs for Sexual Dysfunction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25Electrolytes / Vitamins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25Gastrointestinal Agents

Drugs for Acid Reflux and Ulcer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25 Drugs for Bowel, Intestine and Stomach Conditions . . . . . . . . . . . . . . . . . . . . . . . 26

Genetic or Enzyme Disorder Drugs for Replacement, Modification, Treatment . . . . . . . . . . . . . . . . . . . . . . . . . 26

Genitourinary Agents Drugs for Bladder, Genital and Kidney Conditions. . . . . . . . . . . . . . . . . . . . . . . . . 26 Drugs for Prostate Conditions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27

Hormonal Agents Hormone Replacement and Birth Control . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27 Oral Steroids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30 Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30 Testosterone Replacement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31 Thyroid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31

Immunological Agents Drugs for Immune System Stimulation or Suppression . . . . . . . . . . . . . . . . . . . . . 31

Infertility Agents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32Inflammatory Bowel Disease Agents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32Metabolic Bone Disease Agents

Drugs for Osteoporosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33Ophthalmic Agents

Drugs for Eye Allergy, Infection and Inflammation . . . . . . . . . . . . . . . . . . . . . . . . . 33 Drugs for Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34 Drugs for Miscellaneous Eye Conditions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34

Otic Agents Drugs for Ear Conditions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34

Respiratory Drugs for Anaphylaxis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34

Respiratory Tract / Pulmonary Agents Drugs for Allergies, Cough, Cold . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34 Drugs for Asthma and COPD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35 Drugs for Cystic Fibrosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36 Drugs for Pulmonary Hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36

Skeletal Muscle Relaxants Drugs for Muscle Pain and Spasm. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36

Sleep Disorder Agents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37

3

Understanding your Prescription Drug List (PDL)

What is a PDL?This document is a list of the most commonly prescribed medications. It includes About this PDLboth brand-name and generic prescription medications approved by the Food and Where differences exist between Drug Administration (FDA). Medications are listed by common categories or classes this PDL and your benefit plan and placed in tiers that represent the cost you pay out-of-pocket. They are then documents, the benefit plan listed in alphabetical order. documents rule. This PDL is not

a complete list of medications, How do I use my PDL? and not all medications listed

may be covered by your plan. You and your doctor can consult the PDL to help you select the most cost-effective Please look at the benefit plan prescription medications. This guide tells you if a medication is generic or brand documents provided by your name, and if there are coverage requirements or limits. Bring this list with you when employer or health plan to see you see your doctor. If your medication is not listed here, please visit your plan’s which medications are covered member website or call the toll-free member phone number on your health plan under your plan.ID card.

What are tiers?Tiers are the different cost levels you pay for a medication. Each tier is assigned a cost, set by your employer or benefit plan. This is how much you will pay when you fill a prescription. See page 6 for more information.

When does the PDL change?PDL changes typically occur 2-3 times per year. However, changes that have a positive impact for you — such as coverage for new medications or cost savings — may occur at any time. You can log in to the member website listed on your ID card at any time to check your medication coverage and lower-cost options.

Why are some medications excluded from coverage?We review medications based on their total value, including effectiveness and safety, how much they cost, and the availability of alternative medications to treat the same or similar medical conditions. Certain medications may be excluded from coverage or be subject to prior authorization (sometimes referred to as precertification) if similar alternatives are available at a lower cost. Examples include medications that work the same way, but one is much more expensive than the other, or options that are available without a prescription (also referred to as over-the-counter medications). There are also some instances where the same product can be made by 2 or more manufacturers, but greatly vary in cost. In these instances, only the lower-cost product may be covered.

You should review your benefit plan documents to confirm if any medications are excluded from your plan. You can log in to the member website listed on your ID card at any time to check your medication coverage. Talk to your doctor to see if there are lower-cost options or over-the-counter medications available.

Who decides which medications are covered?Thousands of medications are already available and more come to the market regularly. Often, several medications are available

®to treat the same condition. The UnitedHealthcare Pharmacy and Therapeutics Committee, which includes both internal and external doctors and pharmacists, meets regularly to provide clinical reviews of all medications. Using this information, the PDL

®Management Committee, which includes senior UnitedHealth Group doctors and business leaders, meets to evaluate overall health care value. They also set coverage and tier status for all medications.

4

Medication tips

What is the difference between brand-name and Over-the-counter generic medications?(OTC) medicationsGeneric medications contain the same active ingredients (what makes the An OTC medication may be medication work) as brand-name medications, but they often cost less. Once the the right treatment option for patent for a brand-name medication ends, the FDA can approve a generic version some conditions. Talk to your with the same active ingredients. These types of medications are known as generic doctor about available OTC medications. Sometimes, the same company that makes a brand-name medication options. Even though these also makes the generic version.medications may not be covered by your pharmacy benefit, What if my doctor writes a brand-name prescription?they may cost less than a

If your doctor gives you a prescription for a brand-name medication, ask if a generic prescription medication.equivalent or lower-cost option is available and could be right for you. Generic medications are usually your lowest-cost option, but not always. For some benefit plans, if a brand-name drug is prescribed and a generic equal is available, your cost-share may be the copayment PLUS the cost difference between the brand-name drug and the generic equivalent.

What if I am taking a specialty medication?Specialty medications are high-cost and are used to treat rare or complex conditions that require additional care and support. For most plans, these medications are managed through the specialty pharmacy program. Take advantage of personalized support designed to help you get the most out of your treatment plan. Visit the member website listed on your ID card or call the toll-free phone number on your ID card to learn more.

Please note, not all specialty medications are listed here. If you’re taking a specialty medication that is on a higher tier, call the toll-free phone number on your ID card to talk with a pharmacist about finding lower-cost options.

5

Reading your PDLThe PDL gives you choices so you and your doctor can decide your best course of treatment. In this PDL, brand-name medications are shown in UPPERCASE and generic medications in lowercase.

Tier informationUsing lower-tier medications can help you pay your lowest out-of-pocket cost. Your plan may have multiple or no tiers. Please note: If you have a high deductible plan, the tier cost levels may apply once you hit your deductible.

In the chart below, overall value indicates medications’ effectiveness and safety, cost and the availability of alternative medications to treat the same or similar medical condition(s).

Drug Tier Includes Helpful Tips

Tier 1 $ Lower-cost Use Tier 1 drugs for the Medications that provide the highest overall value. Mostly generic lowest out-of-pocket costs.drugs. Some brand-name drugs may also be included.

Tiers Use Tier 2 or Tier 3 drugs, $$ Mid-range cost 2 and 3 instead of Tier 4, to help reduce your Medications that provide good overall value. Mainly preferred

out-of-pocket costs.brand- name drugs.

Tier 4 Many Tier 4 drugs have lower-cost $$$ Highest-cost options in Tiers 1, 2 or 3. Ask your Medications that provide the lowest overall value. doctor if they could work for you.

Drug list informationIn this drug list, some medications are noted with letters next to them to help you see which ones may have coverage requirements or limits. Your benefit plan sets how these medications may be covered for you.

E May be excluded from coverage or subject to Prior Authorization in Connecticut, New Jersey and New York. (Referred to as First Start in New Jersey) — Lower-cost options are available and covered.

H Health Care Reform Preventive — This medication is part of a health care reform preventive benefit and may be available at no additional cost to you.

H-PA Health Care Reform Preventive with Prior Authorization — May be part of health care reform preventive and available at no additional cost to you if prior authorization criteria is met.

PA Prior Authorization (sometimes referred to as precertification) — Requires your doctor to provide information 1about why you are taking a medication to determine how it may be covered by your plan.

QL Quantity Limits — Specifies the largest quantity of medication covered per copayment or in a defined period of time.

2RS Refill and Save Program — Save money on your copayment when you refill your prescription on time as prescribed. Program eligibility may vary.

SP Specialty Medication — Specialty medications treat complex or rare conditions and may require special storage and handling. You may be required to obtain these medications from a specialty pharmacy.

ST Step Therapy (referred to as First Start in New Jersey) — Requires prior authorization and may require you to 3try one or more other medications before the medication you are requesting may be covered.

1. For certain Student Resources plans, applies to specialty medications and topical retinoids only.2. Not applicable to Student Resources plans.

3. Not applicable to certain Student Resources plans.

6

Reading your PDL (continued)

Coverage detailsSome drug classes in this PDL have additional/important coverage details. Review this list to see if drug classes that apply to you are noted.

• Diabetes: continuous glucose monitors, sensors Coverage is set by the consumer’s prescription drug benefit plan. Please consult plan documents regarding benefit coverage and cost-share. Diabetic self-management items, including continuous glucose monitors, may be covered under the consumer pharmacy and/or medical plan depending on the benefit.

• Infertility Coverage is set by the consumer’s prescription drug benefit plan. Please consult plan documents regarding benefit coverage and cost-share.

• Medications for sexual dysfunction Coverage is set by the consumer’s prescription drug benefit plan. Please consult plan documents regarding benefit coverage and cost-share.

Questions

For the most current list of covered medications or if you have questions:

Call the toll-free member phone number on your ID card.

And, if home delivery services are included in your pharmacy

Visit your plan’s member website listed on your ID card to: benefit, you can also:

• View your pharmacy benefit and coverage information, • Refill prescriptionsincluding prescription history • Check the status of your order

• View medication interactions and side effects • Set up reminders for refills• Locate a participating retail pharmacy by ZIP code • Manage your account• Look up possible lower-cost medication alternatives

• Compare medication pricing and options

7

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

g lidocaine external ointment 5 % 1 QLAnalgesics - Drugs for Paingg acetaminophen-codeine 1 lidocaine external patch 5 % 1 PA, QL

g gacetaminophen-codeine #2 1 lidocaine-prilocaine external cream 1g B LIDODERM E PA, QLacetaminophen-codeine #3 1

Bg acetaminophen-codeine #4 1 LORTAB 4g gapap-caff-dihydrocodeine 1 QL morphine sulfate (concentrate) oral 1

solution 100 mg/5ml, 20 mg/mlg bac 1 QLg morphine sulfate er oral capsule E PA, ST, QLB BELBUCA 3 PA, QL

extended release 24 hourg butalbital-apap-caffeine 1 QL

g morphine sulfate er oral tablet 1 PA, QLB CONZIP E QL extended releaseB DILAUDID ORAL 4 g morphine sulfate oral 1B DURAGESIC-100 E PA, ST, QL g morphine sulfate rectal 1B DURAGESIC-12 E PA, ST, QL B MS CONTIN 3 PA, ST, QLB DURAGESIC-25 E PA, ST, QL B NALOCET E QLB DURAGESIC-50 E PA, ST, QL B NUCYNTA 4 QLB DURAGESIC-75 E PA, ST, QL B NUCYNTA ER 3 PA, QLg endocet 1 B OXAYDO E QLB ESGIC 4 QL B OXYCODONE HCL ER E PA, ST, QLg fentanyl transdermal patch 72 hour 1 PA, QL g oxycodone hcl oral capsule 1

100 mcg/hr, 12 mcg/hr, 25 mcg/hr, g oxycodone hcl oral concentrate 150 mcg/hr, 75 mcg/hr

100 mg/5mlg fentanyl transdermal patch 72 hour E PA, ST, QL

g oxycodone hcl oral solution 137.5 mcg/hr, 62.5 mcg/hr, g87.5 mcg/hr oxycodone hcl oral tablet 10 mg, 1

15 mg, 20 mg, 30 mgB FIORICET 4 QLg oxycodone hcl oral tablet 5 mg 1 QLg hydrocodone bitartrate er oral 1 PA, ST, QLBcapsule extended release 12 hour OXYCODONE-ACETAMINOPHEN E

ORAL SOLUTIONg hydrocodone bitartrate er oral E PA, ST, QLBtablet er 24 hour abuse-deterrent OXYCODONE-ACETAMINOPHEN E

ORAL TABLET 10-300 MG, g hydrocodone-acetaminophen oral 15-300 MGsolution 10-325 mg/15ml,

g7.5-325 mg/15ml oxycodone-acetaminophen oral 1tablet 10-325 mg, 2.5-325 mg, g hydrocodone-acetaminophen oral E5-325 mg, 7.5-325 mgtablet 10-300 mg, 5-300 mg,

B OXYCODONE-ACETAMINOPHEN E QL7.5-300 mgORAL TABLET 2.5-300 MGg hydrocodone-acetaminophen oral 1

Btablet 10-325 mg, 5-325 mg, OXYCONTIN E PA, ST, QL7.5-325 mg B PERCOCET E

g hydromorphone hcl er 1 PA, ST, QL g premium lidocaine 1 QLg hydromorphone hcl oral 1 B PROLATE Eg hydromorphone hcl rectal 1 B QDOLO E PA, QLB HYSINGLA ER E PA, ST, QL

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

88

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

B gROXICODONE ORAL TABLET E indomethacin oral capsule 25 mg, 115 MG, 30 MG 50 mg

B BROXICODONE ORAL TABLET E QL KETOROLAC TROMETHAMINE 4 ST, QL5 MG NASAL

B gSUBSYS E PA, QL ketorolac tromethamine oral 1g Btramadol hcl er 1 (generic for LODINE E

Ultram ER), QL g meloxicam oral capsule E QLg tramadol hcl er (biphasic) E (generic for g meloxicam oral tablet 1

Ryzolt), QLB MOBIC 4

g tramadol hcl oral tablet 100 mg E g nabumetone oral 1

g tramadol hcl oral tablet 50 mg 1B NAPRELAN E

B TREZIX 1 QLB NAPROSYN ORAL SUSPENSION E PA

B ULTRAM EB NAPROSYN ORAL TABLET E

B VTOL LQ 2 PA, QLg naproxen oral suspension 1 PA

B XTAMPZA ER 2 PA, QLg naproxen oral tablet 1

B ZEBUTAL 4 QLg naproxen oral tablet delayed 1

B ZOHYDRO ER E PA, ST, QL releaseB ZTLIDO E PA, QL g naproxen sodium er oral tablet E

Analgesics - Drugs for Pain and Inflammation extended release 24 hour 375 mg, 500 mgB CATAFLAM E

B NAPROXEN SODIUM ER ORAL EB CELEBREX E QLTABLET EXTENDED RELEASE

g celecoxib oral 1 QL 24 HOUR 750 MGg diclofenac potassium 1 g naproxen sodium oral tablet 1g diclofenac sodium er 1 275 mg, 550 mgg Bdiclofenac sodium external gel 1 % E PENNSAID Eg Bdiclofenac sodium external solution E QMIIZ ODT Eg Bdiclofenac sodium oral 1 RELAFEN EB BEC-NAPROSYN ORAL TABLET 3 RELAFEN DS E

DELAYED RELEASE 375 MG B SPRIX 4 ST, QLB EC-NAPROSYN ORAL TABLET 4 B TIVORBEX E

DELAYED RELEASE 500 MGB VIVLODEX E QL

g ec-naproxen 1B VOLTAREN E

g etodolac 1B ZIPSOR E

g etodolac er 1Anti-Addiction / Substance Abuse Treatment Agents

g ibuprofen 1B BUNAVAIL E PA, QL

g ibuprofen oral suspension Eg buprenorphine hcl sublingual 1 QL

B INDOCIN 3g buprenorphine hcl-naloxone hcl 1 QL

g indomethacin er 1B CHANTIX 4 PA, H

B INDOMETHACIN ORAL CAPSULE EB CHANTIX CONTINUING MONTH 4 PA, H20 MG

PAK

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

99

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

B gCHANTIX STARTING MONTH PAK 4 PA, H doxycycline hyclate oral tablet E150 mg, 50 mg, 75 mgg naloxone hcl injection 1

g doxycycline hyclate oral tablet Eg naltrexone hcl oral 1delayed release 100 mg, 150 mg,

B NARCAN 2 QL 200 mg, 50 mg, 75 mgB SUBOXONE E PA, QL B DOXYCYCLINE HYCLATE ORAL EB ZUBSOLV 1 QL TABLET DELAYED RELEASE

80 MGAntibacterials - Drugs for Infectionsg doxycycline monohydrate oral 1B ACTICLATE E

capsule 100 mg, 50 mgg amoxicillin 1

g doxycycline monohydrate oral Eg amoxicillin-potassium clavulanate er E capsule 150 mg, 75 mgg amoxicillin-potassium clavulanate 1 g doxycycline monohydrate oral 1

oral suspension reconstitutedB AUGMENTIN E g doxycycline monohydrate oral 1B AUGMENTIN ES-600 E tabletg avidoxy 1 B FLAGYL 4g Bazithromycin oral 1 KEFLEX 4B BACTRIM 4 g levofloxacin oral 1B BACTRIM DS 4 g metronidazole oral 1g gcefadroxil 1 metronidazole vaginal 1g cefdinir 1 B MINOCYCLINE HCL ER ORAL E PAg CAPSULE EXTENDED RELEASE cefuroxime axetil 1

24 HOURB CENTANY 4 QLg minocycline hcl er oral tablet E PAB CENTANY AT E

extended release 24 hour 105 mg, g cephalexin 1 115 mg, 55 mg, 65 mg, 80 mgB CIPRO ORAL TABLET 4 g minocycline hcl er oral tablet E PAg extended release 24 hour 135 mg, ciprofloxacin hcl oral 1

45 mg, 90 mgg clarithromycin er 1g minocycline hcl oral capsule 1g clarithromycin oral 1g minocycline hcl oral tablet EB CLEOCIN ORAL CAPSULE 4B MINOLIRA E PA150 MG, 300 MGgB mondoxyne nl oral capsule 100 mg 1CLEOCIN ORAL CAPSULE 75 MG 2gg mondoxyne nl oral capsule 75 mg Eclindamycin hcl oral 1gB morgidox oral 1CLINDESSE 2gg mupirocin calcium 1 QLcoremino E PAgB mupirocin external 1 QLDIFICID 3 QLBB NUZYRA ORAL 4 QLDORYX EgB penicillin v potassium 1DORYX MPC EBg SOLODYN E PAdoxycycline hyclate oral capsule 1gg sulfamethoxazole-trimethoprim oral 1doxycycline hyclate oral tablet 1

100 mg, 20 mg

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

1010

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

g Bsulfatrim pediatric 1 KEPPRA XR 4 PA, STB BTARGADOX E LAMICTAL 4 PA, STg Bvandazole 1 LAMICTAL ODT ORAL KIT 21 X 3 PA, ST

25 MG & 7 X 50 MG, 42 X 50 MG & B VIBRAMYCIN ORAL CAPSULE 414X100 MG

B VIBRAMYCIN ORAL SUSPENSION 4B LAMICTAL ODT ORAL KIT 25 & 50 4 PA, STRECONSTITUTED

& 100 MGB XENLETA ORAL 3

B LAMICTAL ODT ORAL TABLET 4 PA, STB XEPI 3 QL DISPERSIBLEB XIMINO E PA B LAMICTAL STARTER 4 PA, STB ZITHROMAX ORAL 4 B LAMICTAL XR 3 PA, STB ZITHROMAX TRI-PAK 4 g lamotrigine er 1 PA, STB ZITHROMAX Z-PAK 4 g lamotrigine oral kit 1 PA, ST

Anticoagulants - Drugs to Treat or Prevent Blood Clots g lamotrigine oral tablet 1B ELIQUIS 2 QL g lamotrigine oral tablet chewable 1B ELIQUIS DVT/PE STARTER PACK 2 QL g lamotrigine oral tablet dispersible 1 PA, STg enoxaparin sodium 1 QL g lamotrigine starter kit-blue 1g jantoven 1 g lamotrigine starter kit-green 1B LOVENOX E QL g lamotrigine starter kit-orange 1B PRADAXA 2 QL g levetiracetam er 1g warfarin sodium oral 1 g levetiracetam oral 1B XARELTO 2 QL B NAYZILAM 3 PA, QLB XARELTO STARTER PACK 2 QL B NEURONTIN 4 PA, ST

Anticonvulsants - Drugs for Seizures g oxcarbazepine 1g carbamazepine er 1 B OXTELLAR XR E PA, STg carbamazepine oral 1 B QUDEXY XR E PA, STB CARBATROL 4 g roweepra 1B DEPAKOTE 4 PA B SPRITAM E PA, STB DEPAKOTE ER 4 PA, ST g subvenite 1B DEPAKOTE SPRINKLES 4 PA, ST g subvenite starter kit-blue 1B DIASTAT ACUDIAL 4 QL g subvenite starter kit-green 1B DIASTAT PEDIATRIC 2 QL g subvenite starter kit-orange 1g diazepam rectal 1 QL B TEGRETOL 3g divalproex sodium er 1 B TEGRETOL-XR 4g divalproex sodium oral 1 B TOPAMAX 4 PA, STg epitol 1 B TOPAMAX SPRINKLE 4 PA, STg gabapentin oral capsule 1 g topiramate er E PA, STg gabapentin oral solution 1 g topiramate oral 1

250 mg/5mlB TRILEPTAL 4 PA, ST

g gabapentin oral tablet 1B TROKENDI XR E PA, ST

B KEPPRA ORAL 4 PA, ST

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

1111

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

B gVALTOCO 3 PA, QL fluoxetine hcl oral tablet 20 mg 1B gVIMPAT ORAL 3 PA fluoxetine hcl oral tablet 60 mg EB gXCOPRI 3 PA fluvoxamine maleate 1B gZONEGRAN 4 PA, ST fluvoxamine maleate er 1 QLg Bzonisamide oral 1 FORFIVO XL E QL

BAntidementia Agents - Drugs for Alzheimer's Disease LEXAPRO Eand Dementia g mirtazapine oral 1

B ARICEPT ORAL TABLET E g nortriptyline hcl oral 1g donepezil hcl oral tablet 10 mg, 1 B PAMELOR E

5 mgg paroxetine hcl 1

g donepezil hcl oral tablet 23 mg Eg paroxetine hcl er 1 QL

g donepezil hcl oral tablet dispersible 1B PAXIL CR E QL

Antidepressants - Drugs for DepressionB PAXIL ORAL SUSPENSION 3

g amitriptyline hcl oral 1B PAXIL ORAL TABLET E

g bupropion hcl er (sr) 1B PRISTIQ E QL

g bupropion hcl er (xl) oral tablet 1B PROZAC Eextended release 24 hour 150 mg, B REMERON 4300 mgBB REMERON SOLTAB 4BUPROPION HCL ER (XL) ORAL E QL

TABLET EXTENDED RELEASE 24 g sertraline hcl oral 1HOUR 450 MG g trazodone hcl oral 1

g bupropion hcl oral 1 B TRINTELLIX 4 ST, QLB CELEXA E g venlafaxine hcl 1g citalopram hydrobromide 1 g venlafaxine hcl er oral capsule 1B CYMBALTA E QL extended release 24 hourg desvenlafaxine succinate er 1 QL g venlafaxine hcl er oral tablet E QLg extended release 24 hourdoxepin hcl oral capsule 1

Bg VIIBRYD 4 QLdoxepin hcl oral concentrate 1BB VIIBRYD STARTER PACK 4DRIZALMA SPRINKLE 4 PA, QLBg WELLBUTRIN SR Eduloxetine hcl oral capsule delayed 1 QL

release particles 20 mg, 30 mg, B WELLBUTRIN XL E60 mg B ZOLOFT E

g duloxetine hcl oral capsule delayed E Antiemetics - Drugs for Nausea and Vomitingrelease particles 40 mgB BONJESTA E PAB EFFEXOR XR EB DICLEGIS E PAg escitalopram oxalate 1g doxylamine-pyridoxine E PAg fluoxetine hcl oral capsule 1B GIMOTI Eg fluoxetine hcl oral capsule delayed 1 QLg metoclopramide hcl oral solution 1releaseg metoclopramide hcl oral tablet 1g fluoxetine hcl oral solution 1g metoclopramide hcl oral tablet Eg fluoxetine hcl oral tablet 10 mg 1 QL

dispersible

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

1212

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

g Bondansetron hcl oral 1 COLCRYS Eg gondansetron odt 1 febuxostat 1 ST, QLg Bprochlorperazine maleate oral 1 GLOPERBA 4 PAg Bpromethazine hcl oral tablet 1 MITIGARE 2g Bpromethazine hcl rectal 1 ULORIC E ST, QLg Bpromethegan 1 ZYLOPRIM 4B REGLAN 4 Antimigraine Agents - Drugs for Migrainesg Bscopolamine 1 AIMOVIG SUBCUTANEOUS 2 PA, ST, QL

SOLUTION AUTO-INJECTOR B TRANSDERM SCOP (1.5 MG) E140 MG/ML, 70 MG/ML

B ZOFRAN EB AMERGE E QL

B ZUPLENZ E QLg eletriptan hydrobromide 1 QL

Antifungals - Drugs for Fungal InfectionsB EMGALITY 2 PA, ST, QL

g ciclodan 1B EMGALITY (300 MG DOSE) 2 PA, ST, QL

g ciclopirox external 1B IMITREX ORAL E QL

g ciclopirox treatment EB IMITREX STATDOSE REFILL E QL

B CRESEMBA ORAL 3B IMITREX STATDOSE SYSTEM E QL

B DIFLUCAN ORAL SUSPENSION 4B IMITREX SUBCUTANEOUS E QLRECONSTITUTEDB MAXALT E QLB DIFLUCAN ORAL TABLET 100 MG, 4B150 MG, 200 MG MAXALT-MLT E QL

B gDIFLUCAN ORAL TABLET 50 MG 3 naratriptan hcl 1 QLB BEXTINA 4 ST, QL ONZETRA XSAIL E QLg Bfluconazole oral 1 RELPAX E QLB BGYNAZOLE-1 3 REYVOW 2 PA, ST, QLg gketoconazole external cream 1 QL rizatriptan benzoate 1 QLg gketoconazole external foam 1 ST, QL sumatriptan succinate oral 1 QLg gketoconazole external shampoo 1 sumatriptan succinate refill 1 QLg gketodan external foam 1 ST, QL sumatriptan succinate 1 QL

subcutaneousB LOPROX EXTERNAL SHAMPOO EB UBRELVY 2 PA, ST, QLg nyamyc 1 QLB ZEMBRACE SYMTOUCH E QLg nystatin external 1 QLB ZOLMITRIPTAN NASAL SOLUTION E ST, QLg nystatin mouth/throat 1

2.5 MGg nystop 1 QL

B ZOLMITRIPTAN NASAL SOLUTION E ST, QLg terbinafine hcl oral 1 QL 5 MGg terconazole 1 B zolmitriptan oral 1 QLB XOLEGEL 3 B ZOMIG NASAL SOLUTION 2.5 MG 2 ST, QL

Antigout Agents - Drugs for Gout B ZOMIG NASAL SOLUTION 5 MG 2 ST, QLg allopurinol oral 1 B ZOMIG ORAL E QLB COLCHICINE ORAL CAPSULE E B ZOMIG ZMT E QLg colchicine oral tablet E

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

1313

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

g hydroxychloroquine sulfate oral 1Antineoplastics - Drugs for CancerBB ALECENSA 2 PA, QL KRINTAFEL 1 QL

B BALUNBRIG 2 PA, QL, SP MALARONE 4g g permethrin external 1anastrozole oral 1

BB ARIMIDEX E PLAQUENIL Eg bexarotene E SP Antiparkinson Agents - Drugs for Parkinson's DiseaseB BCALQUENCE 2 PA, QL, SP APOKYN 2 PA, QL, SPg gcapecitabine 1 QL, SP carbidopa-levodopa 1B gERIVEDGE 2 PA, QL, SP carbidopa-levodopa er 1B BERLEADA 2 PA, QL, SP DUOPA 4 PAB BFEMARA E INBRIJA 3 PA, QL, SPg Bfluorouracil external solution 1 KYNMOBI 3 PA, QL, SPB BGLEEVEC E PA, QL, SP KYNMOBI TITRATION KIT 3 PA, SPB BIBRANCE 2 PA, QL, SP MIRAPEX 4B BIDHIFA 2 PA, QL, SP MIRAPEX ER Eg Bimatinib mesylate 1 PA, QL, SP NOURIANZ 3 PA, QLB gKOSELUGO 3 PA, QL, SP pramipexole dihydrochloride 1g gletrozole oral 1 pramipexole dihydrochloride er EB gLYNPARZA 2 PA, QL, SP ropinirole hcl 1g gmercaptopurine oral 1 ropinirole hcl er EB BNUBEQA 2 PA, QL, SP RYTARY EB BODOMZO 2 PA, QL, SP SINEMET 4B PURIXAN 4 PA, SP Antiplatelets - Drugs for Heart Attack and Stroke

PreventionB REVLIMID 2 PA, QL, SPB BRILINTA 4 QLB ROZLYTREK 2 PA, QL, SPg clopidogrel bisulfate oral 1B SOLTAMOX EB PLAVIX Eg tamoxifen citrate oral tablet 10 mg 1B ZONTIVITY 4 QLg tamoxifen citrate oral tablet 20 mg 1 H-PA

Antipsychotics - Drugs for Mood DisordersB TARGRETIN EXTERNAL 3 QL, SPB ABILIFY E QLB TARGRETIN ORAL 1 SPg aripiprazole oral solution 1B TASIGNA 2 PA, ST, QL, SPg aripiprazole oral tablet 1 QLB VERZENIO 2 PA, QL, SPg aripiprazole oral tablet dispersible 1 QLB VITRAKVI 2 PA, QL, SPg asenapine maleate E QLB XELODA E QL, SPB GEODON ORAL E QLB ZEJULA 2 PA, QL, SPB LATUDA 4 QLAntiparasitics - Drugs for Parasitic Infectionsg olanzapine oral 1 QLB ARAKODA 4 QLg quetiapine fumarate 1g atovaquone-proguanil hcl 1g quetiapine fumarate er 1 QLB ELIMITE 4

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

1414

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

B gRISPERDAL E oseltamivir phosphate oral 1 QLsuspension reconstitutedg risperidone 1

B PREZCOBIX 2B SAPHRIS 1 QLB PREZISTA 2B SEROQUEL Eg ritonavir 1B SEROQUEL XR E QLB RUKOBIA 4 PAB VRAYLAR 4 ST, QLB SITAVIG E QLg ziprasidone hcl 1 QLB SOFOSBUVIR-VELPATASVIR 2 PA, QL, SPB ZYPREXA ORAL E QLB STRIBILD 4 QLB ZYPREXA ZYDIS E QLB SYMFI 2 QLAntivirals - Drugs for Viral InfectionsB SYMFI LO 2 QLg acyclovir oral 1B TAMIFLU ORAL CAPSULE EB ATRIPLA E ST, QLB TAMIFLU ORAL SUSPENSION E QLB BARACLUDE ORAL SOLUTION 2 SP

RECONSTITUTEDB BARACLUDE ORAL TABLET E SP

B TEMIXYS E QLB CIMDUO 2 QL

g tenofovir disoproxil fumarate 1 H-PAB DOVATO 2 QL

B TIVICAY 3g efavirenz-emtricitab-tenofovir E ST, QL

B TIVICAY PD 3g efavirenz-lamivudine-tenofovir 1 QL

B TRIUMEQ 2 QLg emtricitabine-tenofovir df oral tablet 1 QL

B TRUVADA ORAL TABLET 4 QL100-150 mg, 133-200 mg, 100-150 MG, 133-200 MG, 167-250 167-250 mgMG

g emtricitabine-tenofovir df oral tablet 1 QL, HB TRUVADA ORAL TABLET E QL200-300 mg

200-300 MGg entecavir 1 SP

g valacyclovir hcl oral 1 QLB EPCLUSA ORAL TABLET 2 PA, QL

B VALTREX E QL200-50 MGB VEMLIDY 4 ST, SPB EPCLUSA ORAL TABLET 2 PA, QL, SPB400-100 MG VIREAD ORAL POWDER 3

B BGENVOYA 4 QL VIREAD ORAL TABLET 150 MG, 2200 MG, 250 MGB HARVONI ORAL PACKET 2 QL

B VIREAD ORAL TABLET 300 MG EB HARVONI ORAL TABLET 2 PA, ST, QL, SPB VOSEVI 2 PA, QL, SPB ISENTRESS 2B XOFLUZA (40 MG DOSE) 3 QLB ISENTRESS HD 2B XOFLUZA (80 MG DOSE) 3 QLB JULUCA 2 QLB ZEPATIER 2 PA, QL, SPB LEDIPASVIR-SOFOSBUVIR 2 PA, ST, QL, SPB ZOVIRAX ORAL 4B MAVYRET 2 PA, QL, SP

Anxiolytics - Drugs for AnxietyB NORVIR ORAL PACKET 2g alprazolam er 1B NORVIR ORAL SOLUTION 2g alprazolam intensol 1B NORVIR ORAL TABLET Eg alprazolam oral 1B ODEFSEY 4 QLg alprazolam xr 1g oseltamivir phosphate oral capsule 1

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

1515

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

B BATIVAN ORAL E AVALIDE Eg Bbuspirone hcl oral 1 AVAPRO Eg gclonazepam oral 1 benazepril hcl oral 1g gdiazepam intensol 1 benazepril-hydrochlorothiazide 1g Bdiazepam oral 1 BENICAR EB BHALCION 4 BENICAR HCT Eg Bhydroxyzine hcl oral 1 BETAPACE Eg Bhydroxyzine pamoate oral 1 BIDIL 2B gKLONOPIN E bisoprolol fumarate oral 1g glorazepam intensol 1 bisoprolol-hydrochlorothiazide 1g Blorazepam oral concentrate 2 mg/ml 1 BYSTOLIC Eg Blorazepam oral tablet 1 CALAN SR 4g Btriazolam 1 CARDIZEM EB BVALIUM E CARDIZEM CD EB BVISTARIL 4 CARDIZEM LA EB BXANAX E CARDURA 4B BXANAX XR E CAROSPIR 4 PA

g cartia xt 1Bipolar Agents - Drugs for Mood Disordersgg lithium carbonate er 1 carvedilol 1

g glithium carbonate oral 1 chlorthalidone 1B g clonidine hcl oral 1LITHOBID 4 PA

gCardiovascular Agents - Drugs for Heart and Circulation colesevelam hcl EConditions B COREG E

B ACCUPRIL 4 B CORGARD 4g acetazolamide er 1 B CORLANOR 3 PA, QLg acetazolamide oral 1 B COZAAR EB ALDACTONE E B CRESTOR E QLg aliskiren fumarate 1 g diltiazem hcl er 1B ALTACE E g diltiazem hcl er coated beads 1B ALTOPREV E g diltiazem hcl oral 1g amiodarone hcl oral 1 g dilt-xr 1g amlodipine besylate oral 1 B DIOVAN Eg amlodipine besylate-benazepril hcl 1 B DIOVAN HCT Eg amlodipine besylate-valsartan 1 g doxazosin mesylate oral 1g atenolol oral 1 B EDARBI 3g atenolol-chlorthalidone 1 B EDARBYCLOR 3g atorvastatin calcium oral tablet 1 QL, H-PA g enalapril maleate oral 1

10 mg, 20 mgB EPANED 4 PA

g atorvastatin calcium oral tablet 1 QLB EXFORGE E40 mg, 80 mg

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

1616

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

B gEZALLOR SPRINKLE 3 PA lovastatin oral 1 Hg Bezetimibe 1 LOVAZA Eg gezetimibe-simvastatin 1 matzim la 1g Bfenofibrate oral capsule 150 mg, E MAXZIDE 4

50 mg B MAXZIDE-25 4g fenofibrate oral tablet 120 mg, E g metoprolol succinate er 1

40 mg, 48 mgg metoprolol tartrate oral tablet 1

g fenofibrate oral tablet 145 mg, 1 100 mg, 25 mg, 50 mg160 mg, 54 mg

g metoprolol tartrate oral tablet EB FENOGLIDE E 37.5 mg, 75 mgg flecainide acetate 1 B MICARDIS EB FLOLIPID 4 PA B MINIPRESS 4g furosemide oral 1 g minitran 1g gemfibrozil oral 1 B MULTAQ 4 PAB GONITRO E QL g nadolol oral 1g guanfacine hcl 1 B NEXLETOL 2 PA, ST, QLB HEMANGEOL E B NEXLIZET 2 PA, ST, QLg hydralazine hcl oral 1 g niacin (antihyperlipidemic) Eg hydrochlorothiazide oral 1 g niacin er (antihyperlipidemic) 1B HYZAAR E g niacor Eg icosapent ethyl E PA B NIASPAN 4B INDERAL LA E g nifedipine er 1g irbesartan 1 g nifedipine er osmotic release 1g irbesartan-hydrochlorothiazide 1 g nifedipine oral 1g isosorbide mononitrate 1 B NITRO-BID 2g isosorbide mononitrate er 1 B NITRO-DUR 3B KAPSPARGO SPRINKLE 4 g nitroglycerin sublingual 1g labetalol hcl oral 1 g nitroglycerin transdermal 1B LASIX 4 g nitroglycerin translingual E QLB LIPITOR E QL B NITROLINGUAL E QLB LIPOFEN E B NITROMIST 4 QLg lisinopril oral 1 B NITROSTAT 4g lisinopril-hydrochlorothiazide 1 B NITRO-TIME 3B LOPID 4 B NORVASC EB LOPRESSOR 4 g olmesartan medoxomil oral 1g losartan potassium oral 1 g olmesartan medoxomil-hctz 1g losartan potassium-hctz 1 g omega-3-acid ethyl esters 1B LOTENSIN 4 B PACERONE ORAL TABLET 3B LOTENSIN HCT 4 100 MG, 400 MGB LOTREL E

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

1717

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

B BPACERONE ORAL TABLET 200 MG 4 VERELAN 4B BPRALUENT E PA, ST, QL VERELAN PM 4g Bpravastatin sodium 1 VYTORIN Eg Bprazosin hcl oral 1 WELCHOL 1B BPRINIVIL 4 ZESTORETIC EB BPROCARDIA 4 ZESTRIL EB BPROCARDIA XL E ZETIA Eg Bpropranolol hcl er 1 ZIAC ORAL TABLET 10-6.25 MG, 3

2.5-6.25 MGg propranolol hcl oral 1B ZIAC ORAL TABLET 5-6.25 MG 4B QBRELIS 4 PAB ZOCOR Eg quinapril hcl 1

Central Nervous System Agents - Drugs for Attention g ramipril 1Deficit Disorder

B RANEXA EB ADDERALL E

g ranolazine er 1B ADDERALL XR 1 QL

B REPATHA 2 PA, ST, QLB ADHANSIA XR E QL

B REPATHA PUSHTRONEX SYSTEM 2 PA, ST, QLg amphetamine-dextroamphetamine 1

B REPATHA SURECLICK 2 PA, ST, QLg amphetamine-dextroamphetamine E QL

g rosuvastatin calcium 1 QL erg simvastatin oral tablet 10 mg, 1 H-PA B APTENSIO XR E QL

20 mg, 40 mg, 5 mgg atomoxetine hcl 1 QL

g simvastatin oral tablet 80 mg 1B CONCERTA 1 QL

g sotalol hcl oral 1B DEXEDRINE E QL

B SOTYLIZE 4 PAg dexmethylphenidate hcl 1

g spironolactone oral 1g dexmethylphenidate hcl er 1 QL

B TEKTURNA 3g dextroamphetamine sulfate 1

B TEKTURNA HCT 3g dextroamphetamine sulfate er 1 QL

g telmisartan 1B FOCALIN 4

B TENORETIC 100 EB FOCALIN XR E QL

B TENORETIC 50 Eg guanfacine hcl er 1 QL

B TENORMIN EB INTUNIV E QL

B TOPROL XL 4B JORNAY PM E QL

g torsemide 1B METHYLIN 4

g triamterene-hctz 1g methylphenidate hcl er (cd) 1 QL

B TRICOR Eg methylphenidate hcl er (la) oral 1 QL

g valsartan 1 capsule extended release 24 hour g valsartan-hydrochlorothiazide 1 10 mg, 20 mg, 30 mg, 40 mgB gVASOTEC E methylphenidate hcl er (la) oral 1

capsule extended release 24 hour g verapamil hcl er 160 mgg verapamil hcl oral 1

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

1818

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

g Bmethylphenidate hcl er (xr) E QL PLEGRIDY SUBCUTANEOUS 3 PA, QL, SPg Bmethylphenidate hcl er oral tablet 1 QL REBIF 4 PA, ST, QL, SP

extended release 10 mg, 20 mg B REBIF REBIDOSE 4 PA, ST, QL, SPg methylphenidate hcl er oral tablet E QL B REBIF REBIDOSE TITRATION 4 PA, ST, QL, SP

extended release 18 mg, 27 mg, PACK36 mg, 54 mg, 72 mg

B REBIF TITRATION PACK 4 PA, ST, QL, SPg methylphenidate hcl er oral tablet E QL

Central Nervous System Agents - Miscellaneousextended release 24 hourB AUSTEDO 2 PA, QL, SPg methylphenidate hcl oral solution 1B LYRICA 4 PA, ST, QLg methylphenidate hcl oral tablet 1B LYRICA CR E ST, QLg methylphenidate hcl oral tablet 1B NUEDEXTA 2 PAchewablegB pregabalin oral 1 QLMYDAYIS E QLBB RILUTEK 4 SPPROCENTRA 3gB riluzole 1 SPQUILLICHEW ER E QLBB TIGLUTIK 4 PAQUILLIVANT XR E QLBg ZEPOSIA 3 PA, QL, SPrelexxii E QLBB ZEPOSIA 7-DAY STARTER PACK 3 PA, QL, SPRITALIN 4BB ZEPOSIA STARTER KIT 3 PA, QL, SPRITALIN LA E QL

B Dental and Oral Agents - Drugs for Mouth and Throat STRATTERA E QLConditionsB VYVANSE 3 QL

g cavarest 1B ZENZEDI Eg chlorhexidine gluconate mouth/ 1Central Nervous System Agents - Drugs for Multiple

throatSclerosisB CLINPRO 5000 3B AMPYRA E PA, QL, SPB DENTA 5000 PLUS 4B AUBAGIO 3 PA, QL, SPB DENTAGEL 4B AVONEX PEN 2 PA, QL, SPB FLUORIDEX 3B AVONEX PREFILLED 2 PA, QL, SPB FLUORIDEX ENHANCED 3B BAFIERTAM 2 PA, QL, SP

WHITENINGB BETASERON 2 PA, QL, SP

g lidocaine hcl mouth/throat 1B COPAXONE E PA, QL, SP

g lidocaine viscous hcl 1g dalfampridine er 1 PA, QL, SP

B NAFRINSE DAILY/NEUTRAL 2B EXTAVIA E PA, ST, QL, SP

B NAFRINSE WEEKLY 4B GILENYA 3 PA, QL, SP

B PERIDEX 4g glatiramer acetate 1 PA, QL, SP

B periogard 1g glatopa 1 PA, QL, SP

B PREVIDENT 5000 BOOSTER PLUS 3B KESIMPTA 2 PA, QL, SP

B PREVIDENT 5000 DRY MOUTH 4B MAVENCLAD 3 PA, ST, QL, SP

B PREVIDENT 5000 ORTHO 3B MAYZENT 3 PA, QL, SP DEFENSEB PLEGRIDY INTRAMUSCULAR 3 PA, QL, SP B PREVIDENT 5000 PLUS 4B PLEGRIDY STARTER PACK 3 PA, QL, SP B PREVIDENT DENTAL 4

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

1919

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

B gPREVIDENT MOUTH/THROAT 3 clindacin-p 1g Bsf 1 CLINDAGEL E QLg gsf 5000 plus 1 clindamycin phos-benzoyl perox 1 QL

external gel 1.2-5 %g sodium fluoride 5000 plus 1g clindamycin phosphate external 1g sodium fluoride 5000 ppm 1

foamg sodium fluoride dental 1

g clindamycin phosphate external 1Dermatological Agents - Drugs for Skin Conditions lotion

B ABSORICA E PA g clindamycin phosphate external 1 QLg accutane 1 solutionB gACZONE EXTERNAL GEL 5 % 1 QL clindamycin phosphate external 1

swabB ACZONE EXTERNAL GEL 7.5 % 3 QLB CLINDAMYCIN PHOSPHATE GEL EB ALA SCALP 4

1 % EXTERNALg ala-cort external cream 1 % E

g clindamycin phosphate gel 1 % 1 QLg ala-cort external cream 2.5 % 1 externalB ALDARA 4 QL g clobetasol propionate external 1 QLB ALTRENO E PA, QL creamg amnesteem 1 g clobetasol propionate external foam E QLB gAMZEEQ 4 PA, QL clobetasol propionate external gel 1 QLB ATRALIN E PA, QL g clobetasol propionate external 1 QLB liquidAVAR CLEANSER 4

gB clobetasol propionate external E QLAVAR LS CLEANSER ElotionB AVAR-E EMOLLIENT 3

g clobetasol propionate external 1 QLB AVAR-E GREEN 3ointment

B AVAR-E LS 3g clobetasol propionate external E QL

B AVITA E PA, QL shampoog azelaic acid external 1 g clobetasol propionate external 1 QLg solutionbetamethasone dipropionate aug 1

Bg CLOBEX E QLbetamethasone dipropionate 1external B CLOBEX SPRAY E QL

g bp 10-1 1 g clodan external shampoo E QLg calcipotriene-betameth diprop 1 QL g clotrimazole-betamethasone 1 QL

external ointment external creamg calcipotriene-betameth diprop E g clotrimazole-betamethasone 1

external suspension external lotiong calcitriol external 1 QL g dapsone external gel 5 % E QLB CAPEX 2 B DAPSONE EXTERNAL GEL 7.5 % E QLB CARAC 2 B DERMA-SMOOTHE/FS BODY 4 QLg claravis 1 B DERMA-SMOOTHE/FS SCALP 4B CLEOCIN-T 4 B DESONATE 4 ST, QLg clindacin etz external swab 1 g desonide external cream 1 QL

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

2020

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

g gdesonide external gel 1 ST, QL metronidazole external cream 1g gdesonide external lotion 1 QL metronidazole external gel 0.75 % 1g gdesonide external ointment 1 QL metronidazole external gel 1 % EB gDESOWEN 3 QL metronidazole external lotion 1B BDIPROLENE 4 MIRVASO 4 PA, QLB gDIPROLENE AF 4 mometasone furoate external 1B gDUPIXENT 4 PA, ST, QL, SP myorisan 1B gEFUDEX 4 neuac external gel 1 QLB BENSTILAR 4 QL NORITATE EB BEUCRISA 3 ST, QL OLUX E QLB BEVOCLIN 4 PICATO 3 QLB BFINACEA 4 PLEXION Eg Bfluocinolone acetonide body 1 QL PLEXION CLEANSER Eg Bfluocinolone acetonide external 1 QL PLEXION CLEANSING CLOTH Eg Bfluocinolone acetonide scalp 1 RETIN-A E PA, QLg Bfluocinonide external cream 0.05 % 1 RHOFADE 4 PA, QLg gfluocinonide external cream 0.1 % E QL rosadan external cream 1g gfluocinonide external gel 1 rosadan external gel 1g Bfluocinonide external ointment 1 SERNIVO E QLg Bfluocinonide external solution 1 SOOLANTRA 4 QLB gFLUOROPLEX 4 sss 10-5 1B gFLUOROURACIL EXTERNAL 2 sulfacetamide sodium-sulfur 1

CREAM 0.5 % external cream 10-2 %, 10-5 %g gfluorouracil external cream 5 % 1 sulfacetamide sodium-sulfur E

external cream 9.8-4.8 %g hydrocortisone external cream 1 % Eg sulfacetamide sodium-sulfur 1g hydrocortisone external cream 1

external emulsion2.5 %g sulfacetamide sodium-sulfur Eg hydrocortisone external lotion 2.5 % 1

external liquid 10-2 %, 9.8-4.8 %g hydrocortisone external ointment 1

g sulfacetamide sodium-sulfur 11 %, 2.5 %external liquid 9-4 %, 9-4.5 %

g imiquimod external cream 3.75 % E QLg sulfacetamide sodium-sulfur 1

g imiquimod external cream 5 % 1 QL external lotion 10-5 %B IMIQUIMOD PUMP E QL g sulfacetamide sodium-sulfur EB IMPEKLO E QL external lotion 9.8-4.8 %B gIMPOYZ E QL sulfacetamide sodium-sulfur 1

external padg isotretinoin oral 1g sulfacetamide sodium-sulfur 1B KENALOG EXTERNAL E QL

external suspension 10-5 %B METROCREAM 4g sulfacetamide sodium-sulfur EB METROGEL E external suspension 8-4 %

B METROLOTION 4

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

2121

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

g Bsulfacetamide sod-sulfur wash 1 ZYCLARA E QLexternal liquid B ZYCLARA PUMP E QL

B SULFACLEANSE 8/4 E Diabetes - Glucose Monitoringg sulfamez wash 1 B ACCU-CHEK FASTCLIX LANCET 1B SUMADAN WASH E KITB BSUMAXIN 4 ACCU-CHEK FASTCLIX LANCETS 1B gSUMAXIN WASH 3 accu-chek guide kit w/device 3 (Accu-Chek

Guide Me)B SYNALAR E QLB ACCU-CHEK GUIDE ME METER 3B TACLONEX EXTERNAL OINTMENT E QLB ACCU-CHEK GUIDE TEST STRIPS 3 QLB TACLONEX EXTERNAL 3BSUSPENSION ACCU-CHEK SOFTCLIX LANCET 1

DEVICE KITg tazarotene external 1 PA, QLB ACCU-CHEK SOFTXLIX LANCETS 1B TAZORAC 4 PA, QLg bd autoshield duo pen needles 2B TEMOVATE 4 QLg bd ultra-fine insulin syringes 2B TEXACORT 2g bd ultra-fine pen needles 2g tretinoin external cream 1 QLB CONTOUR NEXT EZ KIT 2g tretinoin external gel 0.01 % E QL

W/DEVICEg tretinoin external gel 0.025 % E

B CONTOUR NEXT MONITOR KIT 2g tretinoin external gel 0.05 % E PA, QL W/DEVICEg triamcinolone acetonide external 1 QL B CONTOUR NEXT ONE KIT 2

aerosol solutionB CONTOUR NEXT TEST STRIPS 2 QL

g triamcinolone acetonide external 1B DEXCOM G4 / G5 / G6 RECEIVER, 3 PA, QLcream 0.025 %, 0.1 %

TRANSMITTER, SENSOR g triamcinolone acetonide external 1 QL (INCLUDING PLATINUM,

cream 0.5 % PLATINUM PEDIATRIC)g triamcinolone acetonide external 1 B DEXCOM G4 / G5 / G6 RECEIVER, 3 PA, QL

lotion TRANSMITTER, SENSOR g triamcinolone acetonide external 1 (INCLUDING PLATINUM,

ointment 0.025 %, 0.1 %, 0.5 % PLATINUM PEDIATRIC) DEVICEg Btriamcinolone acetonide external E FREESTYLE LIBRE 14 DAY 3 PA

ointment 0.05 % READERB BTRIANEX E FREESTYLE LIBRE 14 DAY 3 PA

SENSORg triderm external cream 0.1 % 1B FREESTYLE LIBRE 2 READER 3 PAg triderm external cream 0.5 % 1 QLB FREESTYLE LIBRE 2 SENSOR 3 PAB TRIDESILON 1 QLB FREESTYLE LIBRE READER 3 PA, QLB VANOS E QLB FREESTYLE LIBRE SENSOR 3 PAB VECTICAL E QL

SYSTEMB VERDESO E QLB INSULIN PEN NEEDLES 2B WYNZORA E QLB INSULIN SYRINGES 2g zenatane 1B LANCETS 3B ZILXI 4 PA, ST, QL

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

2222

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

B BNOVOFINE AUTOCOVER PEN 2 HUMULIN R U-500 VIAL 1 QLNEEDLE B HUMULIN R VIAL 1 QL

B NOVOFINE PEN NEEDLE 2 B INSULIN ASPART E ST, QLB NOVOFINE PLUS PEN NEEDLE 2 B INSULIN ASPART FLEXPEN E ST, QLB ONETOUCH DELICA PLUS 1 B INSULIN ASPART PENFILL E ST, QL

LANCETSB INSULIN LISPRO E QL

B ONETOUCH ULTRA 2 KIT 1B INSULIN LISPRO (1 UNIT DIAL) E QLW/DEVICEB INSULIN LISPRO JUNIOR E QLB ONETOUCH ULTRA BLUE TEST 1 QL

KWIKPENSTRIPS IN VITRO STRIPB INSULIN LISPRO PROT & LISPRO E QLB ONETOUCH ULTRA MINI KIT 1B LANTUS SOLOSTAR 1 QLW/DEVICEBB LANTUS U-100 VIAL 1 QLONETOUCH ULTRASOFT 1

LANCETS B LEVEMIR U-100 FLEXTOUCH E QLB ONETOUCH VERIO FLEX SYSTEM 1 B LEVEMIR U-100 VIAL E QL

KIT W/DEVICE B LYUMJEV KWIKPEN 2 QLB ONETOUCH VERIO IQ SYSTEM 1 B LYUMJEV VIAL 1 QLB ONETOUCH VERIO KIT W/DEVICE 1 B NOVOLIN 70/30 FLEXPEN E ST, QLB ONETOUCH VERIO REFLECT 1 B NOVOLIN 70/30 FLEXPEN RELION E ST, QLB ONETOUCH VERIO TEST STRIPS 1 QL B NOVOLIN 70/30 RELION E ST, QL

Diabetes - Insulin B NOVOLIN 70/30 VIAL E ST, QLB ADMELOG E QL B NOVOLIN N FLEXPEN E ST, QLB ADMELOG SOLOSTAR E QL B NOVOLIN N FLEXPEN RELION E ST, QLB AFREZZA E PA, QL B NOVOLIN N RELION E ST, QLB BASAGLAR KWIKPEN E QL B NOVOLIN N VIAL E ST, QLB HUMALOG KWIKPEN 2 QL B NOVOLIN R FLEXPEN E ST, QLB HUMALOG MIX 50/50 KWIKPEN 2 QL B NOVOLIN R FLEXPEN RELION E ST, QLB HUMALOG MIX 50/50 VIAL 1 QL B NOVOLIN R RELION E ST, QLB HUMALOG MIX 75/25 KWIKPEN 2 QL B NOVOLIN R VIAL E ST, QLB HUMALOG MIX 75/25 VIAL 1 QL B NOVOLOG FLEXPEN E ST, QLB HUMALOG U-100 JUNIOR 2 QL B NOVOLOG PENFILL E ST, QLKWIKPEN

B NOVOLOG U-100 VIAL E ST, QLB HUMALOG VIAL SUBCUTANEOUS 1 QLB SEMGLEE E QLSOLUTION 100 UNIT/MLB TOUJEO MAX SOLOSTAR 2 QLB HUMALOG VIAL SUBCUTANEOUS 2 QLBSOLUTION CARTRIDGE TOUJEO SOLOSTAR 2 QL

100 UNIT/ML B TRESIBA E QLB HUMULIN 70/30 KWIKPEN 2 QL B TRESIBA FLEXTOUCH E QLB HUMULIN 70/30 VIAL 1 QL Diabetes - Non-Insulin AgentsB HUMULIN N KWIKPEN 2 QL B ACTOS E QLB HUMULIN N VIAL 1 QL B ADLYXIN 4 PA, ST, QLB HUMULIN R U-500 KWIKPEN 2 QL B ADLYXIN STARTER PACK 4 PA, ST, QL

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

2323

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

B BALOGLIPTIN BENZOATE E QL ONGLYZA 2 QLB BALOGLIPTIN-METFORMIN HCL E QL OSENI 2 QLB BALOGLIPTIN-PIOGLITAZONE E QL OZEMPIC 2 PA, ST, QLB gAMARYL 4 pioglitazone hcl 1 QLB BBAQSIMI ONE PACK 2 QL RIOMET EB BBAQSIMI TWO PACK 2 QL RYBELSUS 2 PA, ST, QLB BBYDUREON BCISE 2 PA, ST, QL SOLIQUA 2 QL

AUTOINJECTOR B SYMLINPEN 120 3 QLB BYETTA 10 MCG PEN 2 PA, ST, QL B SYMLINPEN 60 3 QLB BYETTA 5 MCG PEN 2 PA, ST, QL B SYNJARDY 2 QLB FARXIGA E ST, QL B SYNJARDY XR 2 QLB FORTAMET E PA B TRADJENTA 2 QLg glimepiride 1 B TRIJARDY XR 2 QLg glipizide er 1 B TRULICITY 2 PA, ST, QLg glipizide ir 1 B VICTOZA SOLUTION PEN- 2 PA, ST, (2 Pak), g glipizide xl 1 INJECTOR 18 MG/3ML QL

SUBCUTANEOUSg glucagon emergency kit 1 mg 1 QLBinjection 1 mg (Eli Lilly) VICTOZA SOLUTION PEN- 3 PA, ST, (3 Pak),

INJECTOR 18 MG/3ML QLB GLUCAGON EMERGENCY KIT 2 QLSUBCUTANEOUS1 MG INJECTION 1 MG (Fresenius)Drugs for Blood DisordersB GLUCOTROL 4

B ADVATE 2 SPB GLUCOTROL XL 4B ADYNOVATE 4 PA, SPB GLUMETZA E PAB AFSTYLA INTRAVENOUS KIT 1000 4 PAg glyburide oral 1

UNIT, 2000 UNIT, 250 UNIT, 3000 g glyburide-metformin 1 UNIT, 500 UNITB GLYXAMBI 2 ST, QL B AFSTYLA INTRAVENOUS KIT 1500 4 PA, SPB GVOKE HYPOPEN 1-PACK 2 QL UNIT, 2500 UNITB BGVOKE HYPOPEN 2-PACK 2 QL ARANESP (ALBUMIN FREE) 2 QL, SPB BGVOKE PFS 2 QL ELOCTATE 4 PA, SPB BJANUVIA E ST, QL JIVI 4 PA, SPB BJARDIANCE 2 ST, QL KOGENATE FS 2 SPB BJENTADUETO 2 QL KOVALTRY 2 SPB BJENTADUETO XR 2 QL MULPLETA 2 PA, QL, SPB BKAZANO 2 QL NOVOEIGHT 2 SPB BKOMBIGLYZE XR 2 QL NUWIQ 2 SPg Bmetformin hcl er 1 RECOMBINATE 2 SPg Bmetformin hcl er (mod) E PA RETACRIT INJECTION SOLUTION 2 QL, SP

10000 UNIT/ML, 2000 UNIT/ML, g metformin hcl er (osm) E PA3000 UNIT/ML, 4000 UNIT/ML, g metformin hcl ir 1 40000 UNIT/ML

B NESINA 2 QL

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

2424

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

B gRETACRIT INJECTION SOLUTION 2 multivitamin/fluoride oral tablet 120000 UNIT/ML chewable 0.25 mg, 0.5 mg, 1 mg

B BZARXIO 2 SP NASCOBAL 3B BZIEXTENZO 3 SP POLY-VI-FLOR 3

g potassium chloride crys er 1Drugs for Sexual DysfunctiongB ADDYI 4 PA, QL potassium chloride er 1

B gCIALIS ORAL TABLET 10 MG, E QL potassium chloride oral packet 120 MG g potassium chloride oral solution 1

B CIALIS ORAL TABLET 2.5 MG, E ST, QL 20 meq/15ml (10%), 40 meq/15ml 5 MG (20%)

B g potassium citrate er 1IMVEXXY MAINTENANCE PACK 3 QLBB IMVEXXY STARTER PACK 3 QL QUFLORA PEDIATRIC 3

B BINTRAROSA 3 QL UROCIT-K 10 4B B UROCIT-K 15 4OSPHENA 3 PA, QL

Bg sildenafil citrate oral tablet 100 mg, 1 QL UROCIT-K 5 425 mg, 50 mg B VELTASSA 3 PA, QL

B STENDRA 4 PA, QL g vitamin d (ergocalciferol) oral 1g tadalafil oral tablet 10 mg, 20 mg 1 QL capsule 1.25 mg (50000 ut)g tadalafil oral tablet 2.5 mg, 5 mg 1 ST, QL Gastrointestinal Agents - Drugs for Acid Reflux and UlcerB BVIAGRA E QL ACIPHEX E QLB BVYLEESI 4 PA, QL ACIPHEX SPRINKLE E QL

BElectrolytes / Vitamins CARAFATE Eg Bcyanocobalamin injection solution 1 CYTOTEC 4

1000 mcg/ml B DEXILANT 3 QLB CYANOCOBALAMIN INJECTION 3 B FIRST-OMEPRAZOLE 3 PA

SOLUTION 2000 MCG/MLg misoprostol oral 1

B DRISDOL 4B OMECLAMOX-PAK 3 QL

B ERGOCAL 3g omeprazole oral capsule delayed 1

g ergocalciferol oral capsule 1 releaseB FLORIVA PLUS 3 B OMEPRAZOLE+SYRSPEND SF 3 PAg folic acid oral tablet 1 mg 1 ALKAg gklor-con 1 pantoprazole sodium oral packet Eg g pantoprazole sodium tablet delayed 1klor-con 10 1

release 20 mg oralg klor-con m10 1g pantoprazole sodium tablet delayed EB KLOR-CON M15 3

release 20 mg oralg klor-con m20 1

g pantoprazole sodium tablet delayed EB K-TAB 3 release 40 mg oralB LOKELMA 3 PA, QL g pantoprazole sodium tablet delayed 1g multi-vitamin/fluoride 1 release 40 mg oralg Bmultivitamin/fluoride oral solution 1 PROTONIX ORAL E

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

2525

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

B BPYLERA 3 QL SYMPROIC 2 PA, QLB BRABEPRAZOLE SODIUM ORAL E QL TRULANCE 4 PA, ST, QL

CAPSULE SPRINKLE B URSO 250 4g rabeprazole sodium oral tablet 1 QL B URSO FORTE 4

delayed releaseg ursodiol oral 1

g sucralfate oral 1B VIBERZI 4 PA, QL

Gastrointestinal Agents - Drugs for Bowel, Intestine and B XIFAXAN 3 PA, QLStomach ConditionsB ZELNORM 3 PA, ST, QLB ANASPAZ 2

Genetic or Enzyme Disorder - Drugs for Replacement, B CLENPIQ 3Modification, Treatment

g dicyclomine hcl oral 1B CERDELGA 2 PA, SP

g diphenoxylate-atropine 1g clovique 4 PA, SP

B ED-SPAZ 3B CREON 2

g gavilyte-c 1 HB CUPRIMINE E SP

g gavilyte-g 1 QL, HB DEPEN TITRATABS 2 SP

B GOLYTELY 4 QLB ENDARI 4 PA, QL

g hyoscyamine sulfate er 1g nitisinone 1 PA, SP

g hyoscyamine sulfate oral 1B NITYR E PA, SP

g hyoscyamine sulfate sl 1B ORFADIN CAPSULES 1 PA, SP

g hyoscyamine sulfate sublingual 1B ORFADIN SUSPENSION 2 PA, SP

g hyosyne 1B PANCREAZE 3 ST

B LEVBID 4g penicillamine oral 1 SP

B LEVSIN ORAL 4B PERTZYE 4 ST

B LEVSIN/SL 4B STRENSIQ 2 PA, QL, SP

B LINZESS 2 PA, QLB SYPRINE E PA, SP

B LOMOTIL 4B TEGSEDI 2 PA, QL, SP

B MOTEGRITY 3 PA, QLg trientine hcl 1 PA, SP

B MOVIPREP 3 QLB VIOKACE 4 ST

B NULEV 4B ZENPEP 2

g oscimin 1Genitourinary Agents - Drugs for Bladder, Genital and

g oscimin sr 1 Kidney Conditionsg peg-3350/electrolytes 1 QL, H B AURYXIA 3g peg-3350/electrolytes/ascorbat 1 QL B DITROPAN XL 3g peg-kcl-nacl-nasulf-na asc-c 1 QL B GELNIQUE EB PLENVU 3 QL g oxybutynin chloride er 1B SUPREP BOWEL PREP KIT 3 QL g oxybutynin chloride oral 1B SUTAB 3 g phenazo oral tablet 200 mg 1B SYMAX DUOTAB 3 g phenazopyridine hcl oral tablet 1B SYMAX-SL 4 100 mg, 200 mgB BSYMAX-SR 4 PYRIDIUM 3

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

2626

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

B gTOVIAZ 3 camila 1 HB gVELPHORO 2 camrese 1 H

gGenitourinary Agents - Drugs for Prostate Conditions camrese lo 1 Hg g charlotte 24 fe Ealfuzosin hcl er 1

gg finasteride oral tablet 5 mg 1 chateal 1 HB gFLOMAX E chateal eq 1 HB BPROSCAR 4 CLIMARA E QLg B CLIMARA PRO 3 QLtamsulosin hcl 1

gg terazosin hcl 1 cryselle-28 1 HB gUROXATRAL E cyclafem 1/35 1 H

g cyred 1 HHormonal Agents - Hormone Replacement and Birth Control g cyred eq 1 H

g afirmelle 1 H g dasetta 1/35 1 HB ALORA 3 QL g daysee 1 Hg altavera 1 H g deblitane 1 Hg alyacen 1/35 1 H g delyla 1 Hg amethia 1 H B DEPO-PROVERA 4 QLg INTRAMUSCULAR SUSPENSIONamethia lo 1 H

Bg DEPO-PROVERA 4apri 1 HINTRAMUSCULAR SUSPENSION g ashlyna 1 HPREFILLED SYRINGE

g aubra 1 HB DEPO-SUBQ PROVERA 104 2 QL

g aubra eq 1 Hg desogestrel-ethinyl estradiol 1 H

g aurovela 1.5/30 1 HB DIVIGEL 3

g aurovela 1/20 1 Hg dotti E QL

g aurovela 24 fe 1 Hg drospiren-eth estrad-levomefol E

g aurovela fe 1.5/30 1 Hg drospirenone-ethinyl estradiol 1 H

g aurovela fe 1/20 1 HB DUAVEE 3 QL

g aviane 1 HB ELESTRIN 3

B AYGESTIN 4g elinest 1 H

g ayuna 1 Hg eluryng E

g azurette 1 Hg emoquette 1 H

g balziva 1 Hg enskyce 1 H

g bekyree 1 Hg errin 1 H

B BEYAZ Eg estarylla 1 H

B BIJUVA 3B ESTRACE ORAL E

g blisovi 24 fe 1 HB ESTRACE VAGINAL E

g blisovi fe 1.5/30 1 Hg estradiol oral 1

g blisovi fe 1/20 1 Hg estradiol patch twice weekly 0.025 1 (generic for

g briellyn 1 H mg/24hr transdermal Minivelle), QL

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

2727

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

g gestradiol patch twice weekly E (generic for jolessa 1 H0.025 mg/24hr transdermal Vivelle-Dot), QL g juleber 1 H

g estradiol patch twice weekly 1 (generic for g junel 1.5/30 1 H0.0375 mg/24hr transdermal Minivelle), QL

g junel 1/20 1 Hg estradiol patch twice weekly E (generic for

g junel fe 1.5/30 1 H0.0375 mg/24hr transdermal Vivelle-Dot), QLg junel fe 1/20 1 Hg estradiol patch twice weekly 1 (generic for g junel fe 24 1 H0.05 mg/24hr transdermal Minivelle), QLgg kalliga 1 Hestradiol patch twice weekly E (generic for

0.05 mg/24hr transdermal Vivelle-Dot), QL g kariva 1 Hg estradiol patch twice weekly 1 (generic for g kurvelo 1 H

0.075 mg/24hr transdermal Minivelle), QL g larin 1.5/30 1 Hg estradiol patch twice weekly E (generic for g larin 1/20 1 H0.075 mg/24hr transdermal Vivelle-Dot), QL

g larin 24 fe 1 Hg estradiol patch twice weekly 1 (generic for g larin fe 1.5/30 1 H0.1 mg/24hr transdermal Minivelle), QLgg larin fe 1/20 1 Hestradiol patch twice weekly E (generic for g0.1 mg/24hr transdermal Vivelle-Dot), QL larissia 1 H

g gestradiol transdermal patch weekly 1 (generic for lessina 1 HClimara), QL g levonorgest-eth est & eth est E

g estradiol vaginal cream 1 g levonorgest-eth estrad 91-day 1 Hg estradiol vaginal tablet 1 g levonorgestrel-ethinyl estrad oral 1 HB ESTRING 2 QL tablet 0.1-20 mg-mcg, B 0.15-30 mg-mcgESTROGEL 3 QL

gg levora 0.15/30 (28) 1 Hetonogestrel-ethinyl estradiol EgB lillow 1 HEVAMIST 2Bg LO LOESTRIN FE 3falmina 1 HBg LOESTRIN 1.5/30 (21) 4fayosim EBg LOESTRIN 1/20 (21) 4femynor 1 HBg LOESTRIN FE 1.5/30 4gemmily EBg LOESTRIN FE 1/20 Ehailey 1.5/30 1 Hgg lojaimiess 1 Hhailey 24 fe 1 Hgg loryna 1 Hhailey fe 1.5/30 1 HBg LOSEASONIQUE 4hailey fe 1/20 1 Hgg low-ogestrel 1 Hheather 1 Hgg lo-zumandimine 1 Hiclevia 1 Hgg lutera 1 Hincassia 1 Hgg lyleq 1 Hintrovale 1 Hgg lyllana E QLisibloom 1 Hgg lyza 1 Hjaimiess 1 Hgg marlissa 1 Hjasmiel 1 H

g jencycla 1 H

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

2828

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

g Bmedroxyprogesterone acetate 1 QL, H NUVARING 1 Hintramuscular suspension g nymyo 1 H

g medroxyprogesterone acetate 1 H g ocella 1 Hintramuscular suspension prefilled

g orsythia 1 HsyringeB ORTHO MICRONOR 4g medroxyprogesterone acetate oral 1g philith 1 Hg melodetta 24 fe Eg pimtrea 1 HB MENOSTAR 3 QLg pirmella 1/35 1 Hg merzee Eg portia-28 1 Hg mibelas 24 fe EB PREMARIN ORAL 3g microgestin 1.5/30 1 HB PREMARIN VAGINAL 3g microgestin 1/20 1 HB PREMPHASE 3g microgestin 24 fe 1 HB PREMPRO 3g microgestin fe 1.5/30 1 Hg previfem 1 Hg microgestin fe 1/20 1 Hg progesterone micronized oral 1g mili 1 HB PROMETRIUM EB MINASTRIN 24 FE EB PROVERA 4B MINIVELLE E QLB QUARTETTE EB MIRCETTE 4g reclipsen 1 Hg mono-linyah 1 Hg rivelsa EB NATAZIA 2B SAFYRAL Eg necon 0.5/35 (28) 1 HB SEASONIQUE Eg nikki 1 Hg setlakin 1 Hg nora-be 1 Hg sharobel 1 Hg norethin ace-eth estrad-fe oral Eg simliya 1 Hcapsulegg simpesse 1 Hnorethin ace-eth estrad-fe oral 1 H

tablet g sprintec 28 1 Hg norethin ace-eth estrad-fe oral E g sronyx 1 H

tablet chewable g syeda 1 Hg norethindrone acetate oral 1

g tarina 24 fe 1 Hg norethindrone acet-ethinyl est 1 H g tarina fe 1/20 1 Hg norethindrone oral 1 H g tarina fe 1/20 eq 1 Hg norgestimate-eth estradiol 1 H B TAYTULLA Eg norgestimate-ethinyl estradiol 1 H g tri femynor 1 Htriphasic

g tri-estarylla 1 Hg norlyda 1 Hg tri-linyah 1 Hg norlyroc 1 Hg tri-lo-estarylla 1 Hg nortrel 0.5/35 (28) 1 Hg tri-lo-marzia 1 Hg nortrel 1/35 (21) 1 Hg tri-lo-mili 1 Hg nortrel 1/35 (28) 1 H

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

2929

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

g Btri-lo-sprintec 1 H MEDROL ORAL TABLET 32 MG 3g Btri-mili 1 H MEDROL ORAL TABLET THERAPY 4

PACKg tri-nymyo 1 Hg methylprednisolone oral 1g tri-previfem 1 HB MILLIPRED 2g tri-sprintec 1 HB ORAPRED ODT 4g tri-vylibra 1 HB PEDIAPRED 2g tri-vylibra lo 1 Hg prednisolone oral solution 1g tulana 1 Hg prednisolone sodium phosphate 1g tyblume 1 H

oralg tydemy E

g prednisone intensol 1B VAGIFEM E

g prednisone oral 1g vestura 1 H

B RAYOS Eg vienva 1 H

B TAPERDEX 12-DAY 3g viorele 1 H

B TAPERDEX 6-DAY ORAL TABLET 4B VIVELLE-DOT 1 QL THERAPY PACK 1.5 MGg volnea 1 H B TAPERDEX 6-DAY ORAL TABLET 3g vyfemla 1 H THERAPY PACK 1.5 MG (21)g Bvylibra 1 H TAPERDEX 7-DAY 3g Bwera 1 H ZCORT 7-DAY Eg xulane 1 H Hormonal Agents - OtherB gYASMIN 28 3 cabergoline 1B BYAZ 3 DDAVP Eg gyuvafem 1 desmopressin acetate injection 1g gzafemy 1 H desmopressin acetate oral 1g Bzarah 1 H GENOTROPIN E PA, QL, SPg Bzumandimine 1 H GENOTROPIN MINIQUICK E PA, QL, SP

BHormonal Agents - Oral Steroids HUMATROPE E PA, QL, SPB BALKINDI SPRINKLE E PA NOCDURNA 3 PA, QLB BCORTEF 4 NORDITROPIN FLEXPRO E PA, QL, SPB BDECADRON E NUTROPIN AQ NUSPIN 10 2 PA, QL, SPB BDEXABLISS E NUTROPIN AQ NUSPIN 20 2 PA, QL, SPg Bdexamethasone intensol 1 NUTROPIN AQ NUSPIN 5 2 PA, QL, SPg Bdexamethasone oral 1 OMNITROPE E PA, QL, SPB BDXEVO 11-DAY E ORIAHNN 4 PA, QLB BHEMADY E ORILISSA 4 PA, QLB BHIDEX 6-DAY E SOMATULINE DEPOT 4 SPg Bhydrocortisone oral 1 STIMATE 3B BMEDROL ORAL TABLET 16 MG, 4 ZOMACTON E PA, QL, SP

4 MG, 8 MG B ZOMACTON (FOR ZOMA-JET 10) E PA, QL, SPB MEDROL ORAL TABLET 2 MG 2

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

3030

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

Hormonal Agents - Testosterone Replacement Immunological Agents - Drugs for Immune System Stimulation or SuppressionB ANDRODERM 2 PA, QL

B ACTEMRA ACTPEN 3 PA, ST, QL, SPB ANDROGEL E PA, QLB ACTEMRA SUBCUTANEOUS 3 PA, ST, QL, SPB ANDROGEL PUMP E PA, QLB ASTAGRAF XL EB DEPO-TESTOSTERONE 3BINTRAMUSCULAR SOLUTION AZASAN 3

100 MG/ML g azathioprine oral 1B DEPO-TESTOSTERONE 4 B CELLCEPT E

INTRAMUSCULAR SOLUTION B CIMZIA PREFILLED KIT 2 PA, QL, SP200 MG/MLB CIMZIA STARTER KIT 2 PA, QL, SPB FORTESTA E PA, QLB COSENTYX (300 MG DOSE) 3 PA, ST, QL, SPB NATESTO E PA, QLB COSENTYX 150 MG/ML 3 PA, ST, QL, SPB TESTIM 1 PA, QLB COSENTYX SENSOREADY 3 PA, ST, QL, SPg testosterone cypionate 1

(300 MG)intramuscularB COSENTYX SENSOREADY PEN 3 PA, ST, QL, SPg testosterone transdermal E PA, QLg cyclosporine modified 1B VOGELXO E PA, QLB ENBREL MINI 4 PA, ST, QL, SPB VOGELXO PUMP E PA, QLB ENBREL SUBCUTANEOUS 4 PA, ST, QLHormonal Agents - Thyroid

SOLUTIONB ARMOUR THYROID 3

B ENBREL SUBCUTANEOUS 4 PA, ST, QL, SPB CYTOMEL E SOLUTION PREFILLED SYRINGEg euthyrox 1 B ENBREL SUBCUTANEOUS 4 PA, ST, QL, SPg levo-t 1 SOLUTION RECONSTITUTEDB BLEVOTHYROXINE SODIUM ORAL E ENBREL SURECLICK 4 PA, ST, QL, SP

CAPSULE B ENVARSUS XR Eg levothyroxine sodium oral tablet 1 B FIRAZYR 1 PA, QL, SPg levoxyl 1 g gengraf 1g liothyronine sodium oral 1 B HAEGARDA 2 PA, QL, SPg methimazole oral 1 B HUMIRA 2 PA, QL, SPB NATURE-THROID 3 B HUMIRA PEDIATRIC CROHNS 2 PA, QL, SPg np thyroid 1 STARTB BSYNTHROID E HUMIRA PEN 2 PA, QL, SPB BTAPAZOLE 4 HUMIRA PEN-CD/UC/HS STARTER 2 PA, QL, SPB BTHYQUIDITY E PA HUMIRA PEN-PEDIATRIC UC 2 PA, QL, SP

STARTB TIROSINT EB HUMIRA PEN-PS/UV/ADOL HS 2 PA, QL, SPB TIROSINT-SOL 4 PA

STARTg unithroid 1

B HUMIRA PEN-PSOR/UVEIT 2 PA, QL, SPB WESTHROID 3 STARTERB WP THYROID 3 g icatibant acetate E PA, QL, SP

B IMURAN E

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

3131

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

g methotrexate oral 1 Infertility Agentsg gmethotrexate sodium 1 chorionic gonadotropin 1 SP

intramuscularg methotrexate sodium (pf) 1B CRINONE 4 STg mycophenolate mofetil oral 1B ENDOMETRIN 2g mycophenolate sodium 1B FOLLISTIM AQ 2 SPB MYFORTIC Eg ganirelix acetate solution 1 (Ferring), QL, SPB NEORAL E

prefilled syringe 250 mcg/0.5ml B OLUMIANT ORAL TABLET 1 MG 2 PA, QL subcutaneousB OLUMIANT ORAL TABLET 2 MG 2 PA, QL, SP g ganirelix acetate solution 1 (Organon), QL, B ORENCIA CLICKJECT 3 PA, ST, QL, SP prefilled syringe 250 mcg/0.5ml SP

subcutaneousB ORENCIA SUBCUTANEOUS 3 PA, ST, QL, SPg novarel intramuscular solution 1 SPB OTEZLA 2 PA, QL, SP

reconstituted 10000 unitB OTREXUP E QLB NOVAREL INTRAMUSCULAR 3 SPB PROGRAF ORAL CAPSULE 4 SOLUTION RECONSTITUTED

B PROGRAF ORAL PACKET 4 PA 5000 UNITB RAPAMUNE ORAL SOLUTION 4 B OVIDREL 4 SPB RAPAMUNE ORAL TABLET E g pregnyl 1 SPB RASUVO 2 QL Inflammatory Bowel Disease AgentsB REDITREX E QL B ANALPRAM HC 4B RINVOQ 2 PA, QL, SP B ANALPRAM HC SINGLES 4B SIMPONI 2 PA, QL, SP B ANALPRAM-HC EXTERNAL 4g CREAMsirolimus oral 1

BB ANALPRAM-HC EXTERNAL 3SKYRIZI (150 MG DOSE) 2 PA, QL, SPLOTIONB STELARA SUBCUTANEOUS 2 PA, SP

B APRISO 1SOLUTIONBB ASACOL HD ESTELARA SUBCUTANEOUS 2 PA, QL, SP

SOLUTION PREFILLED SYRINGE B AZULFIDINE 4g tacrolimus oral 1 B AZULFIDINE EN-TABS 4B TAKHZYRO 2 PA, QL, SP g budesonide er EB TREMFYA 2 PA, QL, SP g budesonide oral 1B TREXALL 2 B CANASA EB XELJANZ ORAL SOLUTION 2 PA, ST, SP B CORTIFOAM 2B XELJANZ ORAL TABLET 2 PA, ST, QL, SP B DELZICOL EB XELJANZ XR ORAL TABLET 2 PA, ST, QL, SP B DIPENTUM 3

EXTENDED RELEASE 24 HOUR B ENTOCORT EC E11 MGg hydrocortisone ace-pramoxine 1B XELJANZ XR ORAL TABLET 2 PA, ST, QL external cream 1-1 %EXTENDED RELEASE 24 HOUR g hydrocort-pramoxine (perianal) 122 MGB LIALDA 1

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

3232

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

g Bmesalamine er oral capsule E ILEVRO E0.375 gm B INVELTYS 3

g mesalamine oral E g ketorolac tromethamine ophthalmic 1g mesalamine rectal enema 1 B LASTACAFT 3 QLg mesalamine rectal suppository 1 QL B LOTEMAX OPHTHALMIC 3B ORTIKOS E OINTMENTB BPENTASA E LOTEMAX OPHTHALMIC E QL

SUSPENSIONB PROCORT EB LOTEMAX SM 3 QLB PROCTOFOAM HC 2g loteprednol etabonate ophthalmic EB SFROWASA 4

gelg sulfasalazine oral 1

g loteprednol etabonate ophthalmic 1 QLB UCERIS ORAL 1 suspensionB UCERIS RECTAL 2 B MAXITROL 4

Metabolic Bone Disease Agents - Drugs for Osteoporosis B MOXEZA 4g alendronate sodium 1 g moxifloxacin hcl (2x day) 1B BINOSTO E QL g moxifloxacin hcl ophthalmic 1B BONIVA ORAL 4 solutiong gcalcitriol oral 1 neomycin-polymyxin-dexameth 1

ophthalmic ointmentB FOSAMAX 4g neomycin-polymyxin-dexameth 1g ibandronate sodium oral 1

ophthalmic suspension B RAYALDEE E 3.5-10000-0.1B ROCALTROL 4 B NEVANAC 4B TERIPARATIDE (RECOMBINANT) 3 PA B OCUFLOX 4B TYMLOS 3 PA, SP g ofloxacin ophthalmic 1

Ophthalmic Agents - Drugs for Eye Allergy, Infection and g olopatadine hcl ophthalmic solution 1Inflammation 0.1 %

B ACULAR 4 g olopatadine hcl ophthalmic solution EB ACULAR LS 4 0.2 %B gACUVAIL E polymyxin b-trimethoprim 1B BALREX 4 QL POLYTRIM 4B BAZASITE 3 PRED FORTE Eg Bazelastine hcl ophthalmic 1 PRED MILD 3B gBESIVANCE 3 prednisolone acetate ophthalmic 1B BCILOXAN OPHTHALMIC 3 TOBRADEX OPHTHALMIC 3

OINTMENT OINTMENTB BCILOXAN OPHTHALMIC 4 TOBRADEX OPHTHALMIC 4

SOLUTION SUSPENSIONg Bciprofloxacin hcl ophthalmic 1 TOBRADEX ST Eg gerythromycin ophthalmic 1 H-PA tobramycin ophthalmic 1 QLB gEYSUVIS E QL tobramycin-dexamethasone 1

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

3333

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

B TOBREX OPHTHALMIC OINTMENT 3 QL Ophthalmic Agents - Drugs for Miscellaneous Eye ConditionsB TOBREX OPHTHALMIC SOLUTION 4 QL

B CEQUA E PA, QLB VIGAMOX EB FLAREX 2Ophthalmic Agents - Drugs for GlaucomaB RESTASIS 4 PA, QLB ALPHAGAN P OPHTHALMIC 2 QLBSOLUTION 0.1 % RESTASIS MULTIDOSE E PA, QL

B BALPHAGAN P OPHTHALMIC 4 QL XIIDRA 4 PA, QLSOLUTION 0.15 % Otic Agents - Drugs for Ear Conditions

B AZOPT 4 QL B CIPRODEX 1B BETIMOL 2 QL g ciprofloxacin-dexamethasone Eg bimatoprost ophthalmic E QL g neomycin-polymyxin-hc otic 1g brimonidine tartrate ophthalmic 1 QL g ofloxacin otic 1

solution 0.15 %Respiratory - Drugs for Anaphylaxis

g brimonidine tartrate ophthalmic 1B AUVI-Q E QLsolution 0.2 %g epinephrine injection solution auto- E (generic for g brinzolamide 1 QL

injector 0.15 mg/0.15ml Adrenaclick), QLB COMBIGAN 2 QL

g epinephrine solution auto-injector E (generic for B COSOPT 4 0.15 mg/0.3ml injection EpiPen-Single B COSOPT PF E QL Pack), QLg gdorzolamide hcl-timolol mal 1 epinephrine solution auto-injector 1 (generic for

0.15 mg/0.3ml injection EpiPen), QLg dorzolamide hcl-timolol mal pf E QLg epinephrine solution auto-injector E (generic for B ISTALOL 4

0.3 mg/0.3ml injection EpiPen-Single g latanoprost ophthalmic 1 Pack), QLB LUMIGAN 2 B EPINEPHRINE SOLUTION E (generic for B RHOPRESSA 3 QL AUTO-INJECTOR 0.3 MG/0.3ML Adrenaclick), QL

INJECTIONB ROCKLATAN 3 QLg epinephrine solution auto-injector 1 (generic for g timolol maleate ophthalmic 1

0.3 mg/0.3ml injection EpiPen), QLg timolol maleate pf 1g epinephrine solution auto-injector E QLB TIMOPTIC 4 0.3 mg/0.3ml injection

B TIMOPTIC OCUDOSE 2 B EPIPEN 2-PAK E QLOPHTHALMIC SOLUTION 0.25 %B EPIPEN JR 2-PAK E QLB TIMOPTIC OCUDOSE 4B SYMJEPI 2 QLOPHTHALMIC SOLUTION 0.5 %

Respiratory Tract / Pulmonary Agents - Drugs for B TIMOPTIC-XE 4Allergies, Cough, ColdB TRAVATAN Z E QL

g azelastine hcl nasal solution 0.1 %, 1g travoprost (bak free) 1 QL 137 mcg/sprayB VYZULTA E ST, QL g azelastine hcl nasal solution 0.15 % EB XALATAN E g benzonatate oral capsule 100 mg, 1B XELPROS 3 QL 200 mg

g benzonatate oral capsule 150 mg E

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

3434

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

g Bcyproheptadine hcl oral 1 ASMANEX HFA E QLg Bfluticasone propionate nasal 1 QL ATROVENT HFA 3 QLg Bhydrocodone polst-chlorphen polst 1 PA, QL BEVESPI AEROSPHERE 2 QL

er susp B BREO ELLIPTA 3 QL, RSg ipratropium bromide nasal 1 B BREZTRI AEROSPHERE 3 QL, RSg levocetirizine dihydrochloride oral 1 g budesonide inhalation 1 QL

OMNARIS E QL B BUDESONIDE-FORMOTEROL E QL, RSg promethazine hcl oral solution 1 FUMARATEg Bpromethazine hcl oral syrup 1 COMBIVENT RESPIMAT 3 QLg Bpromethazine-codeine 1 PA, QL FASENRA PEN 4 PA, QLg Bpromethazine-dm 1 FLOVENT DISKUS 1 QLg Bpseudoephedrine-bromphen-dm 1 FLOVENT HFA 1 QLB gTESSALON PERLES 4 fluticasone-salmeterol inhalation E QL

aerosol powder breath activated B TUSSICAPS 3 PA, QL100-50 mcg/dose, 250-50 mcg/

B XHANCE E QL dose, 500-50 mcg/doseB ZETONNA 3 QL B FLUTICASONE-SALMETEROL 1 QL

Respiratory Tract / Pulmonary Agents - Drugs for INHALATION AEROSOL POWDER Asthma and COPD BREATH ACTIVATED 113-14 MCG/

ACT, 232-14 MCG/ACT, 55-14 MCG/B ADVAIR DISKUS 1 QLACT

B ADVAIR HFA 3 QL, RSB INCRUSE ELLIPTA E QL

B AIRDUO RESPICLICK 113/14 E QLg ipratropium-albuterol 1B AIRDUO RESPICLICK 232/14 E QLB LEVALBUTEROL HFA INHALATION 3 QL

B AIRDUO RESPICLICK 55/14 E QL AEROSOL 45 MCG/ACTg albuterol sulfate er 1 g montelukast sodium oral 1g albuterol sulfate hfa aerosol solution 1 (ProAir HFA or B NUCALA SUBCUTANEOUS 4 PA, QL, SP

108 (90 base) mcg/act inhalation Proventil HFA), SOLUTION AUTO-INJECTORQL

B NUCALA SUBCUTANEOUS 4 PA, QL, SPB ALBUTEROL SULFATE HFA E (Ventolin HFA), SOLUTION PREFILLED SYRINGE

AEROSOL SOLUTION 108 (90 QLB PERFOROMIST 3 QLBASE) MCG/ACT INHALATIONB PROAIR HFA E QLg albuterol sulfate inhalation 1B PROAIR RESPICLICK E QLg albuterol sulfate oral syrup 1B PROVENTIL HFA E QLg albuterol sulfate oral tablet 1 PAB PULMICORT FLEXHALER 1 QLB ALVESCO E QLB PULMICORT SUSPENSION E QLB ANORO ELLIPTA 3 QLB QVAR REDIHALER E QLB ARNUITY ELLIPTA 1 QLB SEREVENT DISKUS 2 QLB ASMANEX (120 METERED DOSES) E QLB SINGULAIR ORAL PACKET 3B ASMANEX (14 METERED DOSES) E QLB SINGULAIR ORAL TABLET EB ASMANEX (30 METERED DOSES) E QLB SINGULAIR ORAL TABLET EB ASMANEX (60 METERED DOSES) E QL

CHEWABLEB ASMANEX (7 METERED DOSES) E QL

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

3535

Drug Name Drug Requirements Drug Name Drug RequirementsTier  & Limits Tier  & Limits

B gSPIRIVA HANDIHALER 2 QL cyclobenzaprine hcl oral tablet E7.5 mgB SPIRIVA RESPIMAT 2 QL

B FEXMID EB STRIVERDI RESPIMAT 2 QLg metaxalone 1B SYMBICORT 3 QL, RSg methocarbamol oral 1B TRELEGY ELLIPTA 3 QL, RSB OZOBAX 4 PAB VENTOLIN HFA E QLB ROBAXIN-750 4g wixela inhub E QLB SKELAXIN EB XOPENEX HFA 3 QLB SOMA ORAL TABLET 250 MG EB YUPELRI 4 PA, QLB SOMA ORAL TABLET 350 MG ERespiratory Tract / Pulmonary Agents - Drugs for Cystic g tizanidine hcl oral 1FibrosisBB VANADOM EBETHKIS E PA, QL, SPBB KITABIS PAK E PA, QL, SP ZANAFLEX 4

B Sleep Disorder AgentsPULMOZYME 2 PA, QL, SPBB AMBIEN E QLTOBI NEBULIZER E PA, QL, SPBB TOBI PODHALER 3 PA, QL, SP AMBIEN CR E QL

g B BELSOMRA 4 ST, QLtobramycin inhalation nebulization 1 PA, QL, SPsolution 300 mg/4ml B DAYVIGO 4 ST, QL

g tobramycin nebulization solution E PA, QL, SP B EDLUAR E QL300 mg/5ml inhalation

g eszopiclone 1 QLB TOBRAMYCIN NEBULIZATION E PA, QL, SP

B LUNESTA E QLSOLUTION 300 MG/5ML g modafinil 1 PA, QLINHALATIONB PROVIGIL E PA, QLRespiratory Tract / Pulmonary Agents - Drugs for

Pulmonary Hypertension B RESTORIL 4B ADEMPAS 2 PA, QL, SP B SUNOSI 3 PA, QLg bosentan 1 PA, QL, SP g temazepam 1B OPSUMIT 2 PA, QL, SP B WAKIX 4 PA, QL, SPB TRACLEER 2 PA, QL, SP B XYREM 4 PA, QL, SPB TYVASO 2 PA, SP B XYWAV 4 PA, QL, SPB TYVASO REFILL 2 PA, SP g zolpidem tartrate er 1 QLB TYVASO STARTER 2 PA, SP g zolpidem tartrate oral 1 QL

Skeletal Muscle Relaxants - Drugs for Muscle Pain and g zolpidem tartrate sublingual E QLSpasm B ZOLPIMIST 4 ST, QL

B AMRIX Eg baclofen oral 1g carisoprodol oral tablet 250 mg Eg carisoprodol oral tablet 350 mg 1g cyclobenzaprine hcl er Eg cyclobenzaprine hcl oral tablet 1

10 mg, 5 mg

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as First Start in New Jersey).

3636

IndexA ADVAIR DISKUS. . . . . . . . . . . . . . . . . .35 alprazolam oral . . . . . . . . . . . . . . . . . . .15

ADVAIR HFA . . . . . . . . . . . . . . . . . . . . .35 alprazolam xr . . . . . . . . . . . . . . . . . . . .15ABILIFY . . . . . . . . . . . . . . . . . . . . . . . . .14ADVATE . . . . . . . . . . . . . . . . . . . . . . . . .24 ALREX . . . . . . . . . . . . . . . . . . . . . . . . . .33ABSORICA . . . . . . . . . . . . . . . . . . . . . .20ADYNOVATE . . . . . . . . . . . . . . . . . . . . .24 ALTACE . . . . . . . . . . . . . . . . . . . . . . . . .16ACCU-CHEK FASTCLIX LANCET

KIT . . . . . . . . . . . . . . . . . . . . . . . . . . . . .22 afirmelle. . . . . . . . . . . . . . . . . . . . . . . . .27 altavera . . . . . . . . . . . . . . . . . . . . . . . . .27ACCU-CHEK FASTCLIX LANCETS . .22 AFREZZA . . . . . . . . . . . . . . . . . . . . . . .23 ALTOPREV . . . . . . . . . . . . . . . . . . . . . .16accu-chek guide kit w/device . . . . . . .22 AFSTYLA INTRAVENOUS KIT 1000 ALTRENO . . . . . . . . . . . . . . . . . . . . . . .20

UNIT, 2000 UNIT, 250 UNIT, 3000 Accu-Chek Guide Me. . . . . . . . . . . . . .22 ALUNBRIG . . . . . . . . . . . . . . . . . . . . . .14UNIT, 500 UNIT. . . . . . . . . . . . . . . . . . .24ACCU-CHEK GUIDE ME METER . . . .22 ALVESCO . . . . . . . . . . . . . . . . . . . . . . .35AFSTYLA INTRAVENOUS KIT 1500 ACCU-CHEK GUIDE TEST STRIPS . .22 alyacen 1/35 . . . . . . . . . . . . . . . . . . . . .27UNIT, 2500 UNIT. . . . . . . . . . . . . . . . . .24

ACCU-CHEK SOFTCLIX LANCET AMARYL . . . . . . . . . . . . . . . . . . . . . . . .24AIMOVIG SUBCUTANEOUS DEVICE KIT . . . . . . . . . . . . . . . . . . . . . .22 AMBIEN. . . . . . . . . . . . . . . . . . . . . . . . .36SOLUTION AUTO-INJECTOR ACCU-CHEK SOFTXLIX LANCETS . .22 140 MG/ML, 70 MG/ML . . . . . . . . . . .13 AMBIEN CR . . . . . . . . . . . . . . . . . . . . .36ACCUPRIL. . . . . . . . . . . . . . . . . . . . . . .16 AIRDUO RESPICLICK 113/14 . . . . . . .35 AMERGE . . . . . . . . . . . . . . . . . . . . . . . .13accutane . . . . . . . . . . . . . . . . . . . . . . . .20 AIRDUO RESPICLICK 232/14. . . . . . .35 amethia . . . . . . . . . . . . . . . . . . . . . . . . .27acetaminophen-codeine . . . . . . . . . . . .8 AIRDUO RESPICLICK 55/14 . . . . . . . .35 amethia lo . . . . . . . . . . . . . . . . . . . . . . .27acetaminophen-codeine #2 . . . . . . . . .8 ALA SCALP. . . . . . . . . . . . . . . . . . . . . .20 amiodarone hcl oral . . . . . . . . . . . . . . .16acetaminophen-codeine #3 . . . . . . . . .8 ala-cort external cream 1 %. . . . . . . . .20 amitriptyline hcl oral. . . . . . . . . . . . . . . 12acetaminophen-codeine #4 . . . . . . . . .8 ala-cort external cream 2.5 % . . . . . . .20 amlodipine besylate oral . . . . . . . . . . .16acetazolamide er . . . . . . . . . . . . . . . . .16 albuterol sulfate er . . . . . . . . . . . . . . . .35 amlodipine besylate-benazepril hcl . .16acetazolamide oral . . . . . . . . . . . . . . . .16 albuterol sulfate hfa aerosol amlodipine besylate-valsartan . . . . . .16

solution 108 (90 base) mcg/act ACIPHEX . . . . . . . . . . . . . . . . . . . . . . . .25 amnesteem . . . . . . . . . . . . . . . . . . . . . .20inhalation. . . . . . . . . . . . . . . . . . . . . . . .35ACIPHEX SPRINKLE . . . . . . . . . . . . . .25 amoxicillin . . . . . . . . . . . . . . . . . . . . . . .10albuterol sulfate inhalation. . . . . . . . . .35ACTEMRA ACTPEN . . . . . . . . . . . . . . .31 amoxicillin-potassium clavulanate albuterol sulfate oral syrup . . . . . . . . .35ACTEMRA SUBCUTANEOUS. . . . . . .31 er . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .10albuterol sulfate oral tablet . . . . . . . . .35ACTICLATE . . . . . . . . . . . . . . . . . . . . . .10 amoxicillin-potassium clavulanate ALDACTONE. . . . . . . . . . . . . . . . . . . . .16 oral . . . . . . . . . . . . . . . . . . . . . . . . . . . . .10ACTOS. . . . . . . . . . . . . . . . . . . . . . . . . .23ALDARA . . . . . . . . . . . . . . . . . . . . . . . .20 amphetamine-dextroamphetamine . .18ACULAR . . . . . . . . . . . . . . . . . . . . . . . .33ALECENSA . . . . . . . . . . . . . . . . . . . . . . 14 amphetamine-dextroamphetamine ACULAR LS . . . . . . . . . . . . . . . . . . . . .33

er . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .18alendronate sodium . . . . . . . . . . . . . . .33ACUVAIL . . . . . . . . . . . . . . . . . . . . . . . .33AMPYRA . . . . . . . . . . . . . . . . . . . . . . . .19alfuzosin hcl er . . . . . . . . . . . . . . . . . . .27acyclovir oral . . . . . . . . . . . . . . . . . . . . .15AMRIX . . . . . . . . . . . . . . . . . . . . . . . . . .36aliskiren fumarate . . . . . . . . . . . . . . . . .16ACZONE EXTERNAL GEL 5 % . . . . . .20AMZEEQ . . . . . . . . . . . . . . . . . . . . . . . .20ALKINDI SPRINKLE . . . . . . . . . . . . . . .30ACZONE EXTERNAL GEL 7.5 %. . . . .20ANALPRAM HC . . . . . . . . . . . . . . . . . .32allopurinol oral . . . . . . . . . . . . . . . . . . . 13ADDERALL . . . . . . . . . . . . . . . . . . . . . . 18ANALPRAM HC SINGLES. . . . . . . . . .32ALOGLIPTIN BENZOATE. . . . . . . . . . .24ADDERALL XR . . . . . . . . . . . . . . . . . . .18ANALPRAM-HC EXTERNAL ALOGLIPTIN-METFORMIN HCL . . . .24ADDYI . . . . . . . . . . . . . . . . . . . . . . . . . .25CREAM . . . . . . . . . . . . . . . . . . . . . . . . .32ALOGLIPTIN-PIOGLITAZONE. . . . . . .24ADEMPAS . . . . . . . . . . . . . . . . . . . . . . .36ANALPRAM-HC EXTERNAL ALORA. . . . . . . . . . . . . . . . . . . . . . . . . .27ADHANSIA XR . . . . . . . . . . . . . . . . . . . 18 LOTION . . . . . . . . . . . . . . . . . . . . . . . . .32

ALPHAGAN P OPHTHALMIC ADLYXIN . . . . . . . . . . . . . . . . . . . . . . . .23 ANASPAZ . . . . . . . . . . . . . . . . . . . . . . .26SOLUTION 0.1 % . . . . . . . . . . . . . . . . .34ADLYXIN STARTER PACK. . . . . . . . . .23 anastrozole oral . . . . . . . . . . . . . . . . . .14ALPHAGAN P OPHTHALMIC ADMELOG. . . . . . . . . . . . . . . . . . . . . . .23 ANDRODERM. . . . . . . . . . . . . . . . . . . .31SOLUTION 0.15 % . . . . . . . . . . . . . . . .34ADMELOG SOLOSTAR . . . . . . . . . . . .23 ANDROGEL . . . . . . . . . . . . . . . . . . . . .31alprazolam er . . . . . . . . . . . . . . . . . . . . 15ADRENACLICK. . . . . . . . . . . . . . . . . . .34 ANDROGEL PUMP . . . . . . . . . . . . . . .31alprazolam intensol . . . . . . . . . . . . . . . 15

37

ANORO ELLIPTA . . . . . . . . . . . . . . . . .35 aurovela fe 1.5/30. . . . . . . . . . . . . . . . .27 bd ultra-fine pen needles. . . . . . . . . . .22apap-caff-dihydrocodeine . . . . . . . . . . .8 AURYXIA . . . . . . . . . . . . . . . . . . . . . . . .26 bekyree . . . . . . . . . . . . . . . . . . . . . . . . .27APOKYN . . . . . . . . . . . . . . . . . . . . . . . .14 AUSTEDO . . . . . . . . . . . . . . . . . . . . . . .19 BELBUCA . . . . . . . . . . . . . . . . . . . . . . . .8apri . . . . . . . . . . . . . . . . . . . . . . . . . . . . .27 AUVI-Q. . . . . . . . . . . . . . . . . . . . . . . . . .34 BELSOMRA . . . . . . . . . . . . . . . . . . . . .36APRISO . . . . . . . . . . . . . . . . . . . . . . . . .32 AVALIDE . . . . . . . . . . . . . . . . . . . . . . . .16 benazepril hcl oral . . . . . . . . . . . . . . . .16APTENSIO XR. . . . . . . . . . . . . . . . . . . .18 AVAPRO . . . . . . . . . . . . . . . . . . . . . . . .16 benazepril-hydrochlorothiazide . . . . .16ARAKODA . . . . . . . . . . . . . . . . . . . . . . .14 AVAR CLEANSER . . . . . . . . . . . . . . . .20 BENICAR. . . . . . . . . . . . . . . . . . . . . . . .16ARANESP (ALBUMIN FREE). . . . . . . .24 AVAR LS CLEANSER. . . . . . . . . . . . . .20 BENICAR HCT . . . . . . . . . . . . . . . . . . .16ARICEPT ORAL TABLET. . . . . . . . . . .12 AVAR-E EMOLLIENT . . . . . . . . . . . . . .20 benzonatate oral capsule 100 mg,

200 mg. . . . . . . . . . . . . . . . . . . . . . . . . .34ARIMIDEX . . . . . . . . . . . . . . . . . . . . . . .14 AVAR-E GREEN . . . . . . . . . . . . . . . . . .20benzonatate oral capsule 150 mg. . . .34aripiprazole oral solution . . . . . . . . . . .14 AVAR-E LS. . . . . . . . . . . . . . . . . . . . . . .20BESIVANCE . . . . . . . . . . . . . . . . . . . . .33aripiprazole oral tablet . . . . . . . . . . . . . 14 aviane . . . . . . . . . . . . . . . . . . . . . . . . . .27betamethasone dipropionate aug. . . .20aripiprazole oral tablet dispersible . . . 14 avidoxy. . . . . . . . . . . . . . . . . . . . . . . . . .10betamethasone dipropionate ARMOUR THYROID. . . . . . . . . . . . . . .31 AVITA . . . . . . . . . . . . . . . . . . . . . . . . . . .20external . . . . . . . . . . . . . . . . . . . . . . . . .20

ARNUITY ELLIPTA . . . . . . . . . . . . . . . .35 AVONEX PEN . . . . . . . . . . . . . . . . . . . .19BETAPACE . . . . . . . . . . . . . . . . . . . . . .16

ASACOL HD . . . . . . . . . . . . . . . . . . . . .32 AVONEX PREFILLED . . . . . . . . . . . . . .19BETASERON. . . . . . . . . . . . . . . . . . . . .19

asenapine maleate . . . . . . . . . . . . . . . .14 AYGESTIN . . . . . . . . . . . . . . . . . . . . . . .27BETHKIS . . . . . . . . . . . . . . . . . . . . . . . .36

ashlyna . . . . . . . . . . . . . . . . . . . . . . . . .27 ayuna . . . . . . . . . . . . . . . . . . . . . . . . . . .27BETIMOL. . . . . . . . . . . . . . . . . . . . . . . .34

ASMANEX (120 METERED DOSES). .35 AZASAN . . . . . . . . . . . . . . . . . . . . . . . .31BEVESPI AEROSPHERE . . . . . . . . . . .35

ASMANEX (14 METERED DOSES). . .35 AZASITE . . . . . . . . . . . . . . . . . . . . . . . .33bexarotene . . . . . . . . . . . . . . . . . . . . . .14

ASMANEX (30 METERED DOSES). . .35 azathioprine oral. . . . . . . . . . . . . . . . . .31BEYAZ . . . . . . . . . . . . . . . . . . . . . . . . . .27

ASMANEX (60 METERED DOSES). . .35 azelaic acid external. . . . . . . . . . . . . . .20BIDIL . . . . . . . . . . . . . . . . . . . . . . . . . . .16

ASMANEX (7 METERED DOSES). . . .35 azelastine hcl nasal solution 0.1 %, BIJUVA . . . . . . . . . . . . . . . . . . . . . . . . .27137 mcg/spray . . . . . . . . . . . . . . . . . . .34ASMANEX HFA. . . . . . . . . . . . . . . . . . .35bimatoprost ophthalmic. . . . . . . . . . . .34azelastine hcl nasal solution 0.15 % . .34ASTAGRAF XL . . . . . . . . . . . . . . . . . . .31BINOSTO. . . . . . . . . . . . . . . . . . . . . . . .33azelastine hcl ophthalmic . . . . . . . . . .33atenolol oral . . . . . . . . . . . . . . . . . . . . .16bisoprolol fumarate oral. . . . . . . . . . . . 16azithromycin oral . . . . . . . . . . . . . . . . .10atenolol-chlorthalidone . . . . . . . . . . . .16bisoprolol-hydrochlorothiazide . . . . . .16AZOPT. . . . . . . . . . . . . . . . . . . . . . . . . .34ATIVAN ORAL. . . . . . . . . . . . . . . . . . . .16blisovi 24 fe . . . . . . . . . . . . . . . . . . . . . .27AZULFIDINE . . . . . . . . . . . . . . . . . . . . .32atomoxetine hcl . . . . . . . . . . . . . . . . . .18blisovi fe 1/20 . . . . . . . . . . . . . . . . . . . .27AZULFIDINE EN-TABS. . . . . . . . . . . . .32atorvastatin calcium oral tablet blisovi fe 1.5/30. . . . . . . . . . . . . . . . . . .2710 mg, 20 mg . . . . . . . . . . . . . . . . . . . .16 azurette . . . . . . . . . . . . . . . . . . . . . . . . .27BONIVA ORAL . . . . . . . . . . . . . . . . . . .33atorvastatin calcium oral tablet

B40 mg, 80 mg . . . . . . . . . . . . . . . . . . . .16 BONJESTA . . . . . . . . . . . . . . . . . . . . . . 12bac . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .8atovaquone-proguanil hcl . . . . . . . . . .14 bosentan . . . . . . . . . . . . . . . . . . . . . . . .36baclofen oral . . . . . . . . . . . . . . . . . . . . .36ATRALIN . . . . . . . . . . . . . . . . . . . . . . . .20 bp 10-1. . . . . . . . . . . . . . . . . . . . . . . . . .20BACTRIM . . . . . . . . . . . . . . . . . . . . . . .10ATRIPLA . . . . . . . . . . . . . . . . . . . . . . . .15 BREO ELLIPTA . . . . . . . . . . . . . . . . . . .35BACTRIM DS . . . . . . . . . . . . . . . . . . . .10ATROVENT HFA . . . . . . . . . . . . . . . . . .35 BREZTRI AEROSPHERE. . . . . . . . . . .35BAFIERTAM . . . . . . . . . . . . . . . . . . . . . 19AUBAGIO . . . . . . . . . . . . . . . . . . . . . . .19 briellyn . . . . . . . . . . . . . . . . . . . . . . . . . .27balziva . . . . . . . . . . . . . . . . . . . . . . . . . .27aubra . . . . . . . . . . . . . . . . . . . . . . . . . . .27 BRILINTA. . . . . . . . . . . . . . . . . . . . . . . .14BAQSIMI ONE PACK . . . . . . . . . . . . . .24aubra eq . . . . . . . . . . . . . . . . . . . . . . . .27 brimonidine tartrate ophthalmic

solution 0.15 % . . . . . . . . . . . . . . . . . . .34BAQSIMI TWO PACK . . . . . . . . . . . . . .24AUGMENTIN. . . . . . . . . . . . . . . . . . . . .10brimonidine tartrate ophthalmic BARACLUDE ORAL SOLUTION. . . . .15AUGMENTIN ES-600 . . . . . . . . . . . . . .10solution 0.2 % . . . . . . . . . . . . . . . . . . . .34BARACLUDE ORAL TABLET . . . . . . .15aurovela 1/20 . . . . . . . . . . . . . . . . . . . .27brinzolamide . . . . . . . . . . . . . . . . . . . . .34BASAGLAR KWIKPEN. . . . . . . . . . . . .23aurovela 1.5/30 . . . . . . . . . . . . . . . . . . .27budesonide er. . . . . . . . . . . . . . . . . . . .32bd autoshield duo pen needles . . . . .22aurovela 24 fe . . . . . . . . . . . . . . . . . . . .27budesonide inhalation . . . . . . . . . . . . .35bd ultra-fine insulin syringes . . . . . . . .22aurovela fe 1/20 . . . . . . . . . . . . . . . . . .27

38

budesonide oral . . . . . . . . . . . . . . . . . .32 CARDIZEM LA . . . . . . . . . . . . . . . . . . .16 CIPRO ORAL TABLET . . . . . . . . . . . . .10BUDESONIDE-FORMOTEROL CARDURA. . . . . . . . . . . . . . . . . . . . . . .16 CIPRODEX . . . . . . . . . . . . . . . . . . . . . .34FUMARATE. . . . . . . . . . . . . . . . . . . . . .35 carisoprodol oral tablet 250 mg . . . . .36 ciprofloxacin hcl ophthalmic . . . . . . . .33BUNAVAIL . . . . . . . . . . . . . . . . . . . . . . . .9 carisoprodol oral tablet 350 mg . . . . .36 ciprofloxacin hcl oral . . . . . . . . . . . . . .10buprenorphine hcl sublingual . . . . . . . .9 CAROSPIR . . . . . . . . . . . . . . . . . . . . . .16 ciprofloxacin-dexamethasone. . . . . . .34buprenorphine hcl-naloxone hcl . . . . . .9 cartia xt . . . . . . . . . . . . . . . . . . . . . . . . .16 citalopram hydrobromide . . . . . . . . . .12bupropion hcl er (sr) . . . . . . . . . . . . . . .12 carvedilol . . . . . . . . . . . . . . . . . . . . . . . .16 claravis. . . . . . . . . . . . . . . . . . . . . . . . . .20bupropion hcl er (xl) oral tablet CATAFLAM . . . . . . . . . . . . . . . . . . . . . . .9 clarithromycin er. . . . . . . . . . . . . . . . . .10extended release 24 hour 150 mg,

cavarest . . . . . . . . . . . . . . . . . . . . . . . . .19 clarithromycin oral . . . . . . . . . . . . . . . .10300 mg . . . . . . . . . . . . . . . . . . . . . . . . .12cefadroxil. . . . . . . . . . . . . . . . . . . . . . . .10 CLENPIQ . . . . . . . . . . . . . . . . . . . . . . . .26BUPROPION HCL ER (XL) ORAL cefdinir. . . . . . . . . . . . . . . . . . . . . . . . . .10 CLEOCIN ORAL CAPSULE TABLET EXTENDED RELEASE

150 MG, 300 MG . . . . . . . . . . . . . . . . .1024 HOUR 450 MG. . . . . . . . . . . . . . . . . 12 cefuroxime axetil . . . . . . . . . . . . . . . . .10CLEOCIN ORAL CAPSULE 75 MG. . .10bupropion hcl oral . . . . . . . . . . . . . . . .12 CELEBREX . . . . . . . . . . . . . . . . . . . . . . .9CLEOCIN-T . . . . . . . . . . . . . . . . . . . . . .20buspirone hcl oral. . . . . . . . . . . . . . . . .16 celecoxib oral . . . . . . . . . . . . . . . . . . . . .9CLIMARA . . . . . . . . . . . . . . . . . . . .27, 28butalbital-apap-caffeine. . . . . . . . . . . . .8 CELEXA. . . . . . . . . . . . . . . . . . . . . . . . .12CLIMARA PRO . . . . . . . . . . . . . . . . . . .27BYDUREON BCISE CELLCEPT . . . . . . . . . . . . . . . . . . . . . .31

AUTOINJECTOR. . . . . . . . . . . . . . . . . .24 clindacin etz external swab . . . . . . . . .20CENTANY . . . . . . . . . . . . . . . . . . . . . . .10BYETTA 10 MCG PEN . . . . . . . . . . . . .24 clindacin-p. . . . . . . . . . . . . . . . . . . . . . .20CENTANY AT . . . . . . . . . . . . . . . . . . . .10BYETTA 5 MCG PEN . . . . . . . . . . . . . .24 CLINDAGEL . . . . . . . . . . . . . . . . . . . . .20cephalexin. . . . . . . . . . . . . . . . . . . . . . .10BYSTOLIC . . . . . . . . . . . . . . . . . . . . . . .16 clindamycin hcl oral . . . . . . . . . . . . . . .10CEQUA . . . . . . . . . . . . . . . . . . . . . . . . .34

clindamycin phos-benzoyl perox CERDELGA . . . . . . . . . . . . . . . . . . . . . .26Cexternal gel 1.2-5 % . . . . . . . . . . . . . . .20

CHANTIX . . . . . . . . . . . . . . . . . . . . . .9, 10cabergoline . . . . . . . . . . . . . . . . . . . . . .30 clindamycin phosphate external CHANTIX CONTINUING MONTH CALAN SR. . . . . . . . . . . . . . . . . . . . . . .16 foam. . . . . . . . . . . . . . . . . . . . . . . . . . . .20PAK . . . . . . . . . . . . . . . . . . . . . . . . . . . . .9

calcipotriene-betameth diprop clindamycin phosphate external CHANTIX STARTING MONTH PAK . .10external ointment . . . . . . . . . . . . . . . . .20 lotion . . . . . . . . . . . . . . . . . . . . . . . . . . .20charlotte 24 fe . . . . . . . . . . . . . . . . . . . .27calcipotriene-betameth diprop clindamycin phosphate external chateal . . . . . . . . . . . . . . . . . . . . . . . . . .27external suspension . . . . . . . . . . . . . . .20 solution . . . . . . . . . . . . . . . . . . . . . . . . .20chateal eq . . . . . . . . . . . . . . . . . . . . . . .27calcitriol external . . . . . . . . . . . . . . . . .20 clindamycin phosphate external

swab. . . . . . . . . . . . . . . . . . . . . . . . . . . .20chlorhexidine gluconate mouth/calcitriol oral . . . . . . . . . . . . . . . . . . . . .33throat . . . . . . . . . . . . . . . . . . . . . . . . . . .19 CLINDAMYCIN PHOSPHATE GEL CALQUENCE . . . . . . . . . . . . . . . . . . . .14

1 % EXTERNAL . . . . . . . . . . . . . . . . . .20chlorthalidone. . . . . . . . . . . . . . . . . . . .16camila . . . . . . . . . . . . . . . . . . . . . . . . . .27CLINDESSE . . . . . . . . . . . . . . . . . . . . .10chorionic gonadotropin camrese. . . . . . . . . . . . . . . . . . . . . . . . .27

intramuscular . . . . . . . . . . . . . . . . . . . .32 CLINPRO 5000 . . . . . . . . . . . . . . . . . . .19camrese lo. . . . . . . . . . . . . . . . . . . . . . .27CIALIS ORAL TABLET 10 MG, clobetasol propionate external CANASA . . . . . . . . . . . . . . . . . . . . . . . .32 20 MG . . . . . . . . . . . . . . . . . . . . . . . . . .25 cream. . . . . . . . . . . . . . . . . . . . . . . . . . .20

capecitabine . . . . . . . . . . . . . . . . . . . . .14 CIALIS ORAL TABLET 2.5 MG, clobetasol propionate external CAPEX . . . . . . . . . . . . . . . . . . . . . . . . . .20 5 MG . . . . . . . . . . . . . . . . . . . . . . . . . . .25 foam. . . . . . . . . . . . . . . . . . . . . . . . . . . .20CARAC . . . . . . . . . . . . . . . . . . . . . . . . .20 ciclodan. . . . . . . . . . . . . . . . . . . . . . . . .13 clobetasol propionate external gel . . .20CARAFATE . . . . . . . . . . . . . . . . . . . . . .25 ciclopirox external . . . . . . . . . . . . . . . .13 clobetasol propionate external

liquid . . . . . . . . . . . . . . . . . . . . . . . . . . .20carbamazepine er. . . . . . . . . . . . . . . . . 11 ciclopirox treatment . . . . . . . . . . . . . . .13clobetasol propionate external carbamazepine oral . . . . . . . . . . . . . . . 11 CILOXAN OPHTHALMIC lotion . . . . . . . . . . . . . . . . . . . . . . . . . . .20OINTMENT . . . . . . . . . . . . . . . . . . . . . .33CARBATROL. . . . . . . . . . . . . . . . . . . . . 11clobetasol propionate external CILOXAN OPHTHALMIC carbidopa-levodopa . . . . . . . . . . . . . . .14ointment . . . . . . . . . . . . . . . . . . . . . . . .20SOLUTION . . . . . . . . . . . . . . . . . . . . . .33carbidopa-levodopa er. . . . . . . . . . . . . 14clobetasol propionate external CIMDUO . . . . . . . . . . . . . . . . . . . . . . . .15CARDIZEM . . . . . . . . . . . . . . . . . . . . . .16 shampoo . . . . . . . . . . . . . . . . . . . . . . . .20CIMZIA PREFILLED KIT. . . . . . . . . . . . 31CARDIZEM CD . . . . . . . . . . . . . . . . . . .16

CIMZIA STARTER KIT . . . . . . . . . . . . .31

39

clobetasol propionate external cryselle-28. . . . . . . . . . . . . . . . . . . . . . .27 DEPO-TESTOSTERONE solution . . . . . . . . . . . . . . . . . . . . . . . . .20 INTRAMUSCULAR SOLUTION CUPRIMINE . . . . . . . . . . . . . . . . . . . . .26

200 MG/ML. . . . . . . . . . . . . . . . . . . . . .31CLOBEX . . . . . . . . . . . . . . . . . . . . . . . .20 cyanocobalamin injection solution DERMA-SMOOTHE/FS BODY . . . . . .20CLOBEX SPRAY . . . . . . . . . . . . . . . . . .20 1000 mcg/ml. . . . . . . . . . . . . . . . . . . . .25DERMA-SMOOTHE/FS SCALP . . . . .20clodan external shampoo . . . . . . . . . .20 CYANOCOBALAMIN INJECTION

SOLUTION 2000 MCG/ML . . . . . . . . .25 desmopressin acetate injection . . . . .30clonazepam oral . . . . . . . . . . . . . . . . . .16cyclafem 1/35 . . . . . . . . . . . . . . . . . . . .27 desmopressin acetate oral . . . . . . . . .30clonidine hcl oral . . . . . . . . . . . . . . . . .16cyclobenzaprine hcl er. . . . . . . . . . . . .36 desogestrel-ethinyl estradiol . . . . . . . .27clopidogrel bisulfate oral . . . . . . . . . . .14cyclobenzaprine hcl oral tablet DESONATE . . . . . . . . . . . . . . . . . . . . . .20clotrimazole-betamethasone 10 mg, 5 mg . . . . . . . . . . . . . . . . . . . . .36external cream . . . . . . . . . . . . . . . . . . .20 desonide external cream. . . . . . . . . . .20cyclobenzaprine hcl oral tablet clotrimazole-betamethasone desonide external gel. . . . . . . . . . . . . .217.5 mg . . . . . . . . . . . . . . . . . . . . . . . . . .36external lotion . . . . . . . . . . . . . . . . . . . .20 desonide external lotion . . . . . . . . . . .21cyclosporine modified . . . . . . . . . . . . .31clovique . . . . . . . . . . . . . . . . . . . . . . . . .26 desonide external ointment. . . . . . . . .21CYMBALTA . . . . . . . . . . . . . . . . . . . . . .12COLCHICINE ORAL CAPSULE . . . . .13 DESOWEN. . . . . . . . . . . . . . . . . . . . . . .21cyproheptadine hcl oral . . . . . . . . . . . .35colchicine oral tablet . . . . . . . . . . . . . .13 desvenlafaxine succinate er . . . . . . . .12cyred . . . . . . . . . . . . . . . . . . . . . . . . . . .27COLCRYS . . . . . . . . . . . . . . . . . . . . . . . 13 DEXABLISS. . . . . . . . . . . . . . . . . . . . . .30cyred eq. . . . . . . . . . . . . . . . . . . . . . . . .27colesevelam hcl . . . . . . . . . . . . . . . . . .16 dexamethasone intensol . . . . . . . . . . .30CYTOMEL . . . . . . . . . . . . . . . . . . . . . . .31COMBIGAN. . . . . . . . . . . . . . . . . . . . . .34 dexamethasone oral. . . . . . . . . . . . . . .30CYTOTEC . . . . . . . . . . . . . . . . . . . . . . .25COMBIVENT RESPIMAT . . . . . . . . . . .35 DEXCOM G4 / G5 / G6 RECEIVER,

CONCERTA. . . . . . . . . . . . . . . . . . . . . . 18 TRANSMITTER, SENSOR D(INCLUDING PLATINUM, CONTOUR NEXT EZ KIT dalfampridine er . . . . . . . . . . . . . . . . . .19 PLATINUM PEDIATRIC) . . . . . . . . . . . .22W/DEVICE. . . . . . . . . . . . . . . . . . . . . . .22

dapsone external gel 5 % . . . . . . . . . .20 DEXCOM G4 / G5 / G6 RECEIVER, CONTOUR NEXT MONITOR KIT TRANSMITTER, SENSOR DAPSONE EXTERNAL GEL 7.5 % . . .20W/DEVICE. . . . . . . . . . . . . . . . . . . . . . .22(INCLUDING PLATINUM, dasetta 1/35 . . . . . . . . . . . . . . . . . . . . .27CONTOUR NEXT ONE KIT . . . . . . . . .22 PLATINUM PEDIATRIC) DEVICE . . . .22

daysee . . . . . . . . . . . . . . . . . . . . . . . . . .27CONTOUR NEXT TEST STRIPS. . . . .22 DEXEDRINE . . . . . . . . . . . . . . . . . . . . .18DAYVIGO. . . . . . . . . . . . . . . . . . . . . . . .36CONZIP . . . . . . . . . . . . . . . . . . . . . . . . . .8 DEXILANT . . . . . . . . . . . . . . . . . . . . . . .25DDAVP. . . . . . . . . . . . . . . . . . . . . . . . . .30COPAXONE. . . . . . . . . . . . . . . . . . . . . . 19 dexmethylphenidate hcl. . . . . . . . . . . .18deblitane . . . . . . . . . . . . . . . . . . . . . . . .27COREG . . . . . . . . . . . . . . . . . . . . . . . . . 16 dexmethylphenidate hcl er . . . . . . . . .18DECADRON . . . . . . . . . . . . . . . . . . . . .30coremino . . . . . . . . . . . . . . . . . . . . . . . .10 dextroamphetamine sulfate. . . . . . . . .18delyla . . . . . . . . . . . . . . . . . . . . . . . . . . .27CORGARD . . . . . . . . . . . . . . . . . . . . . .16 dextroamphetamine sulfate er . . . . . .18DELZICOL. . . . . . . . . . . . . . . . . . . . . . .32CORLANOR . . . . . . . . . . . . . . . . . . . . .16 DIASTAT ACUDIAL. . . . . . . . . . . . . . . . 11DENTA 5000 PLUS. . . . . . . . . . . . . . . .19CORTEF . . . . . . . . . . . . . . . . . . . . . . . .30 DIASTAT PEDIATRIC . . . . . . . . . . . . . . 11DENTAGEL . . . . . . . . . . . . . . . . . . . . . .19CORTIFOAM. . . . . . . . . . . . . . . . . . . . .32 diazepam intensol . . . . . . . . . . . . . . . .16DEPAKOTE . . . . . . . . . . . . . . . . . . . . . . 11COSENTYX (300 MG DOSE) . . . . . . .31 diazepam oral . . . . . . . . . . . . . . . . . . . .16DEPAKOTE ER . . . . . . . . . . . . . . . . . . . 11COSENTYX 150 MG/ML . . . . . . . . . . .31 diazepam rectal . . . . . . . . . . . . . . . . . . 11DEPAKOTE SPRINKLES . . . . . . . . . . . 11COSENTYX SENSOREADY DICLEGIS . . . . . . . . . . . . . . . . . . . . . . . 12

(300 MG) . . . . . . . . . . . . . . . . . . . . . . . .31 DEPEN TITRATABS . . . . . . . . . . . . . . .26diclofenac potassium. . . . . . . . . . . . . . .9

COSENTYX SENSOREADY PEN . . . .31 DEPO-PROVERA diclofenac sodium er . . . . . . . . . . . . . . .9INTRAMUSCULAR SUSPENSION . . .27COSOPT . . . . . . . . . . . . . . . . . . . . . . . .34diclofenac sodium external gel 1 % . . .9DEPO-PROVERA COSOPT PF . . . . . . . . . . . . . . . . . . . . .34diclofenac sodium external solution. . .9INTRAMUSCULAR SUSPENSION COZAAR . . . . . . . . . . . . . . . . . . . . . . . .16 PREFILLED SYRINGE . . . . . . . . . . . . .27 diclofenac sodium oral. . . . . . . . . . . . . .9

CREON . . . . . . . . . . . . . . . . . . . . . . . . .26 DEPO-SUBQ PROVERA 104. . . . . . . .27 dicyclomine hcl oral . . . . . . . . . . . . . . .26CRESEMBA ORAL. . . . . . . . . . . . . . . .13 DEPO-TESTOSTERONE DIFICID . . . . . . . . . . . . . . . . . . . . . . . . .10CRESTOR . . . . . . . . . . . . . . . . . . . . . . .16 INTRAMUSCULAR SOLUTION DIFLUCAN ORAL SUSPENSION 100 MG/ML. . . . . . . . . . . . . . . . . . . . . .31CRINONE . . . . . . . . . . . . . . . . . . . . . . .32 RECONSTITUTED . . . . . . . . . . . . . . . .13

40

DIFLUCAN ORAL TABLET 100 MG, doxycycline monohydrate oral emtricitabine-tenofovir df oral tablet 150 MG, 200 MG . . . . . . . . . . . . . . . . . 13 tablet . . . . . . . . . . . . . . . . . . . . . . . . . . .10 100-150 mg, 133-200 mg,

167-250 mg . . . . . . . . . . . . . . . . . . . . . .15DIFLUCAN ORAL TABLET 50 MG . . .13 doxylamine-pyridoxine. . . . . . . . . . . . . 12emtricitabine-tenofovir df oral tablet DILAUDID ORAL . . . . . . . . . . . . . . . . . .8 DRISDOL. . . . . . . . . . . . . . . . . . . . . . . .25200-300 mg. . . . . . . . . . . . . . . . . . . . . .15

dilt-xr . . . . . . . . . . . . . . . . . . . . . . . . . . .16 DRIZALMA SPRINKLE. . . . . . . . . . . . . 12enalapril maleate oral. . . . . . . . . . . . . .16

diltiazem hcl er . . . . . . . . . . . . . . . . . . .16 drospiren-eth estrad-levomefol . . . . . .27ENBREL MINI . . . . . . . . . . . . . . . . . . . .31

diltiazem hcl er coated beads . . . . . . .16 drospirenone-ethinyl estradiol . . . . . .27ENBREL SUBCUTANEOUS

diltiazem hcl oral. . . . . . . . . . . . . . . . . .16 DUAVEE. . . . . . . . . . . . . . . . . . . . . . . . .27 SOLUTION . . . . . . . . . . . . . . . . . . . . . .31DIOVAN . . . . . . . . . . . . . . . . . . . . . . . . .16 duloxetine hcl oral capsule delayed ENBREL SUBCUTANEOUS

release particles 20 mg, 30 mg, 60 DIOVAN HCT. . . . . . . . . . . . . . . . . . . . .16 SOLUTION PREFILLED SYRINGE . . .31mg . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12

DIPENTUM . . . . . . . . . . . . . . . . . . . . . .32 ENBREL SUBCUTANEOUS duloxetine hcl oral capsule delayed SOLUTION RECONSTITUTED . . . . . .31diphenoxylate-atropine . . . . . . . . . . . .26 release particles 40 mg . . . . . . . . . . . . 12

ENBREL SURECLICK . . . . . . . . . . . . .31DIPROLENE . . . . . . . . . . . . . . . . . . . . .21 DUOPA . . . . . . . . . . . . . . . . . . . . . . . . .14ENDARI . . . . . . . . . . . . . . . . . . . . . . . . .26DIPROLENE AF . . . . . . . . . . . . . . . . . .21 DUPIXENT. . . . . . . . . . . . . . . . . . . . . . .21endocet . . . . . . . . . . . . . . . . . . . . . . . . . .8DITROPAN XL. . . . . . . . . . . . . . . . . . . .26 DURAGESIC-100 . . . . . . . . . . . . . . . . . .8ENDOMETRIN . . . . . . . . . . . . . . . . . . .32divalproex sodium er . . . . . . . . . . . . . . 11 DURAGESIC-12 . . . . . . . . . . . . . . . . . . .8enoxaparin sodium. . . . . . . . . . . . . . . . 11divalproex sodium oral. . . . . . . . . . . . . 11 DURAGESIC-25 . . . . . . . . . . . . . . . . . . .8enskyce . . . . . . . . . . . . . . . . . . . . . . . . .27DIVIGEL. . . . . . . . . . . . . . . . . . . . . . . . .27 DURAGESIC-50 . . . . . . . . . . . . . . . . . . .8ENSTILAR . . . . . . . . . . . . . . . . . . . . . . .21donepezil hcl oral tablet 10 mg, DURAGESIC-75 . . . . . . . . . . . . . . . . . . .8

5 mg. . . . . . . . . . . . . . . . . . . . . . . . . . . .12 entecavir . . . . . . . . . . . . . . . . . . . . . . . .15DXEVO 11-DAY . . . . . . . . . . . . . . . . . . .30

donepezil hcl oral tablet 23 mg. . . . . .12 ENTOCORT EC. . . . . . . . . . . . . . . . . . .32donepezil hcl oral tablet dispersible. .12 E ENVARSUS XR . . . . . . . . . . . . . . . . . . .31DORYX . . . . . . . . . . . . . . . . . . . . . . . . .10 EPANED. . . . . . . . . . . . . . . . . . . . . . . . .16EC-NAPROSYN ORAL TABLET

DELAYED RELEASE 375 MG . . . . . . . .9DORYX MPC. . . . . . . . . . . . . . . . . . . . .10 EPCLUSA ORAL TABLET 200-50 MG . . . . . . . . . . . . . . . . . . . . . .15EC-NAPROSYN ORAL TABLET dorzolamide hcl-timolol mal . . . . . . . .34

DELAYED RELEASE 500 MG . . . . . . . .9 EPCLUSA ORAL TABLET dorzolamide hcl-timolol mal pf . . . . . .34400-100 MG . . . . . . . . . . . . . . . . . . . . .15ec-naproxen . . . . . . . . . . . . . . . . . . . . . .9dotti . . . . . . . . . . . . . . . . . . . . . . . . . . . .27EPIPEN . . . . . . . . . . . . . . . . . . . . . . . . .34ED-SPAZ . . . . . . . . . . . . . . . . . . . . . . . .26DOVATO . . . . . . . . . . . . . . . . . . . . . . . .15EPIPEN-SINGLE PACK . . . . . . . . . . . .34EDARBI . . . . . . . . . . . . . . . . . . . . . . . . .16doxazosin mesylate oral . . . . . . . . . . .16epinephrine injection solution auto-EDARBYCLOR . . . . . . . . . . . . . . . . . . .16doxepin hcl oral capsule . . . . . . . . . . .12 injector 0.15 mg/0.15ml . . . . . . . . . . . .34EDLUAR . . . . . . . . . . . . . . . . . . . . . . . .36doxepin hcl oral concentrate. . . . . . . .12 epinephrine solution auto-injector efavirenz-emtricitab-tenofovir . . . . . . .15doxycycline hyclate oral capsule . . . .10 0.15 mg/0.3ml injection . . . . . . . . . . . .34

efavirenz-lamivudine-tenofovir. . . . . . .15doxycycline hyclate oral tablet epinephrine solution auto-injector EFFEXOR XR . . . . . . . . . . . . . . . . . . . .12100 mg, 20 mg . . . . . . . . . . . . . . . . . . .10 0.3 mg/0.3ml injection . . . . . . . . . . . . .34EFUDEX. . . . . . . . . . . . . . . . . . . . . . . . .21doxycycline hyclate oral tablet EPIPEN 2-PAK. . . . . . . . . . . . . . . . . . . .34

150 mg, 50 mg, 75 mg . . . . . . . . . . . . .10 ELESTRIN . . . . . . . . . . . . . . . . . . . . . . .27 EPIPEN JR 2-PAK . . . . . . . . . . . . . . . . .34doxycycline hyclate oral tablet eletriptan hydrobromide . . . . . . . . . . .13 epitol . . . . . . . . . . . . . . . . . . . . . . . . . . . 11delayed release 100 mg, 150 mg, ELIMITE . . . . . . . . . . . . . . . . . . . . . . . . .14 ERGOCAL . . . . . . . . . . . . . . . . . . . . . . .25200 mg, 50 mg, 75 mg . . . . . . . . . . . . .10

elinest . . . . . . . . . . . . . . . . . . . . . . . . . .27 ergocalciferol oral capsule . . . . . . . . .25DOXYCYCLINE HYCLATE ORAL ELIQUIS. . . . . . . . . . . . . . . . . . . . . . . . . 11TABLET DELAYED RELEASE ERIVEDGE. . . . . . . . . . . . . . . . . . . . . . . 14

80 MG . . . . . . . . . . . . . . . . . . . . . . . . . .10 ELIQUIS DVT/PE STARTER PACK . . . 11 ERLEADA . . . . . . . . . . . . . . . . . . . . . . .14doxycycline monohydrate oral ELOCTATE. . . . . . . . . . . . . . . . . . . . . . .24 errin . . . . . . . . . . . . . . . . . . . . . . . . . . . .27capsule 100 mg, 50 mg . . . . . . . . . . . .10 eluryng. . . . . . . . . . . . . . . . . . . . . . . . . .27 erythromycin ophthalmic. . . . . . . . . . .33doxycycline monohydrate oral EMGALITY . . . . . . . . . . . . . . . . . . . . . .13 escitalopram oxalate . . . . . . . . . . . . . .12capsule 150 mg, 75 mg . . . . . . . . . . . .10

EMGALITY (300 MG DOSE) . . . . . . . .13 ESGIC . . . . . . . . . . . . . . . . . . . . . . . . . . .8doxycycline monohydrate oral emoquette. . . . . . . . . . . . . . . . . . . . . . .27suspension reconstituted . . . . . . . . . .10 estarylla . . . . . . . . . . . . . . . . . . . . . . . . .27

41

ESTRACE ORAL. . . . . . . . . . . . . . . . . .27 fenofibrate oral tablet 145 mg, fluticasone propionate nasal . . . . . . . .35160 mg, 54 mg . . . . . . . . . . . . . . . . . . . 17ESTRACE VAGINAL . . . . . . . . . . . . . . .27 fluticasone-salmeterol inhalation FENOGLIDE . . . . . . . . . . . . . . . . . . . . . 17 aerosol powder breath activated estradiol oral . . . . . . . . . . . . . . . . . . . . .27

100-50 mcg/dose, 250-50 mcg/fentanyl transdermal patch 72 hour estradiol patch twice weekly dose, 500-50 mcg/dose . . . . . . . . . . .35100 mcg/hr, 12 mcg/hr, 25 mcg/hr, 0.025 mg/24hr transdermal. . . . . .27, 2850 mcg/hr, 75 mcg/hr . . . . . . . . . . . . . .8 FLUTICASONE-SALMETEROL

estradiol patch twice weekly INHALATION AEROSOL POWDER fentanyl transdermal patch 72 hour 0.0375 mg/24hr transdermal. . . . . . . .28 BREATH ACTIVATED 113-14 MCG/37.5 mcg/hr, 62.5 mcg/hr, estradiol patch twice weekly ACT, 232-14 MCG/ACT, 55-14 87.5 mcg/hr. . . . . . . . . . . . . . . . . . . . . . .80.05 mg/24hr transdermal. . . . . . . . . .28 MCG/ACT . . . . . . . . . . . . . . . . . . . . . . .35

FEXMID . . . . . . . . . . . . . . . . . . . . . . . . .36estradiol patch twice weekly fluvoxamine maleate . . . . . . . . . . . . . .12

FINACEA . . . . . . . . . . . . . . . . . . . . . . . .210.075 mg/24hr transdermal . . . . . . . . .28 fluvoxamine maleate er . . . . . . . . . . . . 12finasteride oral tablet 5 mg . . . . . . . . .27estradiol patch twice weekly FOCALIN . . . . . . . . . . . . . . . . . . . . . . . .18

0.1 mg/24hr transdermal . . . . . . . . . . .28 FIORICET . . . . . . . . . . . . . . . . . . . . . . . .8FOCALIN XR . . . . . . . . . . . . . . . . . . . . .18

estradiol transdermal patch weekly . .28 FIRAZYR . . . . . . . . . . . . . . . . . . . . . . . .31folic acid oral tablet 1 mg . . . . . . . . . .25

estradiol vaginal cream . . . . . . . . . . . .28 FIRST-OMEPRAZOLE . . . . . . . . . . . . .25FOLLISTIM AQ . . . . . . . . . . . . . . . . . . .32

estradiol vaginal tablet . . . . . . . . . . . . .28 FLAGYL . . . . . . . . . . . . . . . . . . . . . . . . .10FORFIVO XL . . . . . . . . . . . . . . . . . . . . .12

ESTRING . . . . . . . . . . . . . . . . . . . . . . . .28 FLAREX. . . . . . . . . . . . . . . . . . . . . . . . .34FORTAMET . . . . . . . . . . . . . . . . . . . . . .24

ESTROGEL . . . . . . . . . . . . . . . . . . . . . .28 flecainide acetate . . . . . . . . . . . . . . . . . 17FORTESTA . . . . . . . . . . . . . . . . . . . . . .31

eszopiclone. . . . . . . . . . . . . . . . . . . . . .36 FLOLIPID . . . . . . . . . . . . . . . . . . . . . . . . 17FOSAMAX . . . . . . . . . . . . . . . . . . . . . . .33

etodolac. . . . . . . . . . . . . . . . . . . . . . . . . .9 FLOMAX . . . . . . . . . . . . . . . . . . . . . . . .27FREESTYLE LIBRE 14 DAY

etodolac er . . . . . . . . . . . . . . . . . . . . . . .9 FLORIVA PLUS . . . . . . . . . . . . . . . . . . .25 READER . . . . . . . . . . . . . . . . . . . . . . . .22etonogestrel-ethinyl estradiol . . . . . . .28 FLOVENT DISKUS . . . . . . . . . . . . . . . .35 FREESTYLE LIBRE 14 DAY EUCRISA . . . . . . . . . . . . . . . . . . . . . . . .21 FLOVENT HFA . . . . . . . . . . . . . . . . . . .35 SENSOR . . . . . . . . . . . . . . . . . . . . . . . .22euthyrox. . . . . . . . . . . . . . . . . . . . . . . . .31 fluconazole oral . . . . . . . . . . . . . . . . . .13 FREESTYLE LIBRE 2 READER. . . . . .22EVAMIST . . . . . . . . . . . . . . . . . . . . . . . .28 fluocinolone acetonide body. . . . . . . .21 FREESTYLE LIBRE 2 SENSOR. . . . . .22EVOCLIN . . . . . . . . . . . . . . . . . . . . . . . .21 fluocinolone acetonide external . . . . .21 FREESTYLE LIBRE READER . . . . . . .22EXFORGE . . . . . . . . . . . . . . . . . . . . . . .16 fluocinolone acetonide scalp . . . . . . .21 FREESTYLE LIBRE SENSOR

SYSTEM. . . . . . . . . . . . . . . . . . . . . . . . .22EXTAVIA . . . . . . . . . . . . . . . . . . . . . . . . 19 fluocinonide external cream 0.05 % . .21furosemide oral. . . . . . . . . . . . . . . . . . . 17EXTINA . . . . . . . . . . . . . . . . . . . . . . . . .13 fluocinonide external cream 0.1 % . . .21

EYSUVIS . . . . . . . . . . . . . . . . . . . . . . . .33 fluocinonide external gel . . . . . . . . . . .21 GEZALLOR SPRINKLE. . . . . . . . . . . . . . 17 fluocinonide external ointment . . . . . .21

gabapentin oral capsule . . . . . . . . . . . 11ezetimibe . . . . . . . . . . . . . . . . . . . . . . . . 17 fluocinonide external solution . . . . . . .21

gabapentin oral solution ezetimibe-simvastatin. . . . . . . . . . . . . . 17 FLUORIDEX . . . . . . . . . . . . . . . . . . . . .19 250 mg/5ml. . . . . . . . . . . . . . . . . . . . . . 11

FLUORIDEX ENHANCED gabapentin oral tablet . . . . . . . . . . . . . 11F WHITENING . . . . . . . . . . . . . . . . . . . . .19ganirelix acetate solution falmina . . . . . . . . . . . . . . . . . . . . . . . . . .28 FLUOROPLEX. . . . . . . . . . . . . . . . . . . .21 prefilled syringe 250 mcg/0.5ml

FARXIGA . . . . . . . . . . . . . . . . . . . . . . . .24 FLUOROURACIL EXTERNAL subcutaneous (Ferring) . . . . . . . . . . . .32CREAM 0.5 % . . . . . . . . . . . . . . . . . . . .21FASENRA PEN . . . . . . . . . . . . . . . . . . .35 ganirelix acetate solution fluorouracil external cream 5 % . . . . .21 prefilled syringe 250 mcg/0.5ml fayosim . . . . . . . . . . . . . . . . . . . . . . . . .28

subcutaneous (Organon) . . . . . . . . . .32fluorouracil external solution. . . . . . . . 14febuxostat . . . . . . . . . . . . . . . . . . . . . . .13gavilyte-c . . . . . . . . . . . . . . . . . . . . . . . .26fluoxetine hcl oral capsule. . . . . . . . . .12FEMARA . . . . . . . . . . . . . . . . . . . . . . . .14gavilyte-g . . . . . . . . . . . . . . . . . . . . . . . .26fluoxetine hcl oral capsule delayed femynor . . . . . . . . . . . . . . . . . . . . . 28, 29

release . . . . . . . . . . . . . . . . . . . . . . . . . .12 GELNIQUE . . . . . . . . . . . . . . . . . . . . . .26fenofibrate oral capsule 150 mg, fluoxetine hcl oral solution. . . . . . . . . .12 gemfibrozil oral . . . . . . . . . . . . . . . . . . . 1750 mg. . . . . . . . . . . . . . . . . . . . . . . . . . . 17fluoxetine hcl oral tablet 10 mg . . . . . .12 gemmily . . . . . . . . . . . . . . . . . . . . . . . . .28fenofibrate oral tablet 120 mg,

40 mg, 48 mg . . . . . . . . . . . . . . . . . . . . 17 fluoxetine hcl oral tablet 20 mg. . . . . .12 gengraf . . . . . . . . . . . . . . . . . . . . . . . . .31fluoxetine hcl oral tablet 60 mg. . . . . .12 GENOTROPIN. . . . . . . . . . . . . . . . . . . .30

42

GENOTROPIN MINIQUICK . . . . . . . . .30 HUMALOG MIX 50/50 KWIKPEN . . . .23 hydrocortisone ace-pramoxine external cream 1-1 % . . . . . . . . . . . . . .32GENVOYA . . . . . . . . . . . . . . . . . . . . . . .15 HUMALOG MIX 50/50 VIAL . . . . . . . .23hydrocortisone external cream 1 % . .21GEODON ORAL . . . . . . . . . . . . . . . . . .14 HUMALOG MIX 75/25 KWIKPEN . . . .23hydrocortisone external cream GILENYA . . . . . . . . . . . . . . . . . . . . . . . . 19 HUMALOG MIX 75/25 VIAL. . . . . . . . .232.5 % . . . . . . . . . . . . . . . . . . . . . . . . . . .21

GIMOTI . . . . . . . . . . . . . . . . . . . . . . . . .12 HUMALOG U-100 JUNIOR hydrocortisone external lotion KWIKPEN . . . . . . . . . . . . . . . . . . . . . . .23glatiramer acetate. . . . . . . . . . . . . . . . . 19 2.5 % . . . . . . . . . . . . . . . . . . . . . . . . . . .21

HUMALOG VIAL SUBCUTANEOUS glatopa. . . . . . . . . . . . . . . . . . . . . . . . . .19 hydrocortisone external ointment SOLUTION 100 UNIT/ML . . . . . . . . . .23GLEEVEC . . . . . . . . . . . . . . . . . . . . . . .14 1 %, 2.5 % . . . . . . . . . . . . . . . . . . . . . . .21

HUMALOG VIAL SUBCUTANEOUS glimepiride . . . . . . . . . . . . . . . . . . . . . .24 hydrocortisone oral . . . . . . . . . . . . . . .30SOLUTION CARTRIDGE glipizide er . . . . . . . . . . . . . . . . . . . . . . .24 100 UNIT/ML. . . . . . . . . . . . . . . . . . . . .23 hydromorphone hcl er . . . . . . . . . . . . . .8glipizide ir . . . . . . . . . . . . . . . . . . . . . . .24 HUMATROPE . . . . . . . . . . . . . . . . . . . .30 hydromorphone hcl oral . . . . . . . . . . . .8glipizide xl . . . . . . . . . . . . . . . . . . . . . . .24 HUMIRA . . . . . . . . . . . . . . . . . . . . . . . .31 hydromorphone hcl rectal . . . . . . . . . . .8GLOPERBA. . . . . . . . . . . . . . . . . . . . . . 13 HUMIRA PEDIATRIC CROHNS hydroxychloroquine sulfate oral . . . . .14

START . . . . . . . . . . . . . . . . . . . . . . . . . .31glucagon emergency kit 1 mg hydroxyzine hcl oral . . . . . . . . . . . . . . .16injection 1 mg (Eli Lilly) . . . . . . . . . . . .24 HUMIRA PEN . . . . . . . . . . . . . . . . . . . .31 hydroxyzine pamoate oral . . . . . . . . . .16GLUCAGON EMERGENCY KIT HUMIRA PEN-CD/UC/HS hyoscyamine sulfate er . . . . . . . . . . . .261 MG INJECTION 1 MG (Fresenius) . .24 STARTER. . . . . . . . . . . . . . . . . . . . . . . .31

hyoscyamine sulfate oral . . . . . . . . . . .26GLUCOTROL . . . . . . . . . . . . . . . . . . . .24 HUMIRA PEN-PEDIATRIC UC

hyoscyamine sulfate sl . . . . . . . . . . . . .26START . . . . . . . . . . . . . . . . . . . . . . . . . .31GLUCOTROL XL. . . . . . . . . . . . . . . . . .24hyoscyamine sulfate sublingual . . . . .26HUMIRA PEN-PS/UV/ADOL HS GLUMETZA. . . . . . . . . . . . . . . . . . . . . .24hyosyne . . . . . . . . . . . . . . . . . . . . . . . . .26START . . . . . . . . . . . . . . . . . . . . . . . . . .31glyburide oral . . . . . . . . . . . . . . . . . . . .24HYSINGLA ER . . . . . . . . . . . . . . . . . . . .8HUMIRA PEN-PSOR/UVEIT glyburide-metformin. . . . . . . . . . . . . . .24 STARTER. . . . . . . . . . . . . . . . . . . . . . . .31 HYZAAR . . . . . . . . . . . . . . . . . . . . . . . . 17

GLYXAMBI . . . . . . . . . . . . . . . . . . . . . .24 HUMULIN 70/30 KWIKPEN. . . . . . . . .23GOLYTELY . . . . . . . . . . . . . . . . . . . . . .26 IHUMULIN 70/30 VIAL . . . . . . . . . . . . .23GONITRO . . . . . . . . . . . . . . . . . . . . . . . 17 ibandronate sodium oral . . . . . . . . . . .33HUMULIN N KWIKPEN . . . . . . . . . . . .23guanfacine hcl . . . . . . . . . . . . . . . . 17, 18 IBRANCE. . . . . . . . . . . . . . . . . . . . . . . . 14HUMULIN N VIAL . . . . . . . . . . . . . . . . .23guanfacine hcl er . . . . . . . . . . . . . . . . .18 ibuprofen. . . . . . . . . . . . . . . . . . . . . . . . .9HUMULIN R U-500 KWIKPEN. . . . . . .23GVOKE HYPOPEN 1-PACK . . . . . . . . .24 ibuprofen oral suspension. . . . . . . . . . .9HUMULIN R U-500 VIAL . . . . . . . . . . .23GVOKE HYPOPEN 2-PACK . . . . . . . . .24 icatibant acetate . . . . . . . . . . . . . . . . . .31HUMULIN R VIAL . . . . . . . . . . . . . . . . .23GVOKE PFS. . . . . . . . . . . . . . . . . . . . . .24 iclevia. . . . . . . . . . . . . . . . . . . . . . . . . . .28hydralazine hcl oral . . . . . . . . . . . . . . . 17GYNAZOLE-1 . . . . . . . . . . . . . . . . . . . . 13 icosapent ethyl . . . . . . . . . . . . . . . . . . . 17hydrochlorothiazide oral . . . . . . . . . . . 17

IDHIFA . . . . . . . . . . . . . . . . . . . . . . . . . . 14hydrocodone bitartrate er oral Hcapsule extended release 12 hour . . . .8 ILEVRO . . . . . . . . . . . . . . . . . . . . . . . . .33

HAEGARDA . . . . . . . . . . . . . . . . . . . . .31hydrocodone bitartrate er oral imatinib mesylate . . . . . . . . . . . . . . . . . 14

hailey 1.5/30 . . . . . . . . . . . . . . . . . . . . .28 tablet er 24 hour abuse-deterrent. . . . .8 imiquimod external cream 3.75 %. . . .21hailey 24 fe . . . . . . . . . . . . . . . . . . . . . .28 hydrocodone polst-chlorphen polst imiquimod external cream 5 % . . . . . .21hailey fe 1/20. . . . . . . . . . . . . . . . . . . . .28 er susp. . . . . . . . . . . . . . . . . . . . . . . . . .35

IMIQUIMOD PUMP. . . . . . . . . . . . . . . .21hailey fe 1.5/30 . . . . . . . . . . . . . . . . . . .28 hydrocodone-acetaminophen oral

IMITREX ORAL. . . . . . . . . . . . . . . . . . .13solution 10-325 mg/15ml, HALCION. . . . . . . . . . . . . . . . . . . . . . . .16IMITREX STATDOSE REFILL. . . . . . . .137.5-325 mg/15ml. . . . . . . . . . . . . . . . . . .8HARVONI ORAL PACKET . . . . . . . . . .15IMITREX STATDOSE SYSTEM . . . . . .13hydrocodone-acetaminophen oral HARVONI ORAL TABLET . . . . . . . . . .15 tablet 10-300 mg, 5-300 mg, IMITREX SUBCUTANEOUS . . . . . . . .13

heather . . . . . . . . . . . . . . . . . . . . . . . . .28 7.5-300 mg . . . . . . . . . . . . . . . . . . . . . . .8 IMPEKLO. . . . . . . . . . . . . . . . . . . . . . . .21HEMADY . . . . . . . . . . . . . . . . . . . . . . . .30 hydrocodone-acetaminophen oral IMPOYZ . . . . . . . . . . . . . . . . . . . . . . . . .21tablet 10-325 mg, 5-325 mg, HEMANGEOL . . . . . . . . . . . . . . . . . . . . 17

IMURAN . . . . . . . . . . . . . . . . . . . . . . . .317.5-325 mg . . . . . . . . . . . . . . . . . . . . . . .8HIDEX 6-DAY. . . . . . . . . . . . . . . . . . . . .30IMVEXXY MAINTENANCE PACK . . . .25hydrocort-pramoxine (perianal). . . . . .32HUMALOG KWIKPEN . . . . . . . . . . . . .23

43

IMVEXXY STARTER PACK . . . . . . . . .25 JIVI . . . . . . . . . . . . . . . . . . . . . . . . . . . . .24 LINBRIJA . . . . . . . . . . . . . . . . . . . . . . . . .14 jolessa . . . . . . . . . . . . . . . . . . . . . . . . . .28 labetalol hcl oral . . . . . . . . . . . . . . . . . . 17incassia . . . . . . . . . . . . . . . . . . . . . . . . .28 JORNAY PM . . . . . . . . . . . . . . . . . . . . .18 LAMICTAL. . . . . . . . . . . . . . . . . . . . . . . 11INCRUSE ELLIPTA . . . . . . . . . . . . . . . .35 juleber . . . . . . . . . . . . . . . . . . . . . . . . . .28 LAMICTAL ODT ORAL KIT 21 X

25 MG & 7 X 50 MG, 42 X 50 MG & INDERAL LA . . . . . . . . . . . . . . . . . . . . . 17 JULUCA. . . . . . . . . . . . . . . . . . . . . . . . .1514X100 MG . . . . . . . . . . . . . . . . . . . . . . 11INDOCIN . . . . . . . . . . . . . . . . . . . . . . . . .9 junel 1/20. . . . . . . . . . . . . . . . . . . . . . . .28LAMICTAL ODT ORAL KIT 25 & 50 indomethacin er . . . . . . . . . . . . . . . . . . .9 junel 1.5/30 . . . . . . . . . . . . . . . . . . . . . .28& 100 MG . . . . . . . . . . . . . . . . . . . . . . . 11

INDOMETHACIN ORAL CAPSULE junel fe 1/20 . . . . . . . . . . . . . . . . . . . . .28LAMICTAL ODT ORAL TABLET 20 MG . . . . . . . . . . . . . . . . . . . . . . . . . . .9 junel fe 1.5/30 . . . . . . . . . . . . . . . . . . . .28 DISPERSIBLE . . . . . . . . . . . . . . . . . . . . 11

indomethacin oral capsule 25 mg, junel fe 24 . . . . . . . . . . . . . . . . . . . . . . .28 LAMICTAL STARTER. . . . . . . . . . . . . . 1150 mg. . . . . . . . . . . . . . . . . . . . . . . . . . . .9LAMICTAL XR. . . . . . . . . . . . . . . . . . . . 11KINSULIN ASPART. . . . . . . . . . . . . . . . .23lamotrigine er . . . . . . . . . . . . . . . . . . . . 11INSULIN ASPART FLEXPEN . . . . . . . .23 K-TAB . . . . . . . . . . . . . . . . . . . . . . . . . . .25lamotrigine oral kit . . . . . . . . . . . . . . . . 11INSULIN ASPART PENFILL. . . . . . . . .23 kalliga. . . . . . . . . . . . . . . . . . . . . . . . . . .28lamotrigine oral tablet . . . . . . . . . . . . . 11INSULIN LISPRO . . . . . . . . . . . . . . . . .23 KAPSPARGO SPRINKLE. . . . . . . . . . .17lamotrigine oral tablet chewable. . . . . 11INSULIN LISPRO (1 UNIT DIAL) . . . . .23 kariva . . . . . . . . . . . . . . . . . . . . . . . . . . .28lamotrigine oral tablet dispersible . . . 11INSULIN LISPRO JUNIOR KAZANO . . . . . . . . . . . . . . . . . . . . . . . .24lamotrigine starter kit-blue. . . . . . . . . . 11KWIKPEN . . . . . . . . . . . . . . . . . . . . . . .23 KEFLEX . . . . . . . . . . . . . . . . . . . . . . . . .10lamotrigine starter kit-green . . . . . . . . 11INSULIN LISPRO PROT & LISPRO. . .23 KENALOG EXTERNAL. . . . . . . . . . . . .21lamotrigine starter kit-orange . . . . . . . 11INSULIN PEN NEEDLES . . . . . . . . . . .22 KEPPRA ORAL. . . . . . . . . . . . . . . . . . . 11LANCETS . . . . . . . . . . . . . . . . . . . .22, 23INSULIN SYRINGES. . . . . . . . . . . . . . .22 KEPPRA XR . . . . . . . . . . . . . . . . . . . . . 11LANTUS SOLOSTAR . . . . . . . . . . . . . .23INTRAROSA . . . . . . . . . . . . . . . . . . . . .25 KESIMPTA. . . . . . . . . . . . . . . . . . . . . . .19LANTUS U-100 VIAL . . . . . . . . . . . . . .23introvale . . . . . . . . . . . . . . . . . . . . . . . . .28 ketoconazole external cream . . . . . . .13larin 1/20 . . . . . . . . . . . . . . . . . . . . . . . .28INTUNIV. . . . . . . . . . . . . . . . . . . . . . . . .18 ketoconazole external foam . . . . . . . .13larin 1.5/30 . . . . . . . . . . . . . . . . . . . . . .28INVELTYS . . . . . . . . . . . . . . . . . . . . . . .33 ketoconazole external shampoo. . . . .13larin 24 fe. . . . . . . . . . . . . . . . . . . . . . . .28ipratropium bromide nasal . . . . . . . . .35 ketodan external foam . . . . . . . . . . . . .13larin fe 1/20 . . . . . . . . . . . . . . . . . . . . . .28ipratropium-albuterol . . . . . . . . . . . . . .35 KETOROLAC TROMETHAMINE larin fe 1.5/30 . . . . . . . . . . . . . . . . . . . .28irbesartan . . . . . . . . . . . . . . . . . . . . . . . 17 NASAL. . . . . . . . . . . . . . . . . . . . . . . . . . .9larissia . . . . . . . . . . . . . . . . . . . . . . . . . .28irbesartan-hydrochlorothiazide. . . . . . 17 ketorolac tromethamine ophthalmic. .33LASIX. . . . . . . . . . . . . . . . . . . . . . . . . . . 17ISENTRESS. . . . . . . . . . . . . . . . . . . . . . 15 ketorolac tromethamine oral . . . . . . . . .9LASTACAFT . . . . . . . . . . . . . . . . . . . . .33ISENTRESS HD . . . . . . . . . . . . . . . . . .15 KITABIS PAK. . . . . . . . . . . . . . . . . . . . .36latanoprost ophthalmic . . . . . . . . . . . .34isibloom. . . . . . . . . . . . . . . . . . . . . . . . .28 KLONOPIN . . . . . . . . . . . . . . . . . . . . . .16LATUDA. . . . . . . . . . . . . . . . . . . . . . . . . 14isosorbide mononitrate . . . . . . . . . . . . 17 klor-con . . . . . . . . . . . . . . . . . . . . . . . . .25LEDIPASVIR-SOFOSBUVIR . . . . . . . .15isosorbide mononitrate er . . . . . . . . . . 17 klor-con 10 . . . . . . . . . . . . . . . . . . . . . .25lessina . . . . . . . . . . . . . . . . . . . . . . . . . .28isotretinoin oral . . . . . . . . . . . . . . . . . . .21 klor-con m10 . . . . . . . . . . . . . . . . . . . . .25letrozole oral . . . . . . . . . . . . . . . . . . . . .14ISTALOL . . . . . . . . . . . . . . . . . . . . . . . .34 KLOR-CON M15 . . . . . . . . . . . . . . . . . .25LEVALBUTEROL HFA INHALATION klor-con m20 . . . . . . . . . . . . . . . . . . . . .25

J AEROSOL 45 MCG/ACT . . . . . . . . . . .35KOGENATE FS . . . . . . . . . . . . . . . . . . .24

jaimiess . . . . . . . . . . . . . . . . . . . . . . . . .28 LEVBID . . . . . . . . . . . . . . . . . . . . . . . . .26KOMBIGLYZE XR . . . . . . . . . . . . . . . . .24

jantoven . . . . . . . . . . . . . . . . . . . . . . . . . 11 LEVEMIR U-100 FLEXTOUCH. . . . . . .23KOSELUGO. . . . . . . . . . . . . . . . . . . . . . 14

JANUVIA . . . . . . . . . . . . . . . . . . . . . . . .24 LEVEMIR U-100 VIAL . . . . . . . . . . . . . .23KOVALTRY . . . . . . . . . . . . . . . . . . . . . .24

JARDIANCE . . . . . . . . . . . . . . . . . . . . .24 levetiracetam er . . . . . . . . . . . . . . . . . . 11KRINTAFEL . . . . . . . . . . . . . . . . . . . . . . 14

jasmiel . . . . . . . . . . . . . . . . . . . . . . . . . .28 levetiracetam oral . . . . . . . . . . . . . . . . . 11kurvelo. . . . . . . . . . . . . . . . . . . . . . . . . .28

jencycla . . . . . . . . . . . . . . . . . . . . . . . . .28 levo-t . . . . . . . . . . . . . . . . . . . . . . . . . . .31KYNMOBI . . . . . . . . . . . . . . . . . . . . . . .14

JENTADUETO. . . . . . . . . . . . . . . . . . . .24 levocetirizine dihydrochloride oral . . .35KYNMOBI TITRATION KIT . . . . . . . . .14

JENTADUETO XR. . . . . . . . . . . . . . . . .24 levofloxacin oral . . . . . . . . . . . . . . . . . .10

44

levonorgest-eth est & eth est. . . . . . . .28 lorazepam oral tablet . . . . . . . . . . . . . .16 MEDROL ORAL TABLET 16 MG, 4 MG, 8 MG. . . . . . . . . . . . . . . . . . . . . .30levonorgest-eth estrad 91-day. . . . . . .28 LORTAB. . . . . . . . . . . . . . . . . . . . . . . . . .8MEDROL ORAL TABLET 2 MG. . . . . .30levonorgestrel-ethinyl estrad oral loryna. . . . . . . . . . . . . . . . . . . . . . . . . . .28

tablet 0.1-20 mg-mcg, MEDROL ORAL TABLET 32 MG . . . .30losartan potassium oral . . . . . . . . . . . . 170.15-30 mg-mcg . . . . . . . . . . . . . . . . . .28 MEDROL ORAL TABLET THERAPY losartan potassium-hctz . . . . . . . . . . . 17levora 0.15/30 (28) . . . . . . . . . . . . . . . .28 PACK . . . . . . . . . . . . . . . . . . . . . . . . . . .30

LOSEASONIQUE . . . . . . . . . . . . . . . . .28LEVOTHYROXINE SODIUM ORAL medroxyprogesterone acetate

LOTEMAX OPHTHALMIC CAPSULE . . . . . . . . . . . . . . . . . . . . . . .31 intramuscular suspension . . . . . . . . . .29OINTMENT . . . . . . . . . . . . . . . . . . . . . .33

levothyroxine sodium oral tablet . . . . .31 medroxyprogesterone acetate LOTEMAX OPHTHALMIC intramuscular suspension prefilled levoxyl . . . . . . . . . . . . . . . . . . . . . . . . . .31 SUSPENSION . . . . . . . . . . . . . . . . . . . .33 syringe . . . . . . . . . . . . . . . . . . . . . . . . . .29

LEVSIN ORAL. . . . . . . . . . . . . . . . . . . .26 LOTEMAX SM. . . . . . . . . . . . . . . . . . . .33 medroxyprogesterone acetate oral . .29LEVSIN/SL . . . . . . . . . . . . . . . . . . . . . .26 LOTENSIN. . . . . . . . . . . . . . . . . . . . . . . 17 melodetta 24 fe. . . . . . . . . . . . . . . . . . .29LEXAPRO . . . . . . . . . . . . . . . . . . . . . . .12 LOTENSIN HCT . . . . . . . . . . . . . . . . . . 17 meloxicam oral capsule . . . . . . . . . . . . .9LIALDA . . . . . . . . . . . . . . . . . . . . . . . . .32 loteprednol etabonate ophthalmic meloxicam oral tablet. . . . . . . . . . . . . . .9lidocaine external ointment 5 % . . . . . .8 gel . . . . . . . . . . . . . . . . . . . . . . . . . . . . .33

MENOSTAR . . . . . . . . . . . . . . . . . . . . .29lidocaine external patch 5 % . . . . . . . . .8 loteprednol etabonate ophthalmic

mercaptopurine oral. . . . . . . . . . . . . . . 14suspension . . . . . . . . . . . . . . . . . . . . . .33lidocaine hcl mouth/throat . . . . . . . . .19merzee. . . . . . . . . . . . . . . . . . . . . . . . . .29LOTREL . . . . . . . . . . . . . . . . . . . . . . . . . 17lidocaine viscous hcl . . . . . . . . . . . . . .19mesalamine er oral capsule lovastatin oral . . . . . . . . . . . . . . . . . . . . 17lidocaine-prilocaine external cream . . .8 0.375 gm . . . . . . . . . . . . . . . . . . . . . . . .33

LOVAZA. . . . . . . . . . . . . . . . . . . . . . . . . 17LIDODERM . . . . . . . . . . . . . . . . . . . . . . .8 mesalamine oral . . . . . . . . . . . . . . . . . .33LOVENOX . . . . . . . . . . . . . . . . . . . . . . . 11lillow . . . . . . . . . . . . . . . . . . . . . . . . . . . .28 mesalamine rectal enema . . . . . . . . . .33low-ogestrel. . . . . . . . . . . . . . . . . . . . . .28LINZESS . . . . . . . . . . . . . . . . . . . . . . . .26 mesalamine rectal suppository. . . . . .33LUMIGAN . . . . . . . . . . . . . . . . . . . . . . .34liothyronine sodium oral . . . . . . . . . . .31 metaxalone . . . . . . . . . . . . . . . . . . . . . .36LUNESTA. . . . . . . . . . . . . . . . . . . . . . . .36LIPITOR . . . . . . . . . . . . . . . . . . . . . . . . . 17 metformin hcl er . . . . . . . . . . . . . . . . . .24lutera . . . . . . . . . . . . . . . . . . . . . . . . . . .28LIPOFEN . . . . . . . . . . . . . . . . . . . . . . . . 17 metformin hcl er (mod) . . . . . . . . . . . .24lyleq . . . . . . . . . . . . . . . . . . . . . . . . . . . .28lisinopril oral . . . . . . . . . . . . . . . . . . . . . 17 metformin hcl er (osm) . . . . . . . . . . . . .24lyllana. . . . . . . . . . . . . . . . . . . . . . . . . . .28lisinopril-hydrochlorothiazide . . . . . . . 17 metformin hcl ir. . . . . . . . . . . . . . . . . . .24LYNPARZA . . . . . . . . . . . . . . . . . . . . . .14lithium carbonate er . . . . . . . . . . . . . . .16 methimazole oral . . . . . . . . . . . . . . . . .31LYRICA . . . . . . . . . . . . . . . . . . . . . . . . .19lithium carbonate oral . . . . . . . . . . . . .16 methocarbamol oral . . . . . . . . . . . . . . .36LYRICA CR . . . . . . . . . . . . . . . . . . . . . .19LITHOBID . . . . . . . . . . . . . . . . . . . . . . .16 methotrexate oral . . . . . . . . . . . . . . . . .32LYUMJEV KWIKPEN . . . . . . . . . . . . . .23LO LOESTRIN FE . . . . . . . . . . . . . . . . .28 methotrexate sodium . . . . . . . . . . . . . .32LYUMJEV VIAL . . . . . . . . . . . . . . . . . . .23lo-zumandimine . . . . . . . . . . . . . . . . . .28 methotrexate sodium (pf) . . . . . . . . . .32lyza. . . . . . . . . . . . . . . . . . . . . . . . . . . . .28LODINE . . . . . . . . . . . . . . . . . . . . . . . . . .9 METHYLIN . . . . . . . . . . . . . . . . . . . . . .18

LOESTRIN 1/20 (21) . . . . . . . . . . . . . . .28 M methylphenidate hcl er (cd) . . . . . . . . .18LOESTRIN 1.5/30 (21) . . . . . . . . . . . . .28 methylphenidate hcl er (la) oral MALARONE . . . . . . . . . . . . . . . . . . . . .14LOESTRIN FE 1/20. . . . . . . . . . . . . . . .28 capsule extended release 24 hour marlissa . . . . . . . . . . . . . . . . . . . . . . . . .28

10 mg, 20 mg, 30 mg, 40 mg . . . . . . .18LOESTRIN FE 1.5/30 . . . . . . . . . . . . . .28 matzim la . . . . . . . . . . . . . . . . . . . . . . . . 17methylphenidate hcl er (la) oral lojaimiess. . . . . . . . . . . . . . . . . . . . . . . .28 MAVENCLAD . . . . . . . . . . . . . . . . . . . .19 capsule extended release 24 hour LOKELMA . . . . . . . . . . . . . . . . . . . . . . .25 60 mg. . . . . . . . . . . . . . . . . . . . . . . . . . .18MAVYRET . . . . . . . . . . . . . . . . . . . . . . .15

LOMOTIL. . . . . . . . . . . . . . . . . . . . . . . .26 methylphenidate hcl er (xr) . . . . . . . . .19MAXALT . . . . . . . . . . . . . . . . . . . . . . . .13LOPID . . . . . . . . . . . . . . . . . . . . . . . . . . 17 methylphenidate hcl er oral tablet MAXALT-MLT . . . . . . . . . . . . . . . . . . . .13LOPRESSOR. . . . . . . . . . . . . . . . . . . . . 17 extended release 10 mg, 20 mg . . . . .19MAXITROL . . . . . . . . . . . . . . . . . . . . . .33LOPROX EXTERNAL SHAMPOO . . . .13 methylphenidate hcl er oral tablet MAXZIDE. . . . . . . . . . . . . . . . . . . . . . . . 17

extended release 18 mg, 27 mg, lorazepam intensol . . . . . . . . . . . . . . . .16 MAXZIDE-25 . . . . . . . . . . . . . . . . . . . . .17 36 mg, 54 mg, 72 mg . . . . . . . . . . . . . .19lorazepam oral concentrate MAYZENT . . . . . . . . . . . . . . . . . . . . . . .192 mg/ml . . . . . . . . . . . . . . . . . . . . . . . . .16

45

methylphenidate hcl er oral tablet minocycline hcl oral tablet. . . . . . . . . .10 Nextended release 24 hour . . . . . . . . . .19 MINOLIRA. . . . . . . . . . . . . . . . . . . . . . .10 nabumetone oral . . . . . . . . . . . . . . . . . .9methylphenidate hcl oral solution. . . .19 MIRAPEX. . . . . . . . . . . . . . . . . . . . . . . .14 nadolol oral . . . . . . . . . . . . . . . . . . . . . . 17methylphenidate hcl oral tablet. . . . . .19 MIRAPEX ER. . . . . . . . . . . . . . . . . . . . .14 NAFRINSE DAILY/NEUTRAL . . . . . . .19methylphenidate hcl oral tablet MIRCETTE . . . . . . . . . . . . . . . . . . . . . .29 NAFRINSE WEEKLY. . . . . . . . . . . . . . .19chewable . . . . . . . . . . . . . . . . . . . . . . . .19

mirtazapine oral . . . . . . . . . . . . . . . . . . 12 NALOCET . . . . . . . . . . . . . . . . . . . . . . . .8methylprednisolone oral . . . . . . . . . . .30

MIRVASO . . . . . . . . . . . . . . . . . . . . . . .21 naloxone hcl injection . . . . . . . . . . . . .10metoclopramide hcl oral solution . . . .12

misoprostol oral . . . . . . . . . . . . . . . . . .25 naltrexone hcl oral . . . . . . . . . . . . . . . .10metoclopramide hcl oral tablet . . . . . .12

MITIGARE . . . . . . . . . . . . . . . . . . . . . . . 13 NAPRELAN. . . . . . . . . . . . . . . . . . . . . . .9metoclopramide hcl oral tablet

MOBIC. . . . . . . . . . . . . . . . . . . . . . . . . . .9 NAPROSYN ORAL SUSPENSION . . . .9dispersible. . . . . . . . . . . . . . . . . . . . . . .12modafinil . . . . . . . . . . . . . . . . . . . . . . . .36 NAPROSYN ORAL TABLET . . . . . . . . .9metoprolol succinate er . . . . . . . . . . . . 17mometasone furoate external . . . . . . .21 naproxen oral suspension . . . . . . . . . . .9metoprolol tartrate oral tablet mondoxyne nl oral capsule 100 mg . .10100 mg, 25 mg, 50 mg. . . . . . . . . . . . . 17 naproxen oral tablet . . . . . . . . . . . . . . . .9mondoxyne nl oral capsule 75 mg . . .10metoprolol tartrate oral tablet naproxen oral tablet delayed release . .9

37.5 mg, 75 mg . . . . . . . . . . . . . . . . . . . 17 mono-linyah. . . . . . . . . . . . . . . . . . . . . .29 naproxen sodium er oral tablet METROCREAM . . . . . . . . . . . . . . . . . .21 extended release 24 hour 375 mg, montelukast sodium oral . . . . . . . . . . .35

500 mg. . . . . . . . . . . . . . . . . . . . . . . . . . .9METROGEL . . . . . . . . . . . . . . . . . . . . .21 morgidox oral . . . . . . . . . . . . . . . . . . . .10NAPROXEN SODIUM ER ORAL METROLOTION . . . . . . . . . . . . . . . . . .21 morphine sulfate (concentrate) oral TABLET EXTENDED RELEASE solution 100 mg/5ml, 20 mg/ml . . . . . .8metronidazole external cream . . . . . .21 24 HOUR 750 MG. . . . . . . . . . . . . . . . . .9

morphine sulfate er oral capsule metronidazole external gel 0.75 % . . .21 naproxen sodium oral tablet extended release 24 hour . . . . . . . . . . .8metronidazole external gel 1 %. . . . . .21 275 mg, 550 mg . . . . . . . . . . . . . . . . . . .9morphine sulfate er oral tablet metronidazole external lotion . . . . . . .21 naratriptan hcl. . . . . . . . . . . . . . . . . . . .13extended release . . . . . . . . . . . . . . . . . .8

metronidazole oral . . . . . . . . . . . . . . . .10 NARCAN . . . . . . . . . . . . . . . . . . . . . . . .10morphine sulfate oral . . . . . . . . . . . . . . .8metronidazole vaginal . . . . . . . . . . . . .10 NASCOBAL. . . . . . . . . . . . . . . . . . . . . .25morphine sulfate rectal . . . . . . . . . . . . .8mibelas 24 fe. . . . . . . . . . . . . . . . . . . . .29 NATAZIA . . . . . . . . . . . . . . . . . . . . . . . .29MOTEGRITY . . . . . . . . . . . . . . . . . . . . .26MICARDIS . . . . . . . . . . . . . . . . . . . . . . . 17 NATESTO . . . . . . . . . . . . . . . . . . . . . . .31MOVIPREP . . . . . . . . . . . . . . . . . . . . . .26microgestin 1/20. . . . . . . . . . . . . . . . . .29 NATURE-THROID . . . . . . . . . . . . . . . . .31MOXEZA . . . . . . . . . . . . . . . . . . . . . . . .33microgestin 1.5/30 . . . . . . . . . . . . . . . .29 NAYZILAM . . . . . . . . . . . . . . . . . . . . . . 11moxifloxacin hcl (2x day) . . . . . . . . . . .33microgestin 24 fe . . . . . . . . . . . . . . . . .29 necon 0.5/35 (28) . . . . . . . . . . . . . . . . .29moxifloxacin hcl ophthalmic microgestin fe 1/20 . . . . . . . . . . . . . . .29 neomycin-polymyxin-dexameth solution . . . . . . . . . . . . . . . . . . . . . . . . .33

ophthalmic ointment . . . . . . . . . . . . . .33microgestin fe 1.5/30 . . . . . . . . . . . . . .29 MS CONTIN . . . . . . . . . . . . . . . . . . . . . .8neomycin-polymyxin-dexameth mili . . . . . . . . . . . . . . . . . . . . . . . . . . . . .29 MULPLETA . . . . . . . . . . . . . . . . . . . . . .24ophthalmic suspension MILLIPRED . . . . . . . . . . . . . . . . . . . . . .30 MULTAQ . . . . . . . . . . . . . . . . . . . . . . . . 17 3.5-10000-0.1 . . . . . . . . . . . . . . . . . . . .33

MINASTRIN 24 FE . . . . . . . . . . . . . . . .29 multi-vitamin/fluoride . . . . . . . . . . . . . .25 neomycin-polymyxin-hc otic . . . . . . . .34MINIPRESS . . . . . . . . . . . . . . . . . . . . . . 17 multivitamin/fluoride oral solution . . .25 NEORAL . . . . . . . . . . . . . . . . . . . . . . . .32minitran . . . . . . . . . . . . . . . . . . . . . . . . . 17 multivitamin/fluoride oral tablet NESINA . . . . . . . . . . . . . . . . . . . . . . . . .24MINIVELLE . . . . . . . . . . . . . . . . . . . 27-29 chewable 0.25 mg, 0.5 mg, 1 mg . . . .25

neuac external gel . . . . . . . . . . . . . . . .21MINOCYCLINE HCL ER ORAL mupirocin calcium . . . . . . . . . . . . . . . .10

NEURONTIN . . . . . . . . . . . . . . . . . . . . . 11CAPSULE EXTENDED RELEASE mupirocin external . . . . . . . . . . . . . . . .10NEVANAC . . . . . . . . . . . . . . . . . . . . . . .3324 HOUR . . . . . . . . . . . . . . . . . . . . . . . .10

mycophenolate mofetil oral . . . . . . . . .32NEXLETOL . . . . . . . . . . . . . . . . . . . . . . 17minocycline hcl er oral tablet

mycophenolate sodium . . . . . . . . . . . .32extended release 24 hour 105 mg, NEXLIZET . . . . . . . . . . . . . . . . . . . . . . . 17MYDAYIS . . . . . . . . . . . . . . . . . . . . . . . .19115 mg, 55 mg, 65 mg, 80 mg. . . . . . .10 niacin (antihyperlipidemic). . . . . . . . . . 17MYFORTIC . . . . . . . . . . . . . . . . . . . . . .32minocycline hcl er oral tablet niacin er (antihyperlipidemic) . . . . . . . 17

extended release 24 hour 135 mg, myorisan . . . . . . . . . . . . . . . . . . . . . . . .21niacor. . . . . . . . . . . . . . . . . . . . . . . . . . . 1745 mg, 90 mg . . . . . . . . . . . . . . . . . . . .10NIASPAN . . . . . . . . . . . . . . . . . . . . . . . . 17minocycline hcl oral capsule. . . . . . . .10

46

nifedipine er . . . . . . . . . . . . . . . . . . . . . 17 NOVOEIGHT . . . . . . . . . . . . . . . . . . . . .24 ODOMZO . . . . . . . . . . . . . . . . . . . . . . . 14nifedipine er osmotic release . . . . . . . 17 NOVOFINE AUTOCOVER PEN ofloxacin ophthalmic . . . . . . . . . . . . . .33

NEEDLE. . . . . . . . . . . . . . . . . . . . . . . . .23nifedipine oral . . . . . . . . . . . . . . . . . . . . 17 ofloxacin otic. . . . . . . . . . . . . . . . . . . . .34NOVOFINE PEN NEEDLE . . . . . . . . . .23nikki . . . . . . . . . . . . . . . . . . . . . . . . . . . .29 olanzapine oral . . . . . . . . . . . . . . . . . . . 14NOVOFINE PLUS PEN NEEDLE . . . . .23nitisinone . . . . . . . . . . . . . . . . . . . . . . . .26 olmesartan medoxomil oral. . . . . . . . . 17NOVOLIN 70/30 FLEXPEN . . . . . . . . .23NITRO-BID . . . . . . . . . . . . . . . . . . . . . . 17 olmesartan medoxomil-hctz . . . . . . . . 17NOVOLIN 70/30 FLEXPEN RELION . .23NITRO-DUR . . . . . . . . . . . . . . . . . . . . . 17 olopatadine hcl ophthalmic solution NOVOLIN 70/30 RELION. . . . . . . . . . .23 0.1 %. . . . . . . . . . . . . . . . . . . . . . . . . . . .33NITRO-TIME . . . . . . . . . . . . . . . . . . . . . 17NOVOLIN 70/30 VIAL. . . . . . . . . . . . . .23 olopatadine hcl ophthalmic solution nitroglycerin sublingual . . . . . . . . . . . . 17

0.2 % . . . . . . . . . . . . . . . . . . . . . . . . . . .33NOVOLIN N FLEXPEN . . . . . . . . . . . . .23nitroglycerin transdermal. . . . . . . . . . . 17OLUMIANT ORAL TABLET 1 MG. . . .32NOVOLIN N FLEXPEN RELION . . . . .23nitroglycerin translingual . . . . . . . . . . . 17OLUMIANT ORAL TABLET 2 MG. . . .32NOVOLIN N RELION . . . . . . . . . . . . . .23NITROLINGUAL . . . . . . . . . . . . . . . . . . 17OLUX . . . . . . . . . . . . . . . . . . . . . . . . . . .21NOVOLIN N VIAL . . . . . . . . . . . . . . . . .23NITROMIST. . . . . . . . . . . . . . . . . . . . . . 17OMECLAMOX-PAK . . . . . . . . . . . . . . .25NOVOLIN R FLEXPEN . . . . . . . . . . . . .23NITROSTAT. . . . . . . . . . . . . . . . . . . . . . 17omega-3-acid ethyl esters . . . . . . . . . . 17NOVOLIN R FLEXPEN RELION . . . . .23NITYR . . . . . . . . . . . . . . . . . . . . . . . . . .26omeprazole oral capsule delayed NOVOLIN R RELION . . . . . . . . . . . . . .23NOCDURNA . . . . . . . . . . . . . . . . . . . . .30 release . . . . . . . . . . . . . . . . . . . . . . . . . .25

NOVOLIN R VIAL . . . . . . . . . . . . . . . . .23nora-be . . . . . . . . . . . . . . . . . . . . . . . . .29 OMEPRAZOLE+SYRSPEND SF NOVOLOG FLEXPEN. . . . . . . . . . . . . .23NORDITROPIN FLEXPRO . . . . . . . . . .30 ALKA . . . . . . . . . . . . . . . . . . . . . . . . . . .25NOVOLOG PENFILL. . . . . . . . . . . . . . .23norethin ace-eth estrad-fe oral OMNARIS . . . . . . . . . . . . . . . . . . . . . . .35

capsule . . . . . . . . . . . . . . . . . . . . . . . . .29 NOVOLOG U-100 VIAL. . . . . . . . . . . . .23 OMNITROPE. . . . . . . . . . . . . . . . . . . . .30norethin ace-eth estrad-fe oral np thyroid . . . . . . . . . . . . . . . . . . . . . . .31 ondansetron hcl oral . . . . . . . . . . . . . .13tablet . . . . . . . . . . . . . . . . . . . . . . . . . . .29 NUBEQA . . . . . . . . . . . . . . . . . . . . . . . . 14 ondansetron odt . . . . . . . . . . . . . . . . . .13norethin ace-eth estrad-fe oral NUCALA SUBCUTANEOUS ONETOUCH DELICA PLUS tablet chewable . . . . . . . . . . . . . . . . . .29 SOLUTION AUTO-INJECTOR . . . . . . .35 LANCETS . . . . . . . . . . . . . . . . . . . . . . .23norethindrone acet-ethinyl est . . . . . .29 NUCALA SUBCUTANEOUS ONETOUCH ULTRA 2 KIT norethindrone acetate oral . . . . . . . . .29 SOLUTION PREFILLED SYRINGE . . .35 W/DEVICE. . . . . . . . . . . . . . . . . . . . . . .23norethindrone oral . . . . . . . . . . . . . . . .29 NUCYNTA . . . . . . . . . . . . . . . . . . . . . . . .8 ONETOUCH ULTRA BLUE TEST norgestimate-eth estradiol. . . . . . . . . .29 NUCYNTA ER . . . . . . . . . . . . . . . . . . . . .8 STRIPS IN VITRO STRIP . . . . . . . . . . .23norgestimate-ethinyl estradiol NUEDEXTA . . . . . . . . . . . . . . . . . . . . . .19 ONETOUCH ULTRA MINI KIT triphasic. . . . . . . . . . . . . . . . . . . . . . . . .29 W/DEVICE. . . . . . . . . . . . . . . . . . . . . . .23NULEV. . . . . . . . . . . . . . . . . . . . . . . . . .26NORITATE . . . . . . . . . . . . . . . . . . . . . . .21 ONETOUCH ULTRASOFT NUTROPIN AQ NUSPIN 10 . . . . . . . . .30

LANCETS . . . . . . . . . . . . . . . . . . . . . . .23norlyda. . . . . . . . . . . . . . . . . . . . . . . . . .29 NUTROPIN AQ NUSPIN 20 . . . . . . . . .30ONETOUCH VERIO FLEX SYSTEM norlyroc . . . . . . . . . . . . . . . . . . . . . . . . .29 NUTROPIN AQ NUSPIN 5 . . . . . . . . . .30 KIT W/DEVICE . . . . . . . . . . . . . . . . . . .23nortrel 0.5/35 (28). . . . . . . . . . . . . . . . .29 NUVARING . . . . . . . . . . . . . . . . . . . . . .29 ONETOUCH VERIO IQ SYSTEM. . . . .23nortrel 1/35 (21) . . . . . . . . . . . . . . . . . .29 NUWIQ. . . . . . . . . . . . . . . . . . . . . . . . . .24 ONETOUCH VERIO KIT W/DEVICE . .23nortrel 1/35 (28) . . . . . . . . . . . . . . . . . .29 NUZYRA ORAL . . . . . . . . . . . . . . . . . .10 ONETOUCH VERIO REFLECT . . . . . .23nortriptyline hcl oral . . . . . . . . . . . . . . .12 nyamyc . . . . . . . . . . . . . . . . . . . . . . . . .13 ONETOUCH VERIO TEST STRIPS . . .23NORVASC . . . . . . . . . . . . . . . . . . . . . . . 17 nymyo . . . . . . . . . . . . . . . . . . . . . . . . . .29 ONGLYZA . . . . . . . . . . . . . . . . . . . . . . .24NORVIR ORAL PACKET . . . . . . . . . . .15 nystatin external . . . . . . . . . . . . . . . . . .13 ONZETRA XSAIL . . . . . . . . . . . . . . . . .13NORVIR ORAL SOLUTION . . . . . . . . .15 nystatin mouth/throat. . . . . . . . . . . . . .13 OPSUMIT . . . . . . . . . . . . . . . . . . . . . . .36NORVIR ORAL TABLET. . . . . . . . . . . . 15 nystop . . . . . . . . . . . . . . . . . . . . . . . . . .13 ORAPRED ODT . . . . . . . . . . . . . . . . . .30NOURIANZ . . . . . . . . . . . . . . . . . . . . . . 14ORENCIA CLICKJECT. . . . . . . . . . . . .32Onovarel intramuscular solution ORENCIA SUBCUTANEOUS . . . . . . .32reconstituted 10000 unit . . . . . . . . . . .32 ocella . . . . . . . . . . . . . . . . . . . . . . . . . . .29ORFADIN CAPSULES . . . . . . . . . . . . .26NOVAREL INTRAMUSCULAR OCUFLOX . . . . . . . . . . . . . . . . . . . . . . .33

SOLUTION RECONSTITUTED ORFADIN SUSPENSION . . . . . . . . . . .26ODEFSEY . . . . . . . . . . . . . . . . . . . . . . .155000 UNIT . . . . . . . . . . . . . . . . . . . . . . .32

47

ORIAHNN . . . . . . . . . . . . . . . . . . . . . . .30 PANCREAZE. . . . . . . . . . . . . . . . . . . . .26 potassium chloride crys er . . . . . . . . .25ORILISSA . . . . . . . . . . . . . . . . . . . . . . .30 pantoprazole sodium oral packet . . . .25 potassium chloride er . . . . . . . . . . . . .25orsythia . . . . . . . . . . . . . . . . . . . . . . . . .29 pantoprazole sodium tablet delayed potassium chloride oral packet. . . . . .25

release 20 mg oral . . . . . . . . . . . . . . . .25ORTHO MICRONOR . . . . . . . . . . . . . .29 potassium chloride oral solution 20 pantoprazole sodium tablet delayed meq/15ml (10%), 40 meq/15ml ORTIKOS. . . . . . . . . . . . . . . . . . . . . . . .33release 40 mg oral . . . . . . . . . . . . . . . .25 (20%) . . . . . . . . . . . . . . . . . . . . . . . . . . .25

oscimin . . . . . . . . . . . . . . . . . . . . . . . . .26paroxetine hcl . . . . . . . . . . . . . . . . . . . .12 potassium citrate er . . . . . . . . . . . . . . .25

oscimin sr . . . . . . . . . . . . . . . . . . . . . . .26paroxetine hcl er . . . . . . . . . . . . . . . . . . 12 PRADAXA . . . . . . . . . . . . . . . . . . . . . . . 11

oseltamivir phosphate oral capsule . . 15PAXIL CR. . . . . . . . . . . . . . . . . . . . . . . . 12 PRALUENT . . . . . . . . . . . . . . . . . . . . . .18

oseltamivir phosphate oral PAXIL ORAL SUSPENSION . . . . . . . .12 pramipexole dihydrochloride. . . . . . . . 14suspension reconstituted . . . . . . . . . . 15PAXIL ORAL TABLET. . . . . . . . . . . . . . 12 pramipexole dihydrochloride er . . . . . 14OSENI . . . . . . . . . . . . . . . . . . . . . . . . . .24PEDIAPRED . . . . . . . . . . . . . . . . . . . . .30 pravastatin sodium. . . . . . . . . . . . . . . .18OSPHENA . . . . . . . . . . . . . . . . . . . . . . .25peg-3350/electrolytes . . . . . . . . . . . . .26 prazosin hcl oral . . . . . . . . . . . . . . . . . .18OTEZLA. . . . . . . . . . . . . . . . . . . . . . . . .32peg-3350/electrolytes/ascorbat . . . . .26 PRED FORTE . . . . . . . . . . . . . . . . . . . .33OTREXUP . . . . . . . . . . . . . . . . . . . . . . .32peg-kcl-nacl-nasulf-na asc-c . . . . . . . .26 PRED MILD . . . . . . . . . . . . . . . . . . . . . .33OVIDREL . . . . . . . . . . . . . . . . . . . . . . . .32penicillamine oral . . . . . . . . . . . . . . . . .26 prednisolone acetate ophthalmic . . . .33OXAYDO . . . . . . . . . . . . . . . . . . . . . . . . .8penicillin v potassium. . . . . . . . . . . . . .10 prednisolone oral solution. . . . . . . . . .30oxcarbazepine . . . . . . . . . . . . . . . . . . . 11PENNSAID . . . . . . . . . . . . . . . . . . . . . . .9 prednisolone sodium phosphate OXTELLAR XR . . . . . . . . . . . . . . . . . . . 11

oral . . . . . . . . . . . . . . . . . . . . . . . . . . . . .30PENTASA . . . . . . . . . . . . . . . . . . . . . . .33oxybutynin chloride er . . . . . . . . . . . . .26prednisone intensol . . . . . . . . . . . . . . .30PERCOCET. . . . . . . . . . . . . . . . . . . . . . .8oxybutynin chloride oral . . . . . . . . . . .26prednisone oral. . . . . . . . . . . . . . . . . . .30PERFOROMIST . . . . . . . . . . . . . . . . . .35OXYCODONE HCL ER. . . . . . . . . . . . . .8pregabalin oral . . . . . . . . . . . . . . . . . . .19PERIDEX . . . . . . . . . . . . . . . . . . . . . . . .19oxycodone hcl oral capsule . . . . . . . . .8pregnyl. . . . . . . . . . . . . . . . . . . . . . . . . .32periogard. . . . . . . . . . . . . . . . . . . . . . . .19oxycodone hcl oral concentrate PREMARIN ORAL . . . . . . . . . . . . . . . .29100 mg/5ml. . . . . . . . . . . . . . . . . . . . . . .8 permethrin external . . . . . . . . . . . . . . .14PREMARIN VAGINAL. . . . . . . . . . . . . .29oxycodone hcl oral solution . . . . . . . . .8 PERTZYE. . . . . . . . . . . . . . . . . . . . . . . .26premium lidocaine . . . . . . . . . . . . . . . . .8oxycodone hcl oral tablet 10 mg, phenazo oral tablet 200 mg. . . . . . . . .26

15 mg, 20 mg, 30 mg . . . . . . . . . . . . . . .8 PREMPHASE . . . . . . . . . . . . . . . . . . . .29phenazopyridine hcl oral tablet oxycodone hcl oral tablet 5 mg. . . . . . .8 100 mg, 200 mg . . . . . . . . . . . . . . . . . .26 PREMPRO. . . . . . . . . . . . . . . . . . . . . . .29OXYCODONE-ACETAMINOPHEN philith . . . . . . . . . . . . . . . . . . . . . . . . . . .29 PREVIDENT 5000 BOOSTER PLUS. .19ORAL SOLUTION. . . . . . . . . . . . . . . . . .8 PICATO . . . . . . . . . . . . . . . . . . . . . . . . .21 PREVIDENT 5000 DRY MOUTH. . . . .19OXYCODONE-ACETAMINOPHEN pimtrea . . . . . . . . . . . . . . . . . . . . . . . . .29 PREVIDENT 5000 ORTHO ORAL TABLET 10-300 MG, DEFENSE . . . . . . . . . . . . . . . . . . . . . . .19pioglitazone hcl . . . . . . . . . . . . . . . . . .245-300 MG . . . . . . . . . . . . . . . . . . . . . . . .8

PREVIDENT 5000 PLUS . . . . . . . . . . .19pirmella 1/35 . . . . . . . . . . . . . . . . . . . . .29oxycodone-acetaminophen oral PREVIDENT DENTAL. . . . . . . . . . . . . .19PLAQUENIL . . . . . . . . . . . . . . . . . . . . .14tablet 10-325 mg, 2.5-325 mg, PREVIDENT MOUTH/THROAT. . . . . .205-325 mg, 7.5-325 mg . . . . . . . . . . . . . .8 PLAVIX. . . . . . . . . . . . . . . . . . . . . . . . . .14previfem. . . . . . . . . . . . . . . . . . . . . . . . .29OXYCODONE-ACETAMINOPHEN PLEGRIDY INTRAMUSCULAR . . . . . .19

ORAL TABLET 2.5-300 MG. . . . . . . . . .8 PREZCOBIX . . . . . . . . . . . . . . . . . . . . .15PLEGRIDY STARTER PACK . . . . . . . .19OXYCONTIN . . . . . . . . . . . . . . . . . . . . . .8 PREZISTA . . . . . . . . . . . . . . . . . . . . . . .15PLEGRIDY SUBCUTANEOUS. . . . . . .19OZEMPIC. . . . . . . . . . . . . . . . . . . . . . . .24 PRINIVIL . . . . . . . . . . . . . . . . . . . . . . . .18PLENVU. . . . . . . . . . . . . . . . . . . . . . . . .26OZOBAX . . . . . . . . . . . . . . . . . . . . . . . .36 PRISTIQ. . . . . . . . . . . . . . . . . . . . . . . . .12PLEXION . . . . . . . . . . . . . . . . . . . . . . . .21

PROAIR HFA . . . . . . . . . . . . . . . . . . . . .35PLEXION CLEANSER . . . . . . . . . . . . .21PPROAIR RESPICLICK . . . . . . . . . . . . .35PLEXION CLEANSING CLOTH. . . . . .21PACERONE ORAL TABLET PROCARDIA . . . . . . . . . . . . . . . . . . . . .18POLY-VI-FLOR. . . . . . . . . . . . . . . . . . . .25100 MG, 400 MG . . . . . . . . . . . . . . . . . 17PROCARDIA XL . . . . . . . . . . . . . . . . . .18polymyxin b-trimethoprim . . . . . . . . . .33PACERONE ORAL TABLET PROCENTRA . . . . . . . . . . . . . . . . . . . .19200 MG . . . . . . . . . . . . . . . . . . . . . . . . .18 POLYTRIM . . . . . . . . . . . . . . . . . . . . . .33prochlorperazine maleate oral . . . . . .13PAMELOR . . . . . . . . . . . . . . . . . . . . . . .12 portia-28 . . . . . . . . . . . . . . . . . . . . . . . .29

48

PROCORT. . . . . . . . . . . . . . . . . . . . . . .33 R RINVOQ. . . . . . . . . . . . . . . . . . . . . . . . .32PROCTOFOAM HC . . . . . . . . . . . . . . .33 RIOMET. . . . . . . . . . . . . . . . . . . . . . . . .24RABEPRAZOLE SODIUM ORAL

CAPSULE SPRINKLE. . . . . . . . . . . . . .26progesterone micronized oral . . . . . . .29 RISPERDAL. . . . . . . . . . . . . . . . . . . . . .15rabeprazole sodium oral tablet PROGRAF ORAL CAPSULE . . . . . . . .32 risperidone . . . . . . . . . . . . . . . . . . . . . .15delayed release. . . . . . . . . . . . . . . . . . .26PROGRAF ORAL PACKET . . . . . . . . .32 RITALIN . . . . . . . . . . . . . . . . . . . . . . . . .19ramipril. . . . . . . . . . . . . . . . . . . . . . . . . .18PROLATE . . . . . . . . . . . . . . . . . . . . . . . .8 RITALIN LA . . . . . . . . . . . . . . . . . . . . . .19RANEXA . . . . . . . . . . . . . . . . . . . . . . . .18promethazine hcl oral solution . . . . . .35 ritonavir . . . . . . . . . . . . . . . . . . . . . . . . .15ranolazine er . . . . . . . . . . . . . . . . . . . . .18promethazine hcl oral syrup . . . . . . . .35 rivelsa. . . . . . . . . . . . . . . . . . . . . . . . . . .29RAPAMUNE ORAL SOLUTION . . . . .32promethazine hcl oral tablet . . . . . . . .13 rizatriptan benzoate . . . . . . . . . . . . . . .13RAPAMUNE ORAL TABLET . . . . . . . .32promethazine hcl rectal . . . . . . . . . . . . 13 ROBAXIN-750 . . . . . . . . . . . . . . . . . . . .36RASUVO . . . . . . . . . . . . . . . . . . . . . . . .32promethazine-codeine. . . . . . . . . . . . .35 ROCALTROL. . . . . . . . . . . . . . . . . . . . .33RAYALDEE . . . . . . . . . . . . . . . . . . . . . .33promethazine-dm . . . . . . . . . . . . . . . . .35 ROCKLATAN. . . . . . . . . . . . . . . . . . . . .34RAYOS. . . . . . . . . . . . . . . . . . . . . . . . . .30promethegan . . . . . . . . . . . . . . . . . . . .13 ropinirole hcl . . . . . . . . . . . . . . . . . . . . .14REBIF. . . . . . . . . . . . . . . . . . . . . . . . . . .19PROMETRIUM . . . . . . . . . . . . . . . . . . .29 ropinirole hcl er. . . . . . . . . . . . . . . . . . . 14REBIF REBIDOSE. . . . . . . . . . . . . . . . .19propranolol hcl er . . . . . . . . . . . . . . . . . 18 rosadan external cream. . . . . . . . . . . .21REBIF REBIDOSE TITRATION propranolol hcl oral . . . . . . . . . . . . . . . 18 rosadan external gel. . . . . . . . . . . . . . .21PACK . . . . . . . . . . . . . . . . . . . . . . . . . . .19

PROSCAR . . . . . . . . . . . . . . . . . . . . . . .27 rosuvastatin calcium . . . . . . . . . . . . . .18REBIF TITRATION PACK . . . . . . . . . . .19

PROTONIX ORAL. . . . . . . . . . . . . . . . .25 roweepra . . . . . . . . . . . . . . . . . . . . . . . . 11reclipsen . . . . . . . . . . . . . . . . . . . . . . . .29

PROVENTIL HFA . . . . . . . . . . . . . . . . .35 ROXICODONE ORAL TABLET RECOMBINATE . . . . . . . . . . . . . . . . . .24 15 MG, 30 MG. . . . . . . . . . . . . . . . . . . . .9PROVERA . . . . . . . . . . . . . . . . . . . .27, 29REDITREX. . . . . . . . . . . . . . . . . . . . . . .32 ROXICODONE ORAL TABLET 5 MG . .9PROVIGIL . . . . . . . . . . . . . . . . . . . . . . .36REGLAN . . . . . . . . . . . . . . . . . . . . . . . .13 ROZLYTREK . . . . . . . . . . . . . . . . . . . . . 14PROZAC . . . . . . . . . . . . . . . . . . . . . . . .12RELAFEN . . . . . . . . . . . . . . . . . . . . . . . .9 RUKOBIA. . . . . . . . . . . . . . . . . . . . . . . .15pseudoephedrine-bromphen-dm . . . .35RELAFEN DS . . . . . . . . . . . . . . . . . . . . .9 RYBELSUS . . . . . . . . . . . . . . . . . . . . . .24PULMICORT FLEXHALER. . . . . . . . . .35relexxii . . . . . . . . . . . . . . . . . . . . . . . . . .19 RYTARY. . . . . . . . . . . . . . . . . . . . . . . . .14PULMICORT SUSPENSION . . . . . . . .35RELPAX . . . . . . . . . . . . . . . . . . . . . . . . .13 RYZOLT . . . . . . . . . . . . . . . . . . . . . . . . . .9PULMOZYME . . . . . . . . . . . . . . . . . . . .36REMERON . . . . . . . . . . . . . . . . . . . . . . 12

PURIXAN. . . . . . . . . . . . . . . . . . . . . . . .14 SREMERON SOLTAB . . . . . . . . . . . . . . .12PYLERA. . . . . . . . . . . . . . . . . . . . . . . . .26 SAFYRAL . . . . . . . . . . . . . . . . . . . . . . .29REPATHA . . . . . . . . . . . . . . . . . . . . . . .18PYRIDIUM . . . . . . . . . . . . . . . . . . . . . . .26 SAPHRIS . . . . . . . . . . . . . . . . . . . . . . . .15REPATHA PUSHTRONEX SYSTEM . .18

scopolamine . . . . . . . . . . . . . . . . . . . . .13REPATHA SURECLICK . . . . . . . . . . . .18QSEASONIQUE. . . . . . . . . . . . . . . . . . . .29RESTASIS . . . . . . . . . . . . . . . . . . . . . . .34QBRELIS . . . . . . . . . . . . . . . . . . . . . . . .18SEMGLEE . . . . . . . . . . . . . . . . . . . . . . .23RESTASIS MULTIDOSE. . . . . . . . . . . .34QDOLO . . . . . . . . . . . . . . . . . . . . . . . . . .8SEREVENT DISKUS. . . . . . . . . . . . . . .35RESTORIL . . . . . . . . . . . . . . . . . . . . . . .36QMIIZ ODT . . . . . . . . . . . . . . . . . . . . . . .9SERNIVO. . . . . . . . . . . . . . . . . . . . . . . .21RETACRIT INJECTION SOLUTION QUARTETTE. . . . . . . . . . . . . . . . . . . . .29

10000 UNIT/ML, 2000 UNIT/ML, SEROQUEL. . . . . . . . . . . . . . . . . . . . . .15QUDEXY XR . . . . . . . . . . . . . . . . . . . . . 11 3000 UNIT/ML, 4000 UNIT/ML, SEROQUEL XR. . . . . . . . . . . . . . . . . . .15quetiapine fumarate . . . . . . . . . . . . . . .14 40000 UNIT/ML . . . . . . . . . . . . . . . . . .24sertraline hcl oral . . . . . . . . . . . . . . . . .12quetiapine fumarate er. . . . . . . . . . . . . 14 RETACRIT INJECTION SOLUTION setlakin . . . . . . . . . . . . . . . . . . . . . . . . .2920000 UNIT/ML . . . . . . . . . . . . . . . . . .25QUFLORA PEDIATRIC. . . . . . . . . . . . .25sf. . . . . . . . . . . . . . . . . . . . . . . . . . . .20, 25RETIN-A. . . . . . . . . . . . . . . . . . . . . . . . .21QUILLICHEW ER . . . . . . . . . . . . . . . . .19sf 5000 plus. . . . . . . . . . . . . . . . . . . . . .20REVLIMID . . . . . . . . . . . . . . . . . . . . . . .14QUILLIVANT XR . . . . . . . . . . . . . . . . . .19SFROWASA . . . . . . . . . . . . . . . . . . . . .33REYVOW . . . . . . . . . . . . . . . . . . . . . . . .13quinapril hcl . . . . . . . . . . . . . . . . . . . . .18sharobel. . . . . . . . . . . . . . . . . . . . . . . . .29RHOFADE . . . . . . . . . . . . . . . . . . . . . . .21QVAR REDIHALER. . . . . . . . . . . . . . . .35sildenafil citrate oral tablet 100 mg, RHOPRESSA . . . . . . . . . . . . . . . . . . . .3425 mg, 50 mg . . . . . . . . . . . . . . . . . . . .25RILUTEK . . . . . . . . . . . . . . . . . . . . . . . .19simliya . . . . . . . . . . . . . . . . . . . . . . . . . .29riluzole . . . . . . . . . . . . . . . . . . . . . . . . . .19

49

simpesse . . . . . . . . . . . . . . . . . . . . . . . .29 SUBSYS. . . . . . . . . . . . . . . . . . . . . . . . . .9 SYMFI . . . . . . . . . . . . . . . . . . . . . . . . . .15SIMPONI . . . . . . . . . . . . . . . . . . . . . . . .32 subvenite . . . . . . . . . . . . . . . . . . . . . . . . 11 SYMFI LO . . . . . . . . . . . . . . . . . . . . . . .15simvastatin oral tablet 10 mg, subvenite starter kit-blue . . . . . . . . . . . 11 SYMJEPI . . . . . . . . . . . . . . . . . . . . . . . .3420 mg, 40 mg, 5 mg . . . . . . . . . . . . . . .18 subvenite starter kit-green. . . . . . . . . . 11 SYMLINPEN 120. . . . . . . . . . . . . . . . . .24simvastatin oral tablet 80 mg . . . . . . .18 subvenite starter kit-orange. . . . . . . . . 11 SYMLINPEN 60. . . . . . . . . . . . . . . . . . .24SINEMET. . . . . . . . . . . . . . . . . . . . . . . .14 sucralfate oral . . . . . . . . . . . . . . . . . . . .26 SYMPROIC . . . . . . . . . . . . . . . . . . . . . .26SINGULAIR ORAL PACKET . . . . . . . .35 sulfacetamide sod-sulfur wash SYNALAR . . . . . . . . . . . . . . . . . . . . . . .22SINGULAIR ORAL TABLET. . . . . . . . .35 external liquid . . . . . . . . . . . . . . . . . . . .22 SYNJARDY . . . . . . . . . . . . . . . . . . . . . .24SINGULAIR ORAL TABLET sulfacetamide sodium-sulfur SYNJARDY XR . . . . . . . . . . . . . . . . . . .24CHEWABLE . . . . . . . . . . . . . . . . . . . . .35 external cream 10-2 %, 10-5 % . . . . . .21

SYNTHROID . . . . . . . . . . . . . . . . . . . . .31sirolimus oral. . . . . . . . . . . . . . . . . . . . .32 sulfacetamide sodium-sulfur

SYPRINE . . . . . . . . . . . . . . . . . . . . . . . .26external cream 9.8-4.8 % . . . . . . . . . . .21SITAVIG . . . . . . . . . . . . . . . . . . . . . . . . .15sulfacetamide sodium-sulfur TSKELAXIN . . . . . . . . . . . . . . . . . . . . . . .36external emulsion . . . . . . . . . . . . . . . . .21

SKYRIZI (150 MG DOSE). . . . . . . . . . .32 TACLONEX EXTERNAL sulfacetamide sodium-sulfur OINTMENT . . . . . . . . . . . . . . . . . . . . . .22sodium fluoride 5000 plus. . . . . . . . . .20 external liquid 10-2 %, 9.8-4.8 %. . . . .21

TACLONEX EXTERNAL sodium fluoride 5000 ppm . . . . . . . . .20 sulfacetamide sodium-sulfur SUSPENSION . . . . . . . . . . . . . . . . . . . .22sodium fluoride dental . . . . . . . . . . . . .20 external liquid 9-4 %, 9-4.5 % . . . . . . .21tacrolimus oral . . . . . . . . . . . . . . . . . . .32SOFOSBUVIR-VELPATASVIR . . . . . . . 15 sulfacetamide sodium-sulfur tadalafil oral tablet 10 mg, 20 mg . . . .25external lotion 10-5 %. . . . . . . . . . . . . .21SOLIQUA. . . . . . . . . . . . . . . . . . . . . . . .24tadalafil oral tablet 2.5 mg, 5 mg. . . . .25sulfacetamide sodium-sulfur SOLODYN . . . . . . . . . . . . . . . . . . . . . . .10

external lotion 9.8-4.8 % . . . . . . . . . . .21 TAKHZYRO . . . . . . . . . . . . . . . . . . . . . .32SOLTAMOX . . . . . . . . . . . . . . . . . . . . . . 14sulfacetamide sodium-sulfur TAMIFLU ORAL CAPSULE . . . . . . . . .15SOMA ORAL TABLET 250 MG . . . . . .36 external pad . . . . . . . . . . . . . . . . . . . . .21 TAMIFLU ORAL SUSPENSION SOMA ORAL TABLET 350 MG . . . . . .36 sulfacetamide sodium-sulfur RECONSTITUTED . . . . . . . . . . . . . . . .15

SOMATULINE DEPOT . . . . . . . . . . . . .30 external suspension 10-5 % . . . . . . . .21 tamoxifen citrate oral tablet 10 mg . . .14SOOLANTRA . . . . . . . . . . . . . . . . . . . .21 sulfacetamide sodium-sulfur tamoxifen citrate oral tablet 20 mg. . .14

external suspension 8-4 % . . . . . . . . .21sotalol hcl oral. . . . . . . . . . . . . . . . . . . .18 tamsulosin hcl. . . . . . . . . . . . . . . . . . . .27SULFACLEANSE 8/4 . . . . . . . . . . . . . .22SOTYLIZE . . . . . . . . . . . . . . . . . . . . . . .18 TAPAZOLE . . . . . . . . . . . . . . . . . . . . . .31sulfamethoxazole-trimethoprim oral. .10SPIRIVA HANDIHALER . . . . . . . . . . . .36 TAPERDEX 12-DAY. . . . . . . . . . . . . . . .30sulfamez wash . . . . . . . . . . . . . . . . . . .22SPIRIVA RESPIMAT . . . . . . . . . . . . . . .36 TAPERDEX 6-DAY ORAL TABLET sulfasalazine oral . . . . . . . . . . . . . . . . .33spironolactone oral . . . . . . . . . . . . . . .18 THERAPY PACK 1.5 MG . . . . . . . . . . .30sulfatrim pediatric. . . . . . . . . . . . . . . . . 11sprintec 28 . . . . . . . . . . . . . . . . . . . . . .29 TAPERDEX 6-DAY ORAL TABLET SUMADAN WASH . . . . . . . . . . . . . . . .22 THERAPY PACK 1.5 MG (21). . . . . . . .30SPRITAM . . . . . . . . . . . . . . . . . . . . . . . . 11sumatriptan succinate oral . . . . . . . . . 13 TAPERDEX 7-DAY. . . . . . . . . . . . . . . . .30SPRIX. . . . . . . . . . . . . . . . . . . . . . . . . . . .9sumatriptan succinate refill . . . . . . . . .13 TARGADOX. . . . . . . . . . . . . . . . . . . . . . 11sronyx . . . . . . . . . . . . . . . . . . . . . . . . . .29sumatriptan succinate TARGRETIN EXTERNAL . . . . . . . . . . .14sss 10-5 . . . . . . . . . . . . . . . . . . . . . . . . .21subcutaneous . . . . . . . . . . . . . . . . . . . .13 TARGRETIN ORAL. . . . . . . . . . . . . . . .14STELARA SUBCUTANEOUS SUMAXIN . . . . . . . . . . . . . . . . . . . . . . .22SOLUTION . . . . . . . . . . . . . . . . . . . . . .32 tarina 24 fe. . . . . . . . . . . . . . . . . . . . . . .29SUMAXIN WASH . . . . . . . . . . . . . . . . .22STELARA SUBCUTANEOUS tarina fe 1/20. . . . . . . . . . . . . . . . . . . . .29

SOLUTION PREFILLED SYRINGE . . .32 SUNOSI . . . . . . . . . . . . . . . . . . . . . . . . .36 tarina fe 1/20 eq . . . . . . . . . . . . . . . . . .29STENDRA . . . . . . . . . . . . . . . . . . . . . . .25 SUPREP BOWEL PREP KIT . . . . . . . .26 TASIGNA . . . . . . . . . . . . . . . . . . . . . . . . 14STIMATE . . . . . . . . . . . . . . . . . . . . . . . .30 SUTAB . . . . . . . . . . . . . . . . . . . . . . . . . .26 TAYTULLA. . . . . . . . . . . . . . . . . . . . . . .29STRATTERA . . . . . . . . . . . . . . . . . . . . .19 syeda . . . . . . . . . . . . . . . . . . . . . . . . . . .29 tazarotene external. . . . . . . . . . . . . . . .22STRENSIQ. . . . . . . . . . . . . . . . . . . . . . .26 SYMAX DUOTAB . . . . . . . . . . . . . . . . .26 TAZORAC . . . . . . . . . . . . . . . . . . . . . . .22STRIBILD. . . . . . . . . . . . . . . . . . . . . . . .15 SYMAX-SL. . . . . . . . . . . . . . . . . . . . . . .26 TEGRETOL . . . . . . . . . . . . . . . . . . . . . . 11STRIVERDI RESPIMAT . . . . . . . . . . . .36 SYMAX-SR . . . . . . . . . . . . . . . . . . . . . .26 TEGRETOL-XR . . . . . . . . . . . . . . . . . . . 11SUBOXONE. . . . . . . . . . . . . . . . . . . . . .10 SYMBICORT . . . . . . . . . . . . . . . . . . . . .36 TEGSEDI . . . . . . . . . . . . . . . . . . . . . . . .26

50

TEKTURNA . . . . . . . . . . . . . . . . . . . . . . 18 tobramycin ophthalmic . . . . . . . . . . . .33 tri-vylibra . . . . . . . . . . . . . . . . . . . . . . . .30TEKTURNA HCT . . . . . . . . . . . . . . . . .18 tobramycin-dexamethasone . . . . . . . .33 tri-vylibra lo . . . . . . . . . . . . . . . . . . . . . .30telmisartan . . . . . . . . . . . . . . . . . . . . . .18 TOBREX OPHTHALMIC triamcinolone acetonide external

OINTMENT . . . . . . . . . . . . . . . . . . . . . .34 aerosol solution . . . . . . . . . . . . . . . . . .22temazepam . . . . . . . . . . . . . . . . . . . . . .36TOBREX OPHTHALMIC triamcinolone acetonide external TEMIXYS . . . . . . . . . . . . . . . . . . . . . . . .15SOLUTION . . . . . . . . . . . . . . . . . . . . . .34 cream 0.025 %, 0.1 %. . . . . . . . . . . . . .22

TEMOVATE . . . . . . . . . . . . . . . . . . . . . .22TOPAMAX . . . . . . . . . . . . . . . . . . . . . . . 11 triamcinolone acetonide external

tenofovir disoproxil fumarate. . . . . . . . 15 cream 0.5 % . . . . . . . . . . . . . . . . . . . . .22TOPAMAX SPRINKLE . . . . . . . . . . . . . 11TENORETIC 100. . . . . . . . . . . . . . . . . .18 triamcinolone acetonide external topiramate er. . . . . . . . . . . . . . . . . . . . . 11TENORETIC 50. . . . . . . . . . . . . . . . . . .18 lotion . . . . . . . . . . . . . . . . . . . . . . . . . . .22

topiramate oral . . . . . . . . . . . . . . . . . . . 11TENORMIN . . . . . . . . . . . . . . . . . . . . . . 18 triamcinolone acetonide external

TOPROL XL. . . . . . . . . . . . . . . . . . . . . .18 ointment 0.025 %, 0.1 %, 0.5 % . . . . . .22terazosin hcl . . . . . . . . . . . . . . . . . . . . .27torsemide . . . . . . . . . . . . . . . . . . . . . . .18 triamcinolone acetonide external terbinafine hcl oral . . . . . . . . . . . . . . . .13TOUJEO MAX SOLOSTAR . . . . . . . . .23 ointment 0.05 % . . . . . . . . . . . . . . . . . .22terconazole . . . . . . . . . . . . . . . . . . . . . . 13TOUJEO SOLOSTAR . . . . . . . . . . . . . .23 triamterene-hctz . . . . . . . . . . . . . . . . . .18TERIPARATIDE (RECOMBINANT) . . .33TOVIAZ . . . . . . . . . . . . . . . . . . . . . . . . .27 TRIANEX . . . . . . . . . . . . . . . . . . . . . . . .22TESSALON PERLES . . . . . . . . . . . . . .35TRACLEER . . . . . . . . . . . . . . . . . . . . . .36 triazolam . . . . . . . . . . . . . . . . . . . . . . . .16TESTIM . . . . . . . . . . . . . . . . . . . . . . . . .31TRADJENTA . . . . . . . . . . . . . . . . . . . . .24 TRICOR . . . . . . . . . . . . . . . . . . . . . . . . .18testosterone cypionate tramadol hcl er . . . . . . . . . . . . . . . . . . . .9 triderm external cream 0.1 %. . . . . . . .22intramuscular . . . . . . . . . . . . . . . . . . . .31tramadol hcl er (biphasic) . . . . . . . . . . .9 triderm external cream 0.5 % . . . . . . .22testosterone transdermal. . . . . . . . . . .31tramadol hcl oral tablet 100 mg . . . . . .9 TRIDESILON . . . . . . . . . . . . . . . . . . . . .22TEXACORT . . . . . . . . . . . . . . . . . . . . . .22tramadol hcl oral tablet 50 mg . . . . . . .9 trientine hcl . . . . . . . . . . . . . . . . . . . . . .26THYQUIDITY. . . . . . . . . . . . . . . . . . . . .31TRANSDERM SCOP (1.5 MG). . . . . . .13 TRIJARDY XR . . . . . . . . . . . . . . . . . . . .24TIGLUTIK. . . . . . . . . . . . . . . . . . . . . . . .19TRAVATAN Z. . . . . . . . . . . . . . . . . . . . .34 TRILEPTAL . . . . . . . . . . . . . . . . . . . . . . 11timolol maleate ophthalmic . . . . . . . . .34travoprost (bak free) . . . . . . . . . . . . . . .34 TRINTELLIX . . . . . . . . . . . . . . . . . . . . .12timolol maleate pf . . . . . . . . . . . . . . . . .34trazodone hcl oral. . . . . . . . . . . . . . . . . 12 TRIUMEQ . . . . . . . . . . . . . . . . . . . . . . .15TIMOPTIC . . . . . . . . . . . . . . . . . . . . . . .34TRELEGY ELLIPTA. . . . . . . . . . . . . . . .36 TROKENDI XR . . . . . . . . . . . . . . . . . . . 11TIMOPTIC OCUDOSE

OPHTHALMIC SOLUTION 0.25 % . . .34 TREMFYA . . . . . . . . . . . . . . . . . . . . . . .32 TRULANCE. . . . . . . . . . . . . . . . . . . . . .26TIMOPTIC OCUDOSE TRESIBA . . . . . . . . . . . . . . . . . . . . . . . .23 TRULICITY . . . . . . . . . . . . . . . . . . . . . .24OPHTHALMIC SOLUTION 0.5 % . . . .34 TRESIBA FLEXTOUCH . . . . . . . . . . . .23 TRUVADA ORAL TABLET TIMOPTIC-XE . . . . . . . . . . . . . . . . . . . .34 100-150 MG, 133-200 MG, tretinoin external cream. . . . . . . . . . . .22

167-250 MG. . . . . . . . . . . . . . . . . . . . . .15TIROSINT . . . . . . . . . . . . . . . . . . . . . . .31 tretinoin external gel 0.01 % . . . . . . . .22TRUVADA ORAL TABLET TIROSINT-SOL . . . . . . . . . . . . . . . . . . . 31 tretinoin external gel 0.025 % . . . . . . .22 200-300 MG . . . . . . . . . . . . . . . . . . . . .15TIVICAY . . . . . . . . . . . . . . . . . . . . . . . . .15 tretinoin external gel 0.05 % . . . . . . . .22 tulana . . . . . . . . . . . . . . . . . . . . . . . . . . .30TIVICAY PD . . . . . . . . . . . . . . . . . . . . . . 15 TREXALL. . . . . . . . . . . . . . . . . . . . . . . .32 TUSSICAPS . . . . . . . . . . . . . . . . . . . . .35TIVORBEX. . . . . . . . . . . . . . . . . . . . . . . .9 TREZIX . . . . . . . . . . . . . . . . . . . . . . . . . .9 tyblume . . . . . . . . . . . . . . . . . . . . . . . . .30tizanidine hcl oral . . . . . . . . . . . . . . . . .36 tri femynor . . . . . . . . . . . . . . . . . . . . . . .29 tydemy . . . . . . . . . . . . . . . . . . . . . . . . . .30TOBI NEBULIZER. . . . . . . . . . . . . . . . .36 tri-estarylla. . . . . . . . . . . . . . . . . . . . . . .29 TYMLOS . . . . . . . . . . . . . . . . . . . . . . . .33TOBI PODHALER . . . . . . . . . . . . . . . . .36 tri-linyah . . . . . . . . . . . . . . . . . . . . . . . . .29 TYVASO . . . . . . . . . . . . . . . . . . . . . . . .36TOBRADEX OPHTHALMIC tri-lo-estarylla . . . . . . . . . . . . . . . . . . . .29 TYVASO REFILL. . . . . . . . . . . . . . . . . .36OINTMENT . . . . . . . . . . . . . . . . . . . . . .33

tri-lo-marzia . . . . . . . . . . . . . . . . . . . . . .29 TYVASO STARTER . . . . . . . . . . . . . . .36TOBRADEX OPHTHALMIC tri-lo-mili . . . . . . . . . . . . . . . . . . . . . . . . .29SUSPENSION . . . . . . . . . . . . . . . . . . . .33

Utri-lo-sprintec. . . . . . . . . . . . . . . . . . . . .30TOBRADEX ST . . . . . . . . . . . . . . . . . . .33tri-mili . . . . . . . . . . . . . . . . . . . . . . . . . . .30 UBRELVY . . . . . . . . . . . . . . . . . . . . . . .13tobramycin inhalation nebulization tri-nymyo . . . . . . . . . . . . . . . . . . . . . . . .30 UCERIS ORAL . . . . . . . . . . . . . . . . . . .33solution 300 mg/4ml . . . . . . . . . . . . . .36tri-previfem . . . . . . . . . . . . . . . . . . . . . .30 UCERIS RECTAL . . . . . . . . . . . . . . . . .33tobramycin nebulization solution

300 mg/5ml inhalation . . . . . . . . . . . . .36 tri-sprintec . . . . . . . . . . . . . . . . . . . . . . .30 ULORIC . . . . . . . . . . . . . . . . . . . . . . . . .13

51

ULTRAM . . . . . . . . . . . . . . . . . . . . . . . . .9 VICTOZA SOLUTION PEN- XINJECTOR 18 MG/3ML unithroid . . . . . . . . . . . . . . . . . . . . . . . .31 XALATAN. . . . . . . . . . . . . . . . . . . . . . . .34SUBCUTANEOUS (3 Pak) . . . . . . . . . .24

UROCIT-K 10. . . . . . . . . . . . . . . . . . . . .25 XANAX. . . . . . . . . . . . . . . . . . . . . . . . . .16vienva. . . . . . . . . . . . . . . . . . . . . . . . . . .30

UROCIT-K 15. . . . . . . . . . . . . . . . . . . . .25 XANAX XR. . . . . . . . . . . . . . . . . . . . . . .16VIGAMOX . . . . . . . . . . . . . . . . . . . . . . .34

UROCIT-K 5. . . . . . . . . . . . . . . . . . . . . .25 XARELTO . . . . . . . . . . . . . . . . . . . . . . . 11VIIBRYD. . . . . . . . . . . . . . . . . . . . . . . . .12

UROXATRAL. . . . . . . . . . . . . . . . . . . . .27 XARELTO STARTER PACK . . . . . . . . . 11VIIBRYD STARTER PACK . . . . . . . . . .12

URSO 250 . . . . . . . . . . . . . . . . . . . . . . .26 XCOPRI . . . . . . . . . . . . . . . . . . . . . . . . . 12VIMPAT ORAL. . . . . . . . . . . . . . . . . . . .12

URSO FORTE . . . . . . . . . . . . . . . . . . . .26 XELJANZ ORAL SOLUTION . . . . . . . .32VIOKACE. . . . . . . . . . . . . . . . . . . . . . . .26

ursodiol oral . . . . . . . . . . . . . . . . . . . . .26 XELJANZ ORAL TABLET . . . . . . . . . .32viorele . . . . . . . . . . . . . . . . . . . . . . . . . .30

XELJANZ XR ORAL TABLET V VIREAD ORAL POWDER. . . . . . . . . . .15 EXTENDED RELEASE 24 HOUR VIREAD ORAL TABLET 150 MG, VAGIFEM . . . . . . . . . . . . . . . . . . . . . . . .30 11 MG . . . . . . . . . . . . . . . . . . . . . . . . . .32200 MG, 250 MG . . . . . . . . . . . . . . . . .15valacyclovir hcl oral . . . . . . . . . . . . . . . 15 XELJANZ XR ORAL TABLET VIREAD ORAL TABLET 300 MG . . . .15 EXTENDED RELEASE 24 HOUR VALIUM . . . . . . . . . . . . . . . . . . . . . . . . .16

22 MG . . . . . . . . . . . . . . . . . . . . . . . . . .32VISTARIL . . . . . . . . . . . . . . . . . . . . . . . .16valsartan . . . . . . . . . . . . . . . . . . . . . . . . 18XELODA. . . . . . . . . . . . . . . . . . . . . . . . .14vitamin d (ergocalciferol) oral valsartan-hydrochlorothiazide. . . . . . .18

capsule 1.25 mg (50000 ut). . . . . . . . .25 XELPROS . . . . . . . . . . . . . . . . . . . . . . .34VALTOCO . . . . . . . . . . . . . . . . . . . . . . .12

VITRAKVI . . . . . . . . . . . . . . . . . . . . . . . 14 XENLETA ORAL . . . . . . . . . . . . . . . . . . 11VALTREX . . . . . . . . . . . . . . . . . . . . . . . .15

VIVELLE-DOT . . . . . . . . . . . . . . . . 28, 30 XEPI . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11VANADOM . . . . . . . . . . . . . . . . . . . . . .36

VIVLODEX . . . . . . . . . . . . . . . . . . . . . . . .9 XHANCE . . . . . . . . . . . . . . . . . . . . . . . .35vandazole . . . . . . . . . . . . . . . . . . . . . . . 11

VOGELXO . . . . . . . . . . . . . . . . . . . . . . .31 XIFAXAN . . . . . . . . . . . . . . . . . . . . . . . .26VANOS. . . . . . . . . . . . . . . . . . . . . . . . . .22

VOGELXO PUMP . . . . . . . . . . . . . . . . .31 XIIDRA . . . . . . . . . . . . . . . . . . . . . . . . . .34VASOTEC . . . . . . . . . . . . . . . . . . . . . . .18

volnea . . . . . . . . . . . . . . . . . . . . . . . . . .30 XIMINO . . . . . . . . . . . . . . . . . . . . . . . . . 11VECTICAL . . . . . . . . . . . . . . . . . . . . . . .22

VOLTAREN . . . . . . . . . . . . . . . . . . . . . . .9 XOFLUZA (40 MG DOSE) . . . . . . . . . .15VELPHORO. . . . . . . . . . . . . . . . . . . . . .27

VOSEVI . . . . . . . . . . . . . . . . . . . . . . . . . 15 XOFLUZA (80 MG DOSE) . . . . . . . . . .15VELTASSA. . . . . . . . . . . . . . . . . . . . . . .25

VRAYLAR . . . . . . . . . . . . . . . . . . . . . . . 15 XOLEGEL . . . . . . . . . . . . . . . . . . . . . . .13VEMLIDY . . . . . . . . . . . . . . . . . . . . . . . .15

VTOL LQ . . . . . . . . . . . . . . . . . . . . . . . . .9 XOPENEX HFA . . . . . . . . . . . . . . . . . . .36venlafaxine hcl . . . . . . . . . . . . . . . . . . . 12

vyfemla . . . . . . . . . . . . . . . . . . . . . . . . .30 XTAMPZA ER . . . . . . . . . . . . . . . . . . . . .9venlafaxine hcl er oral capsule

VYLEESI . . . . . . . . . . . . . . . . . . . . . . . .25 xulane . . . . . . . . . . . . . . . . . . . . . . . . . .30extended release 24 hour . . . . . . . . . .12vylibra . . . . . . . . . . . . . . . . . . . . . . . . . .30 XYREM . . . . . . . . . . . . . . . . . . . . . . . . .36venlafaxine hcl er oral tablet VYTORIN. . . . . . . . . . . . . . . . . . . . . . . .18extended release 24 hour . . . . . . . . . .12 XYWAV . . . . . . . . . . . . . . . . . . . . . . . . .36VYVANSE . . . . . . . . . . . . . . . . . . . . . . .19VENTOLIN HFA. . . . . . . . . . . . . . . 35, 36

YVYZULTA . . . . . . . . . . . . . . . . . . . . . . . .34verapamil hcl er . . . . . . . . . . . . . . . . . . 18YASMIN 28 . . . . . . . . . . . . . . . . . . . . . .30verapamil hcl oral . . . . . . . . . . . . . . . . . 18

W YAZ . . . . . . . . . . . . . . . . . . . . . . . . . . . .30VERDESO . . . . . . . . . . . . . . . . . . . . . . .22WAKIX . . . . . . . . . . . . . . . . . . . . . . . . . .36 YUPELRI . . . . . . . . . . . . . . . . . . . . . . . .36VERELAN . . . . . . . . . . . . . . . . . . . . . . .18warfarin sodium oral. . . . . . . . . . . . . . . 11 yuvafem . . . . . . . . . . . . . . . . . . . . . . . . .30VERELAN PM . . . . . . . . . . . . . . . . . . . .18WELCHOL. . . . . . . . . . . . . . . . . . . . . . . 18

VERZENIO. . . . . . . . . . . . . . . . . . . . . . . 14 ZWELLBUTRIN SR . . . . . . . . . . . . . . . . . 12vestura . . . . . . . . . . . . . . . . . . . . . . . . . .30 zafemy . . . . . . . . . . . . . . . . . . . . . . . . . .30WELLBUTRIN XL . . . . . . . . . . . . . . . . .12VIAGRA . . . . . . . . . . . . . . . . . . . . . . . . .25 ZANAFLEX . . . . . . . . . . . . . . . . . . . . . .36wera . . . . . . . . . . . . . . . . . . . . . . . . . . . .30VIBERZI . . . . . . . . . . . . . . . . . . . . . . . . .26 zarah . . . . . . . . . . . . . . . . . . . . . . . . . . .30WESTHROID. . . . . . . . . . . . . . . . . . . . .31VIBRAMYCIN ORAL CAPSULE . . . . . 11 ZARXIO . . . . . . . . . . . . . . . . . . . . . . . . .25wixela inhub . . . . . . . . . . . . . . . . . . . . .36VIBRAMYCIN ORAL SUSPENSION ZCORT 7-DAY . . . . . . . . . . . . . . . . . . . .30WP THYROID . . . . . . . . . . . . . . . . . . . .31RECONSTITUTED . . . . . . . . . . . . . . . . 11

ZEBUTAL. . . . . . . . . . . . . . . . . . . . . . . . .9WYNZORA . . . . . . . . . . . . . . . . . . . . . .22VICTOZA SOLUTION PEN-ZEJULA . . . . . . . . . . . . . . . . . . . . . . . . .14INJECTOR 18 MG/3ML

SUBCUTANEOUS (2 Pak) . . . . . . . . . .24 ZELNORM. . . . . . . . . . . . . . . . . . . . . . .26

52

ZEMBRACE SYMTOUCH . . . . . . . . . .13 ZUBSOLV . . . . . . . . . . . . . . . . . . . . . . .10zenatane . . . . . . . . . . . . . . . . . . . . . . . .22 zumandimine. . . . . . . . . . . . . . . . . . . . .30ZENPEP. . . . . . . . . . . . . . . . . . . . . . . . .26 ZUPLENZ . . . . . . . . . . . . . . . . . . . . . . .13ZENZEDI . . . . . . . . . . . . . . . . . . . . . . . .19 ZYCLARA . . . . . . . . . . . . . . . . . . . . . . .22ZEPATIER . . . . . . . . . . . . . . . . . . . . . . .15 ZYCLARA PUMP . . . . . . . . . . . . . . . . .22ZEPOSIA . . . . . . . . . . . . . . . . . . . . . . . .19 ZYLOPRIM . . . . . . . . . . . . . . . . . . . . . .13ZEPOSIA 7-DAY STARTER PACK . . . .19 ZYPREXA ORAL. . . . . . . . . . . . . . . . . .15ZEPOSIA STARTER KIT. . . . . . . . . . . .19 ZYPREXA ZYDIS . . . . . . . . . . . . . . . . .15ZESTORETIC . . . . . . . . . . . . . . . . . . . .18ZESTRIL . . . . . . . . . . . . . . . . . . . . . . . . 18ZETIA. . . . . . . . . . . . . . . . . . . . . . . . . . . 18ZETONNA . . . . . . . . . . . . . . . . . . . . . . .35ZIAC ORAL TABLET 10-6.25 MG, 2.5-6.25 MG . . . . . . . . . . . . . . . . . . . . .18ZIAC ORAL TABLET 5-6.25 MG . . . . .18ZIEXTENZO. . . . . . . . . . . . . . . . . . . . . .25ZILXI. . . . . . . . . . . . . . . . . . . . . . . . . . . .22ziprasidone hcl . . . . . . . . . . . . . . . . . . . 15ZIPSOR . . . . . . . . . . . . . . . . . . . . . . . . . .9ZITHROMAX ORAL . . . . . . . . . . . . . . . 11ZITHROMAX TRI-PAK . . . . . . . . . . . . . 11ZITHROMAX Z-PAK . . . . . . . . . . . . . . . 11ZOCOR . . . . . . . . . . . . . . . . . . . . . . . . .18ZOFRAN . . . . . . . . . . . . . . . . . . . . . . . .13ZOHYDRO ER. . . . . . . . . . . . . . . . . . . . .9ZOLMITRIPTAN NASAL SOLUTION 2.5 MG . . . . . . . . . . . . . . . . . . . . . . . . . .13ZOLMITRIPTAN NASAL SOLUTION 5 MG . . . . . . . . . . . . . . . . . . . . . . . . . . .13zolmitriptan oral . . . . . . . . . . . . . . . . . .13ZOLOFT. . . . . . . . . . . . . . . . . . . . . . . . .12zolpidem tartrate er . . . . . . . . . . . . . . .36zolpidem tartrate oral . . . . . . . . . . . . . .36zolpidem tartrate sublingual . . . . . . . .36ZOLPIMIST . . . . . . . . . . . . . . . . . . . . . .36ZOMACTON . . . . . . . . . . . . . . . . . . . . .30ZOMACTON (FOR ZOMA-JET 10) . . .30ZOMIG NASAL SOLUTION 2.5 MG . .13ZOMIG NASAL SOLUTION 5 MG . . . .13ZOMIG ORAL . . . . . . . . . . . . . . . . . . . .13ZOMIG ZMT . . . . . . . . . . . . . . . . . . . . .13ZONEGRAN . . . . . . . . . . . . . . . . . . . . .12zonisamide oral. . . . . . . . . . . . . . . . . . .12ZONTIVITY . . . . . . . . . . . . . . . . . . . . . . 14ZOVIRAX ORAL . . . . . . . . . . . . . . . . . .15ZTLIDO . . . . . . . . . . . . . . . . . . . . . . . . . .9

53

Nondiscrimination notice and access to communication services UnitedHealthcare® and its subsidiaries do not discriminate on the basis of race, color, national origin, age, disability or sex in their health programs or activities.

If you think you were treated unfairly because of your sex, age, race, color, disability or national origin, you can send a complaint to the Civil Rights Coordinator.

Online: [email protected]

Mail: Civil Rights Coordinator UnitedHealthcare Civil Rights Grievance P.O. Box 30608 Salt Lake City, UT 84130

You must send the complaint within 60 days of your experience. A decision will be sent to you within 30 days. If you disagree with the decision, you have 15 days to ask us to look at it again. If you need help with your complaint, please call the toll-free phone number listed on your ID card, TTY 711, Monday through Friday, 8 a.m. to 8 p.m., or at the times listed in your health plan documents.

You can also file a complaint with the U.S. Dept. of Health and Human Services.

Online: https://ocrportal.hhs.gov/ocr/portal/lobby.jsf Complaint forms are available at http://www.hhs.gov/ocr/office/file/index.html

Phone: Toll-free 1-800-368-1019, 1-800-537-7697 (TDD)

Mail: U.S. Dept. of Health and Human Services 200 Independence Avenue SW Room 509F, HHH Building Washington, D.C. 20201

We provide free services to help you communicate with us, including letters in other languages or large print. Or, you can ask for an interpreter. To ask for help, please call the toll-free phone number listed on your ID card, TTY 711, Monday through Friday, 8 a.m. to 8 p.m., or at the times listed in your health plan documents.

54

請注意:如果您說中文 (Chinese),我們免費為您提供語言協助服務。請撥打會員卡所列的免付費會員電話號碼。

XIN LƯU Ý: Nếu quý vị nói tiếng Việt (Vietnamese), quý vị sẽ được cung cấp dịch vụ trợ giúp về ngôn ngữ miễn phí. Vui lòng gọi số điện thoại miễn phí ở mặt sau thẻ hội viên của quý vị.

ATANSYON: Si w pale Kreyòl ayisyen (Haitian Creole), ou kapab benefisye sèvis ki gratis pou ede w nan lang pa w. Tanpri rele nimewo gratis ki sou kat idantifikasyon w.

توجه: ا�ر �بان �ما فارسی (Farsi) است، خدمات امداد �بان� به �ور راي�ان در اختيار �ما م� با�د. ل��ا با �مار� تل�ن راي�ان� �ه رو� �ارت �ناساي� �ما قيد �د� تما� ب�يريد.

ध्यान दें: यदि आप हिंदी (Hindi) बोलते है, आपको भाषा सहायता सेबाए,ं नि:शुल्क उपलब्ध हैं। कृपया अपने पहचान पत्र पर सूचीबद्ध टोल-फ्री फोन नंबर पर कॉल करें।

CEEB TOOM: Yog koj hais Lus Hmoob (Hmong), muaj kev pab txhais lus pub dawb rau koj. Thov hu rau tus xov tooj hu deb dawb uas teev muaj nyob rau ntawm koj daim yuaj cim qhia tus kheej.

ចំណាប់អារម្មណ៍ៈ បើសិនអ្នកនិយាយភាសាខ្មែរ(Khmer)សេវាជំនួយភាសាដោយឥតគិតថ្លៃ គឺមានសំរាប់អ្នក។ សូមទូរស័ព្ទទៅលេខឥតគិតថ្លៃ ដែលមាននៅលើអត្ដសញ្ញាណប័ណ្ណរបស់អ្នក។

PAKDAAR: Nu saritaem ti Ilocano (Ilocano), ti serbisyo para ti baddang ti lengguahe nga awanan bayadna, ket sidadaan para kenyam. Maidawat nga awagan iti toll-free a numero ti telepono nga nakalista ayan iti identification card mo.

DÍÍ BAA’ÁKONÍNÍZIN: Diné (Navajo) bi]aad bee yini�ti�go, saad bee ika�anída�awo�ígíí, t�ii jíík�eh, bee ni�ahóót�i�. 7�ii sh��dí ninaaltsoos nit��i]í bee néého]inígíí bine�d���� t�ii jíík�ehgo béésh bee hane�í biki�ígíí �bee hodíilnih.

OGOW: Haddii aad ku hadasho Soomaali (Somali), adeegyada taageerada luqadda, oo bilaash ah, ayaad heli kartaa. Fadlan wac lambarka telefonka khadka bilaashka ee ku yaalla kaarkaaga aqoonsiga.

55

Multi-language interpreter servicesMulti-language interpreter services

ATTENTION: If you speak English, language assistance services, free of charge, are available to you. Please call the toll-free phone number listed on your identification card.

ATENCIÓN: Si habla español (Spanish), hay servicios de asistencia de idiomas, sin cargo, a su disposición. Llame al número de teléfono gratuito que aparece en su tarjeta de identificación.

알림: 한국어(Korean)를 사용하시는 경우 언어 지원 서비스를 무료로 이용하실 수 있습니다. 귀하의 신분증 카드에 기재된 무료 회원 전화번호로 문의하십시오.

PAALALA: Kung nagsasalita ka ng Tagalog (Tagalog), may makukuha kang mga libreng serbisyo ng tulong sa wika. Pakitawagan ang toll-free na numero ng telepono na nasa iyong identification card.

ВНИМАНИЕ: бесплатные услуги перевода доступны для людей, чей родной язык является русском (Russian). Позвоните по бесплатному номеру телефона, указанному на вашей идентификационной карте.

تنبيه: إذا كنت تتحدث العربية (Arabic)، فإن خدمات المساعدة اللغوية المجانية متاحة لك. الرجاء الاتصال على رقم الهاتف المجاني الموجود على ّ معرف العضوية.

ATTENTION : Si vous parlez français (French), des services d’aide linguistique vous sont proposés gratuitement. Veuille] appeler le numéro de téléphone gratuit figurant sur votre carte d�identification.

U:$*$: -e�eli mówis] po polsku (Polish), udost�pnili�my darmowe us�ugi t�umac]a. Prosimy ]ad]woni� pod be]p�atny numer telefonu podany na karcie identyfikacyjnej.

$7(Nd�2: 6e você fala português (Portuguese), contate o servioo de assistência de idiomas gratuito. Ligue gratuitamente para o número encontrado no seu cartmo de identificaomo.

ATTENZIONE: in caso la lingua parlata sia l’italiano (Italian), sono disponibili servizi di assistenza linguistica gratuiti. Per favore chiamate il numero di telefono verde indicato sulla vostra tessera identificativa.

ACHTUNG: Falls Sie Deutsch (German) sprechen, stehen Ihnen kostenlos sprachliche Hilfsdienstleistungen zur Verfügung. Bitte rufen Sie die gebührenfreie Rufnummer auf der Rückseite Ihres Mitgliedsausweises an.

注意事項:日本語(Japanese)を話される場合、無料の言語支援サービスをご利用いただけます。健康保険証に記載されているフリーダイヤルにお電話ください。

This document applies to commercial group and student health plan members of UnitedHealthcare.

Insurance coverage provided by or through UnitedHealthcare Insurance Company or its affiliates. Administrative services provided by UnitedHealthcare Insurance Company, UnitedHealthcare Services, Inc. or their affiliates. Health Plan coverage provided by or through a UnitedHealthcare company. OptumRx is an affiliate of UnitedHealthcare Insurance Company. UnitedHealthcare® is a registered trademark owned by UnitedHealth Group Incorporated. All other trademarks are the property of their respective owners.

4/21 ©2021 United HealthCare Services, Inc. WF4331172-K 2021 Prescription Drug List — Traditional 4-Tier